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Abstract 
The aim of this study was to. further elucidate the mechanisms whereby growth 
.. 
. hormone (GH) exerts its ~hronic effect on adipose tissue metabolism, and in particular 
the effects of GH on lipolysis. Previous studies had shown that turnout necrosis factor 
alpha (TNFa.) chronically increases basal lipolysis in rat epididymal cidipocytes: an 
effect that is similar to that of GH. Other research had implicated a protein with a half-
life of less than 3 hours in the regulation of lipolysis and lipogenesis by GR. This led 
to the investigation if TNFa. might be this putative protein involved in mediating the 
chronic metabolic effects of GH. Initial studies used ovine adipose tissue explants. 
TNFa. caused a small increase in basal lipolysis and attenuated insulin effects on 
lipogenesis. However, the effects ofTNFa. were smaller than those ofGH and TNFa. 
did not appear to mimic the effects of GH on isoproterenol-stimulated lipolysis in this 
system. Therefore TNFa. was not the protein involved in GH regulation of lipolysis 
and lipogenesis. 
Previous studies in the laboratory on the mechanism of GH action had used inhibition 
of signal transduction components in an ex.plant system. More specific effects could be 
observed by using an antisense approach, but this required the use of a cell culture 
system rather than adipose tissue explants. The suitability of an ovine cell culture 
system was established for investigating the molecular basis of the lipolytic effects of 
GH; in particular the inhibitory effects of GH on adenosine inhibition of lipolysis. The 
lipolytic system partially developed in primary ovine adipocytes, but the antilipolytic 
system did not appear. to develop. However, by. manipulating the differentiation 
conditions, I significantly improved both cell differentiation and the lipolytic response 
and sensitivity to isoproterenol, but there· was no improvement in response to 
adenosine. As an alternative, the suitability of the murine cell line, 3T3-F442A, was 
.. . 
investigat.ed ·for determining the molecular basis of the lipolytic effects of GH. 
However, although the lipolytic system did· develop in differentiated 3T3-F442A 
adipocytes and response to isoproterenol was observed, the antilipolytic system did not 
appear io develop either. This line of investigation was not pursued further. 
Therefore, I decided to investigate the effects of GH and insulin on the lipogenic 
system in 3T3-F442A adipocytes i.nstead, with a view to extending previous 
observations by others (Millar, 1998) in the laboratory on the roles of specific isoforms 
of protein kinase C (PKC) on the modulation of lipogenesis by insulin and GH. The 
main objective was to determine the role of PKC isoforms in the modulation of the 
effect of insulin and GH on activation' and expression (mRNA) of the lipogenic enzyme 
. acetyl CoA carboxylase (ACC). However, the effect of the hormones on lipogenesis, 
and especially ACC, was considered to be too small to investigate the roles of specific 
PKC isoforms, despite trying many different ways of improving the hormone effects. 
A possible explanation for the poor response to insulin was that the lipogenic system 
was not "switching off' in the absence of insulin, so isoproterenol was added to the 
3T3-F442A adipocytes to decrease lipogenesis. Isoproterenol did reduce the rate of 
lipogenesis, but the effect of insulin was still small. Therefore, modulation of the effect 
of specific phosphodiesterase (POE) isoforms on lipogenesis was explored as an 
alternative. The use of specific POE inhibitors showed that both POE3 and PDE4 
enzymes were involved in the modulation of lipogenesis in 3T3-F442A adipocytes. 
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CHAPTER ONE 
INTRODUCTION 
1.1 General 
White adipose tissue occurs in a number of distinct depots throughout the body, at 
least some of which have' specialised roles. Adipose tissue is important in internal 
metabolism, especially in relation to storage and mobilisation of fatty acids. Both the 
amount. and the topographical localisation of the adipose tissue seem to be of 
importance for the health consequences of obesity. Reserves of lipid in adipose tissue 
have a 'vital role in mammalian physiology, and are particularly important for 
successful lactation in most species, including domestic ruminants in which milk yield 
increases initially more rapidly than food intake (Bauman & Currie, 1980). This 
results in a transient period of negative energy balance, when use of reserves of stored 
nutrients becomes very important (Vernon & Flint, 1984). Lipolysis (hydrolysis of 
. . . 
triglycerides to fatty acids) is increased during lactation due to changes in the 
concentrations of acutely acting factors, and in the ability of adipocytes to respond to 
them. Decreased lipid synthesis (esterification of fatty acids to triglycerides) in 
addition to enhanced lipolysis leads to substantial loss of adipose tissue lipid reserves 
during lactation (Chilliard 1987; Vernon, 1989; McNamara, 1991). The factors 
responsible have not been fully.resolved, but insulin and growth honnone have been 
implicated in ruminants, and insulin and prolactin in rats and other laboratory species 
(Chilliard 1987; Vernon, 1989; McNamara, 1991). 
Obesity is strongly linked with insulin resistance, and is a major cause of morbidity in 
the developed world (Reaven, 1988; DeFronzo et al., 1992). Therefore, factors 
regulating adipose tissue metabolism have been investigated with increasing 
enthusiasm over the past two decades. 
1.2 Adipose tissue 
In lower vertebrates such as fish and most amphibians and reptiles, adipose tissue 
occurs in a few large depots in the abdomen. There, it can undergo extensive changes 
in mass without affecting the position of the animal's centre of gravity (Pond, 1978). 
Fish, amphibians and reptiles are all poikilotherms, and so have relatively low energy 
requirements, thus they need only limited amounts of adipose tissue. The evolution of 
homeotherms greatly increased the energy requirements of animals, so in mammals 
we find . large amounts of white adipose tissue. Thus, a highly developed adipose 
tissue system is characteristic of all lllammalian species (pond, 1984). The major 
form of adipose tissue in adult mammals is white adipose tissue, which is found in 
distinct sites throughout the body and is located mostly in the abdominal cavity, under 
the skin (subcutaneous depots) or within the musculature (inter- and intra-muscular 
depots) (pond, 1992). In some animals, adipose tissue can constitute as much as 50% 
of the body weight, and in some grotesquely obese humans it can be even higher (Flint 
& Vernon, 1993). Obesity is characterised by an increased fat mass and occurs when 
the intake of food exceeds the energy requirement of the body for a sustained period 
(Spiegelman, 1996). In all mammals, there is very little variation in the pattern of 
distribution of fat depots, and appears to have occurred early in mammalian evolution 
(Pond & Mattacks, 1985). 
Mature adipocytes are the main cellular component of white adipose tissue, and are 
uniquely equipped to function in energy storage and balance under tight hormonal 
control. Mature adipocytes make up approximately 25% of the cell population, and 
are formed from precursor cells which proliferate and differentiate into mature 
adipocytes (Ailhaud et al., 1992; Flint & Vernon, 1993; Gregoire et al., 1998), but 
2 
adipocytes themselves do not divide., The stromal-vascular fraction of adipose tissue 
contains endothelial cells, mast cells and blood cells, as well as these precursor cells at 
different stages of development (Flint & Vernon, 1993), which can be induced to 
proliferate and differentiate in vitro in chemically defmed media. 
The main, but not only, function of white adipose tissue is uptake, storage and 
controlled releas'e of lipids, which are all processes that can involve large and rapid 
changes in tissue mass. An additional role that adipose tissue plays is that of 
insulation. For example, in both reindeer and polar bears, it has been shown that after 
, , 
intensive feeding and rapid fattening during the brief arctic summer and autumn, the 
subcutaneous depots enlarge disproportionately, and may become more than lOOmm 
thick over the rump and hind-quarters (Pond et al., 1993). Their findings suggest that 
all the skin-side of the adipose tissue is normally cooler than the inner side, as 
expected on the insulation hypothesis, and that the composition of the storage lipids is 
adapted to this situation. However, the theory that subcutaneous adipose tissue is for 
insulation is not always the case, as in most land animals and ducks this fat is the fIrst 
to be utilised in conditions of po?r nutrition (see Flint & Vernon, 1993). Adipose 
. 
tissue that surrounds vital organs may also serve as protection. It has also been 
suggested that cardiac and some intermuscular adipose tissue depots may playa 
critical, localised role in providing fatty acids as a source of fuel for adjacent muscle 
fibres (Marchington et al., 1989). Adipose tissue plays a role in buoyancy in many 
species of fIsh. 
Several lines of evidence indicate that adipocytes can function as endocrine cells, 
releasing not only fatty acids, but also a variety of bioactive peptides (Flier, 1995) and 
3 
other factors (Richelson, 1992; Mohamed-Ali et ai., 1998). Production of such 
secreted signalling molecules varies between adipocytes in different adipose tissue 
depots. For ,example, leptin, the adipocyte-specific product of ob gene that plays a 
major role in the control of body weight in rodents (Zhang et ai., 1994), is expressed 
more in the adipocytes from the subcutaneous depots than abdominal depots (Hube et 
ai., 1996; Montague et ai.,' 1997). Adipose tissue is also important for the immune 
system.' Immune system-related proteins produced by adipocytes include adipsin, 
adipocyte complement-related protein (Acrp30/AdipoQ), tumour necrosis factor alpha 
(TNFa.) and macrophage migration ~bitory factor (MIF); leptin ~s also required for 
efficient functioning of the immune system (Lord et ai., 1998). Vasoactive peptides 
that are secreted by adipocytes include angiotensinogen and plasminogen activator 
inhibitor type 1 (P AI-I), and white adipose tissue contains all the main components of 
the renin-angiotensin system (Jonsson et ai., 1994). Angiotensinogen could playa 
role in regulating adipose tissue blood supply and fatty acid efflux from fat (Frederich 
et ai., 1992), while PAI-l may be involved in the development of vascular diseases 
associated with abdominal obesity (Alessi et ai., 1997; Lundgren et ai., 1996; 
Shimomura et ai., 1996). 
The other type of adipose tissue is brown adipose tissue. This is more prevalent in 
young animals, and has, an important role in heat production by non-shivering 
thennogenesis. It is typically found in a small number of defined depots (Himms-
Hagen, et ai., 1972) and has dense blood and nerve supplies (Fawcett, 1952; Ballard, 
1974), as well as large numbers of mitochondria and the protein thennogenin (Cannon 
et ai., 1982). These differences, as well as others found between white and brown 
adipose tissue, indicate the major functional distinction between these tissue. 
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However, this proj~ct was concerned with· white adipose tissue, so all following 
information will focus.on white adipose tissue only. 
1.2.1 Adipose tissue development 
In most species, white adipose tissue forms before birth. This has been assessed by 
morphological studies performed on human, pig, mouse and rat embryos (Desnoyers 
& Vodovar, 1977; Poissonnet et al. J 1983; Poissonnet et al. J 1988; Slavin, 1979). 
White adipose tissue expansion takes place rapidly after birth as a result of increased 
fat cell size, as well as an increase in adipocyte cell number. The potential to generate 
new fat cells persists even at the adult stage. 
Several studies on multi potent clonal cell lines have suggested that adipocyte lineage 
derives from an embryonic stem cen precursor with the capacity to differentiate into 
the mesodermal cell types of adipocytes, chondrocytes, osteoblasts and myocytes. It 
has been shown that treatment of a murine embryonic cell line C3HI0T1I2 with a 
demethylating agent induces areas of muscle, cartilage and fat cells (Konieczny & 
Emerson, 1984; Taylor & Jones, 1979), and so the C3HI0T1I2 cell line may represent 
multipotential stem cells that are blocked at the mesodermal pathway. 
For the past two decades, in vitro systems have been extensively used to· study 
adipocyte differentiation. Various pre-adipose cell lines and primary cultures of 
adipose-derived stromal vascular cells have been used from rats (Bjorntorp et al. J 
1980; Deslex et al. J 1987; Wiederer & Loffier, 1987; Sztalryd et al. J 1989, 1991; 
Gregoire et al. J 1990; Kirkland et al., 1990, 1996; Sztalryd & Faust, 1990; Wabitsch 
et al., 1996), pigs (Hausman et a1., 1992), humans (Hauner et al. J 1988; Hauner & 
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Entenmann, 1991) and sheep (Soretet al., 1999). Pre-adipose cell lines, as well as 
primary pre-adipocytes; are already committed solely to the adipocyte lineage, 
although they' may represent different' stages of adipocyte development. The most 
frequently used cell lines are 3T3-Ll and 3T3-F442A. These were clonally isolated 
from S~ss 3T3 cells derived from disaggregated 17 to 19 day mouse embryos (Green 
&.Meuth, 1974; Green & Kehinde, 1975; Green & Kehinde, 1976). Ob1771 cells 
from dedifferentiated adipocytes have also been utilised to study adipocyte 
differentiation (Doglio et ai., 1986). However, most of the mechanisms that have 
been elucidated have been found using .these cell lines. 
The committed pre-adipocyte maintains the capacity for growth, but has to withdraw 
from the cell cycle (growth arrest) before adipocyte conversion.' Acquisition of the 
adipocyte phenotype is characterised ·by chronological changes in the expression of 
numerous genes during adipocyte differentiation, which take place mainly at the 
transcription level, although post-transcriptional regulation occurs for some adipocyte 
genes (Wilkison et al., 1990; Moustaid & SuI, 1991). As well as the activation of 
genes, those genes that are inhibitory to adipogenesis are repressed. Two transcription 
factors, CCAAT/enhancer binding protein alpha (CIEBP-a) and peroxisome 
proliferation-activated receptor gamma (pPAR-y) have been shown to transactivate 
adipocyte specific genes .. PP AR-y is largely adipocyte-specific, and is expressed at 
low but detectable levels in pre-adipocytes. Its expression' rapidly increases after 
hormonal induction of differentiation, and maximum levels of expression are attained 
in mature adipocytes (Brun et al., 1996; Chawla & Lazar, 1994). Both CIEBP-a and 
PP AR-y also appear to be involved in the growth arrest that is required for adipocyte 
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differentiation (Umek et al., 1991; Timchenko et al., 1996; Altiok et al., 1997). After 
growth arrest at confluence, pre-adipocytes must receive an appropriate combination 
of mitogenic ,and adipogenic signals to continue through subsequent differentiation 
steps. Studies on pre-adipose cell lines have shown that growth-arrested cells undergo 
at least ?ne round of DNA replication and cell doubling. This has been proposed to 
lead to the cional amplification of committed cells (pairault & Green, 1979). During 
adipocyte differentiation, cells convert from a fibroblastic to a spherical shape, and 
dramatic changes occur in cell morphology, cytoskeletal components, and the level 
and type of extracellular matrix (ECM) components. Decrease in actin and tubulin 
, , 
expression is an early event in adipocyte differentiation that precedes overt changes in 
morphology and the expression of adipocyte-specific genes (Spiegelman & Farmer, 
1982). These changes in cell shape reflect a distinct process in differentiation, and are 
not the result of accumulated lipid ,stores. It is likely that these changes could 
influence the expression and action of PP ARs and CIEBPs during adipocyte 
differentiation. A switch in collagen gene expression is also an early event of 
adipocyte differentiation (Aratani & Kitagawa, 1988; Weiner, et al., 1989; Darimont 
et al., 1994). During the termi~al phase of differentiation, adipocytes in culture 
greatly increase de novo lipogenesis and acquire sensitivity to insulin. The activity, 
protein and mRNA levels for enzymes involved in triacylglycerol metabolism increase 
up to 1 DO-fold (Spiegelman et al., 1983; Paulauskis & Sul, 1988; Weiner et al., 1991). 
Adrenergic and insulin receptor numbers increase (Lai et al., 1982; Feve et al., 1990; 
Guest et al., 1990; Feve et al., 1991), as well as the number of glucose transporters 
(Garcia de Herreros & Birnbaum, 1989). and the adipocytes also synthesise other 
adipose tissue-specific products (Spiegelman et al., 1983; Bemlohr et al., 1984; 
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Greenberg et al., 1993; Ibrahimi et al., 1996;Sfeir et al., 1997) and produce a number 
of secreted products. 
It. is generally accepted that mature, lipid-filled adipocytes that have progressed 
beyond a specific stage in adipocyte differentiation are committed to subsequent 
terminal differentiation, and can neither dedifferentiate nor enter mitosis (Wier & 
Scott, 1986; Wang & Scott, 1993). However, the precise stage beyond which 
adipocytes can be considered terminally differentiated is not clearly defined, and the 
progressive dedifferentiation of mature adipocytes followed by cell division has also 
. . 
been reported (Sugihara et al., 1986). 
1.2.2 Adipose tissue metaholism 
Food energy in animals is stored primarily as triacylglycerols in lipid storage droplets 
of adipocytes. The important features of adipocyte metabolism are the synthesis, 
storage, and subsequent hydrolysis of these triacylglycerols, and the relative rates of 
their synthesis and breakdown detennine the amount of lipid within the adipocyte. 
The fatty acids required for triglyceride esterification within the adipocytes are 
provided by lipogenesis (de novo synthesis) or by the triacylglycerols of very low 
density lipoproteins (VLDL) and chylomicrons. Lipoprotein lipase (LPL) is secreted 
by adipocytes and is transported to the endothelial cells lining the capillaries and 
attaches to the outer surface of the plasma membrane facing the lumen of the 
capillary. LPL hydrolyses the triglycerides of plasma chylomicrons and VLDL. It is 
thought that transport into the cell of resulting fatty acids and monoglycerols is 
facilitated by a fatty acid translocase located in the plasma membrane (Scow & 
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Blanchette-Mackie, 1985). LPL activity (Haugebak et aI., 1974; Lee & Kauffman, 
1974; Savard & Greenwood, 1988; Rebuffe-Scrive et al., 1989; Bjomtorp et aI., 1990) 
and the rate of lipogenesis (Lee & KaUffman, 1974; Whitehurst et al., 1981; Fried et 
al;, 1982) vary between adipose tissue depots in ruminants, rats, pigs and humans. 
The total rate of lipid accumulation is also dependent on the rate of lipolysis. The 
mobilisation of fatty acids is catalysed by the enzyme hormone sensitive lipase (HSL), 
and is under complex acute and chronic endocrine control 01 emon, 1992). Lipolysis, 
and its response to catecholamines, i~ also reported to vary between adipose tissue 
depots in rats (Hartman & Christ, 1978), dogs (Berlan et al., 1982) and humans 
(Rebuffe-Scrive et al., 1989). 
1.2.3 Lipogenesis 
The rate oflipogenesis (fatty acid synthesis) is regulated by a number of enzymes, the 
most important of which is acetyl CoA carboxylase (ACC) which is subject to both 
chronic (gene expression) and acute control. ACC exists in both active and inactive 
states, with insulin and catecho~amines causing an increase and decrease in the 
activation status of the enzyme, respectively. Insulin also acts chronically to increase 
gene transcription and, therefore, the amount of ACC 01 emon, 1992). ACC catalyses 
the conversion of acetyl CoA to malonyl CoA 01 emon, 1992), and fatty acid 
synthetase (F AS) converts malonyl CoA to fatty acids. Acetate, glucose and possibly 
lactate are the most important precursors of acetyl CoA, but it can also be produced 
from a number of amino acids. There are certain basic differences between ruminants 
and non-ruminants with regard to fatty acid synthesis. The major precursor for 
lipogenesis in adipose tissue is glucose in non-ruminants (Ballard et al., 1969), 
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whereas acetate rather than glucose has been shown to be the principle precursor in 
adipose tissue from ruminants such as sheep, cattle and goats (Ingle et at., 1972; 
Whitehurst eta/., 1978; Liepa et al., 1978). 
NADP~ is also required for lipogenesis, and can be derived from three systems; 
glucose..;6-phosphate and 6-phosphogluconate dehydrogenases, malic enzyme and 
NADP-isocitrate' dehydrogenase. Isocitrate dehydrogenase has special importance in 
ruminants (Vernon, 1980), whilst the importance of the others varies with species. 
1.2.4 Lipolysis 
White adipose tissue metabolism also involves the hydrolysis of triacylglycerols to 
glycerol and free fatty acids in the process termed lipolysis, and is under complex 
acute and chronic endocrine control (Vernon, 1992). Some of the fatty acids released 
from ester linkage are re-esterified, and are retained in the cell. The rate of lipolysis 
can be measured by glycerol release, as adipocytes are deficient in the glycerol kinase, 
and so glycerol produced by lipolysis cannot be phosphorylated and used for re-
esterification (Margolis & Vaugh~, 1962). 
Adipocytes possess both <X2- and ~-adrenergic receptors (Vernon & Sasaki, 1991). 
Lipolysis is stimulated acutely by catecholamines acting via the ~-adrenergic receptor 
and glucagon acting via the glucagon receptor, and inhibited by adenosine acting via 
the adenosine Al receptor, and also catecholamines acting via the <X2-adrenergic 
receptor. Responsiveness to the acutely acting factors is modulated by steroid and 
thyroid hormones, and by GH (Vernon 1992). 
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Binding of catecholamines to the~-adrenergic receptor in the plasma membrane 
causes activation and dissociation of the heterotrimeric OTP-binding protein, Os. This 
in turn causes activation 'of adenylate 'cyclase (AC) which catalyses the synthesis of 
cAMP from ATP; cAMP activates protein kinase A (PKA). cAMP 
phosph?diesterases modulate the concentration of cAMP by degrading it to AMP 
(Bolger~ 1994; Beavo, 1995). Insulin activates cAMP phosphodiesterases and so 
decreases cAMP levels (Conti et al., 1991; Manganiello, 1995). The rate-limiting 
enzyme; hormone-sensitive lipase (HSL), can be phosphorylated and activated by the 
cAMP-dependent PKA, so changes. in both adenyl ate cyclase, (AC) and cAMP 
phosphodiesterase activities modulate the rate of lipolysis (Belfrage, 1985). It has 
been observed that, on lipolytic stimulation, HSL translocates from the cytosol to its 
substrate on the surface of the lipid storage droplet (Egan et al., 1992). Perilipins are a 
family of proteins found tightly bound to the limiting surface of the lipid droplet, and 
are acutely phosphorylated by PKA upon lipolytic stimulation. It has been suggested 
that both HSL and perilipin redistribute during lipolysis, and that perilipin may serve a 
role by acting as a barrier to deny access of HSL to its lipid substrate in unstimulated 
adipocytes (Clifford et al., 1997) .. HSL hydrolyses triacylglycerides by cleaving two 
molecules of fatty acids. The resulting mono glycerol is hydrolysed to glycerol and 
fatty acid by monoacylglycerol lipase 01 emon, 1992). The rate-limiting step is 
thought to be the cleavage of the fIrst fatty acid moiety by HSL, while 
monoacylglycerol is normally present in trace amounts in the tissue as 
monoacylglycerollipase is very active 01 emon, 1992). 
AC activity can be regulated by both stimulatory and inhibitory receptors, which exert 
their actions through the heterotrimeric O-proteins, Os and OJ, respectively. 0-
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proteins comprises an (X-subunit, together with p- and y-subunits. Activation of a 
heterotrlmeric G-protein by an agonist-liganded receptor results in exchange of bound 
GDP for Gn> at the binding site present in the (X-subunit, and dissociation of the py 
complex. The active (X-subunit is then able to interact with the catalytic subunit of AC 
(Levitzki, 1990), and eIther stimulate or inhibit its activity, which in turn causes an 
increase or decrease in the rate of lipolysis. The dissociated py complex from Gi 
possibly' also binds to Gsa subunits, therefore also inducing the inhibition of AC 
(Levitzki, 1990; Birnbaumer, 1992; Tang & Gilman, 1992). Adenosine (Vernon et 
al., 1991) and prostaglandin E (pGE) (Richelsen, 1992) are produced in adipose 
tissue, and act via their own receptors to inhibit lipolysis. Catecholamines can also 
inhibit lipolysis by this mechanism by acting via the (X2-receptor. Therefore, the 
activity of HSL at· any time is thus determined by the balance struck between 
stimulatory and inhibitory agonists (Rodbell, 1980). 
1.2.5 Hormonal regulation of adipose tissue metabolism 
Adipocyte metabolism is regulated both acutely and chronically by a number of 
hormones and other factors. Lipolysis in adipose tissue is under complex acute 
control (Vernon, 1992) by both stimulatory (catecholamines, glucagon) and inhibitory 
(insulin, adenosine, prostaglandins, fatty acids) factors. Growth hormone (GH), 
glucocorticoids, sex steroids and thyroid hormones chronically control the ability of 
these acute factors to influence the rate of lipolysis. 
GH acts chronically to increase lipolysis and decrease lipogenesis by altering the 
ability of adipose tissue to respond to acute endocrine and other signals, but it also 
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seems to have some conflicting actions. GH can exert an acute, transient, insulin-like 
effect in laboratory species (Goodman et ai., 1987; Vernon & Flint, 1989), although 
the physiological significance of this is' unclear as the conditions required (absence of 
the honnone for a period of several hours) are. unlikely to occur in vi.vo. It has also 
been suggested that GHcan have an acute lipolytic response in some species, although 
this has -not been completely resolved; GH does not appear to have an acute lipolytic 
effect in ·runiinarits and pigs (Boyd & Bauman, 1989; Vernon & Flint, 1989; Etherton 
& Smith; 1991) .. 
Although the effects of GH on many tissues are mediated via insulin-like growth 
factor-I (iGF-n, this is not the case for adipocytes, where GH exerts its effects directly 
via its cell sUrface receptor (Vernon & Flint, 1989). GH decreases the rate of 
lipogenesis in adipocytes in vivo by suppressing the transcription of acetyl CoA 
carboxylase (ACC) (Bauman & Vernon, 1993) and fatty acid synthase (FAS) (Harris 
et aI., 1993) mRNA. The activities of ACC and FAS are also decreased after chronic 
. GH treatment of adipose tissue oradipocytes in vitro (Dietz & Schwarz, 1991; 
Bauman & Vernon, 1993; Vemo~ et al., 1993). GH also inhibits the activation of 
, . 
ACC by insulin by possibly inhibiting the synthesis of a protei.n required for the 
mediation of the insulin-induced activation of the enzyme (Vernon et ai., 1991). 
Chronic treatment with GH suppresses the ability of fat cells to respond to insulin in 
the absence of any change in their capacity to bind the honnone (Foster et al., 1988). 
The insulin-antagonistic effects of GH may be important in the development of insulin 
resistance, which is associated with obesity and diabetes mellitus (Fowelin et al., 
1991). 
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Glucocorticoids hav~ been shown. ,to mcrease ~-adrenergic receptor number, but 
decrease maximum AC activity in rats (Giudicelli et al., 1989; Ros et al., 1989). 
Dexamethasone, a glucocorticoid analogue, has also been shown. to increase the 
response and sensitivity to the ~-agonist, isoproterenol, and decrease maximum AC 
activity, in sheep adipose tissue (Finley et al., 1990). Prolonged' exposure to 
dexamethasone also increases the response to <l2-adrenergic agents and to adenosine 
in sheep' adipose tissue (Vernon et al., 1991b). Hypothyroidism in rats has been 
shown. to decrease the response to ~-agonists, and increase the response to adenosine 
and prostaglandin E2 (Malbon et al., .1988; Vernon et a/., 1991a). The effects of 
adenosine and prostaglandin E2 were fOWld to involve an increase in Gi activity, and 
were not due to receptor level changes (Malbon et al., 1988; Milligan & Saggerson, 
1990). Hyperthyroidism in rats increased the response to ~-agonists and decreased the 
response to adenosine, due to a decreaSe in adenosine receptor number (Malbon et al., 
,1988). 
,Insulin is the major anabolic hormone of the body (Vernon & Flint, 1989),promoting 
lipid synthesis and inhibiting lipolysis in adipose tissue, as well as increasing glucose 
I , 
transport and the uptake of other metabolites. Insulin decreases the rate of lipolysis 
partly by activating a cyclic AMP phosphodiesterase. There is at least one more 
mechanism involved in the decrease of lipolysis by insulin, and this probably involves 
the activation of protein phosphatase 2A, resulting in the dephosphorylation of HSL 
(Yeaman, 1990). It is well established that incubation of adipose tissue with insulin 
markedly increases the rate of fatty acid synthesis. This involves a series of changes 
depending on the serum, including enhanced glucose transport and activation of 
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enzymes such as pyruvate dehydrogenase and acetyl CoA carboxylase. Chronically, 
insulin causes an increase in the gene expression of lipogenic enzymes. In ruminant 
animals, in which acetate is the major precursor of fatty acids, activation of ACC is of 
particular importance in the overall control of lipogenic processes .. Increased total 
ACCactivity and the proportion of the enzyme in the active state is ·also observed 
after chronic incubation with insulin (Vernon et at., 1991). The signalling pathways 
of insulin are described in section 1.5. 
1.3 Growth hormone 
Growth honnone (GH) is a member of a protein family which also includes prolactin 
and placental lactogen. These genes are believed to have evolved from a common 
ancestral gene . (Miller & Eberhardt, 1983). GH, also known as somatotropin, is 
synthesised and secreted by the anterior pituitary gland. The secretion of GH from the 
pituitary gland is regulated by two peptides; growth honnone-releasing factor, which 
stimulates release, and somatostatin, which inhibits its release (page et al., 1989) 
GH isolated from various vertebrate species has been shown to possess highly 
conserved structural features (Miller & Eberhardt, 1983; Nicoll et al., 1986; Watahiki 
et aI., 1989). It is a single chain peptide honnone of 191 amino acids (Wallis, 1989), 
and is "species specific". (for review, see Bauman &Vernon, 1993). Human GH 
(hGH) and bovine GH (bGH) have only 65% homology, arid so bGH cannot bind . 
effectively to the human GH receptor (Wallis, 1989). Ovine GH (oGH) and bGH only 
differ by one amino acid however, and so bGH is biologically active in sheep. bGH 
has four naturally produced variants. Recombinant bGH's have extra amino acids at 
the N-tenninus, but are similar to bGH biologically (Bauman & Vernon, 1993). 
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1.3.1 Growth hormone and lipid metabolism 
Downs (1930) and Bierring and Nielson (1932) were first to show that an alkaline 
extract of the anterior pituitary gland reduced carcass fat in rats. This was verified by 
Lee and Schaffer (1934), who reported that pair-fed rats injected with, a crude alkaline 
extract of bovine pituitaries not only gained more weight, but also contained 
proportionally more muscle and les~ fat. This introduced the idea that GH and the 
metabolism' of lipids were related. In 1945, GH was isolated and purified from the 
anterior pituitary (Li et al., 1945), which led to the first experiments to be conducted 
to show that crude preparations of GH could reduce carcass fat in rats (Li et al., 1948). 
. ' 
Later studies also gave backing to the fact that prolonged treatment of rats with 
preparations rich in GH decreased the amount of body fat (Goodman & Schwarz, 
1974; Rao &' Ramachandran, 1977), while the availability of recombinant GH has 
shown similar effects in ruminants (aart & Johnsson, 1986; Boyd & Bauman, 1989; 
Bauman, 1992; Steele & Evock-Clover, 1993). 
GH is thought to be a homeorhetic hormone regulating the partitioning of absorbed 
nutrients between different tissll:es and organs. For example, in ruminants treated with 
GH, it causes a large increase in milk production which needs different physiological 
processes involving the metabolism of nutrients in a number of tissues to be modified 
(Bauman & Vernon, 1993). This effect of GH on milk production, as well as it 
increasing growth in animals and decreasing adiposity, has made (recombinant) GH 
important commercially. 
GH affects many differen.t organs within the body, both directly and indirectly. The 
direct actions of GH are primarily concerned with nutrient partitioning. The indirect 
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GH effects are exerted via IGF's (insulin-like growth factors) produced either locally 
or released into the ci~culation by the liver. GH can have acute insulin-like effects on 
cell metabol~sm (a minor'effect of GH treatment) or chronic effects, promoting linear 
growth, cellular proliferation and differentiation, along with diabetogenic effects on 
metabolism. 
1.3.2 Effed of growth hormone on lipolysis 
As previously stated, it is well established that GH is important not only for linear 
growth, but also for adipocyte differentiation and energy metabolism in both animals 
and man. GH treatment of GH-deficient adults reduces the abdominal fat mass and 
decreases fat cell size (Rosenbaum et al., 1989; Martin et al., 1989). It is not yet fully 
understood how these effects of GH on adipocyte cells are' mediated. Chronic 
exposure to GH in vivo has been sho,wn to increase plasma free fatty acids, to inhibit 
the conversion of glucose into lipid and to decrease the lipid content of adipose tissue 
(Goodman & Schwarz, 1974). However, the in vitro effects of GH on lipid 
metabolism, particularly on lipolysis, have been controversial. Pituitary GH was 
shown to be lipolytic in isolat~d adipose tissue or adipocytes, but this required the 
presence of the glucocorticoid, dexamethasone (Fain et al., 1965; Goodman, 1968a). 
Acute incubation with GH was then shown to potentiate other lipolytic stimuli in rat 
adipose tissue, such as epinephrine or theophylline (Goodman, 1968b; Goodman, 
1968c), suggesting that GH modulated other lipolytic stimuli" rather than acting as an 
initiator of lipolysis (Goodman & Schwarz, 1974). Highly purified pituitary GH 
preparations of human GH (hGH) of recombinant DNA origin failed to show lipolytic 
activity (Frigeri, 1980 ;' Frigeri et al., 1982; Bowden et al., 1985), suggesting that 
contaminants in pituitary GH preparations possessed the lipolytic activity rather than 
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GH. However, later studies indicated that these same GH preparations were lipolytic 
in vitro in rat adip~se tissue in the presence of dexamethasone (Goodman & 
Grichting, 1?83; Goodman, 1984) .. Pituitary and hGH had comparable lipolytic 
activity in chicken adipose tissue (Campbell & Scanes; 1985), and were also reported 
to be lipolytic when administered to hypopituitary children (Van Vliet et al., 1987), 
showing the" importance of.the action. of GH in overall metabolic regulation in humans 
as well as showing the intrinsic lipolytic activity ofhGH. 
Chronic treatment with bGH in vivo increases the lipolytic response of adipose tissue 
to catecholamines in vitro in rats (Vernon et al., 1987) and sheep, and in vivo in cows 
(McCutcheon & Bauman, 1986; Peters, 1986; Sechen et al., 1990). In vitro studies of 
chronic GH incubation with sheep adipose tissue explants also increased the response 
and sensitivity to the ~-agonist, isoprenaline, and increased ligand binding to the ~­
adrenergic receptor (Watt et al., 1991). Other studies (Vernon et al., 1993) suggest 
that GH enhances lipolysis by increasing the amount of HSL activity associated with 
the lipid droplet. 
However, chronic treatment with GH in vivo has no effect on the lipolytic response to 
catecholamines in vitro in bovine adipose tissue (Peters, 1986; Lanna et al., 1992), 
which raised the possibility that the major effects of GH may be on the antilipolytic 
system. Chronic treatment with bGH in vivo reduces the response to the antilipolytic 
effects of the adenosine analogue PIA in rat tissue (Doris et al., 1994; Vernon et aL, 
1987), sheep adipose tissue (Doris et al., 1996) and bovine tissue (Lanna et al., 1992) 
in vitro, while chronic ctiIture of sheep adipose tissue explants with GH decreases the 
response to both adenosine (PIA) and <l2-agOnists (Vernon et al., 1991b; Doris et al., 
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1996, 1998). The effect of GH seems to involve a break in the coupling between the 
inhibitory protein Gj and AC (Doris et al., 1998). Thus, it seems that GH is able to 
modulate si~allingthrough both the lipolytic and antilipolytic systems. 
1.3.3 . Effect of growth hormone on lipogenesis 
GH can have both insulin-antagonistic and insulin-like effects on lipogenesis. The 
insulin-like effects are acute and include accelerated transport and metabolism of 
glucose (Goodman, 1965; Goodman, 1966). The molecular basis of this insulin-like 
effect has not been fully elucidated, but GH can increase tyrosine phosphorylation of 
insulin receptor substrate-l (IRS-I) (Souza et al., 1994); a very early step in the 
insulin signal transduction system (Quon et al., 1994; White & Kahn, 1994). After a 
period of 2 hours, the insulin-like effects of GH are lost and the chronic, insulin-
antagonistic, anti-lipogenic and lipolysis-enhancing effects start to appear (Goodman 
et al., 1987; Gocidman, 1993). However, the insulin-like effect of GH is only seen if 
the adipose tissue has not been exposed to GH for a period, so the physiological 
significance is uncertain. This. acute insulin-like effect of GH is not seen in sheep 
adipose tissue 01 ernon, 1996). 
It has been well documented that GH acts chronically to decrease the rate of 
lipogenesis, and to antagonise insulin stimulation of lipogenesis in adipose tissue from 
various species, both in vivo and in vitro (Nyberg & Smith, 1977; Vernon, 1982; 
Walton & Etherton, 1986; Etherton et al., 1987). This is due at least in part to growth 
honnone suppressing the transcription of acetyl CoA carboxylase (ACC) (Bauman & 
Vernon, 1993) and fatty acid synthase (FAS) (Harris et al., 1993) mRNA. Decreases 
in the activities of ACC and F AS are also observed following chronic incubation of 
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adipocytes with GH'(Dietz & Schwarz, 1991; Bauman & Vernon, 1993; Goodman, 
1993; Vernon et al.,01993). GH also inhibits the activation of ACC by insulin, 
possibly by inhibiting the' sYnthesis of a protein required for mediation of the insulin-
, ' 
induced activation of the enzyme (Vemon et al., 1991). GH also increases the rate of 
lipolysis, as described above, and increased lipolysis, if resulting in an ,accumulation 
of fatty acids in adipocytes, can l~ad to decreased lipogenesis (Vernon, 1977). 
However, the signalling system involved in the chronic, insulin-antagonistic effect of 
GH on lipogenesis in adipose tissue is not known. Indeed, the system responsible for 
the insulin induction of lipogenesis itself has not been fully elucidated. 
1.3.4 Growth hormone and differentiation 
GH exerts a wide variety of actions on cellular differentiation and proliferation either 
directly or indirectly via IGF's, maiI?1y mediated by regulating the transcription of 
specific genes (Roupas & Herington, 1994). GH promotes differentiation of several 
pre-adipocyte cell lines, including 3T3-F442A cells and ob 1771 cells (Green et al., 
1985; Doglio et al., 1986). GH has been shown to induce insulin-like growth factor-l 
(IGF-l) gene expression in ob. 1771 pre-adipocytes (Doglio et al., 1987), and to 
increase the sensitivity of 3T3-F442A cells to the actions ofIGF-l (Zezulak & Green, 
1986). IGF-l cannot substitute for GH in either cell type, however (Nixon & Green, 
1984a; Nixon & Green, 1984b; Dani et al., 1990; Catalioto et al., 1992). It has,been 
shown that in 3T3-F442A pre-adipocytes, exposure to, GH is essential to 
differentiation (Yarwood et al., 1998), hence it is perceived as a "commitment factor" 
(Wabitsch et al., 1995; Hwang et al., 1997; Gregoire et al., 1998). Following 
exposure to GH, there is an increase in the number of newly differentiated cells by 
clonal expansion, mediated by the mitotic actions of IGF-l (Green et al., 1985). 
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However, GH dose not promote the differentiation of all cell types. For example, in 
the case of 3T3-Ll cells, IGF-l and insulin are required for differentiation (Smith et 
al., 1988). 
It has been shown that in 3T3-F442A pre-adipocytes, GH also alters the expression of 
various cytoskeletal proteins (Guller et al., 1992). This may be an explanation for the 
morphologicat changes observed in the initial stages of differentiation. GH also 
stimulates the transcription of early response genes c-fos and / or c-jun (Doglio et al., 
1989; Sumantran et al., 1992), which coincides with transcriptional activation of 
CIEBPo and translational activation of CIEBP~. This may contribute to GH's 
differentiation-promoting effects (Clarkson et al., 1995), although the exact 
mechanism by which GH exerts its adipogenic effects in pre-adipocytes is still poorly 
understood. 
In contrast to pre-adipocyte cell lines, GH does not appear to be needed for the 
differentiation of primary pre-adipocytes, for rat or humans (Ailhaud et al., 1992; 
Wabitsch et al., 1995) or sheep (Soret et al., 1999). Indeed, it inhibits differentiation 
(Hausman & Martin, 1989; Hausman et al., 1992; Wabitsch et al., 1995, 1996a, 
1996b; Soret et al., 1999). GH does stimulate proliferation of human pre-adipocytes 
(Hausman & Martin, 1989; Gaskins et al., 1990; Wabitsch et al., 1995; Wabitsch et 
al., 1996a), however, but this effect appears to be induced viaIGF-l (Wabitsch et al., 
1996a). 
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1.3.5 The growth hormone receptor 
Explanations of the ab~lity of one hormone to direct multiple biological effects have 
suggested the, existence of ti'ssue-specific subtypes of GH receptors (Smal et aI., 1987; 
Press, 1988) or the existence of multiple active domains within the GH molecule 
(Kostyo, 1986; Salem, '1988). The first stage in GH action involves ,binding to a 
specific, membrane-associated receptor. GH receptors have been demonstrated on 
adipocytes from' rats to man, confirming that the hormone can act directly on the 
tissue. The GH receptor has been cloned from several species including man (Leung et 
al., 1987), rat (Mathews et al., 1989), mouse (Smith et al., 1989), cow (Hauser et al., 
1990) and sheep (Adams et al., 1990). The GH receptor (GH-R) appears to be highly 
conserved in all species where it has been cloned so far, and is a single, membrane-
spanning protein of -624 amino acids. It belongs to the GH / prolactin / cytokine 
receptor superfamily (Mathews, 1991; Kelly et af., 1992), and has three domains 
(Waters et af., 1990) ; 
(1) an extracellular domain of -250 amino acids, which is very similar to the GH-
binding protein of plasma, 
(2) a short trans-membrane domain of -25 amino acids, and 
(3) an intracellular domain of -350 amino· acids which lacks intrinsic tyrosine kinase 
domains. 
The number of receptors varies with depot, sex and age (Vernon & Flint, 1989). 
A very early step in GH-R signalling is the growth hormone-induced sequestration and 
activation of a GH-R tyrosine kinase, JAK-2 (Argetsinger et al., 1993). GH binding 
has also been shown to promote dimerisation of the GH-R extracellular domain 
(Cunningham et al., 1991; de Vos et al., 1992) ; altered forms of GH that are unable to 
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cause this dimerisation are also incapable of eliciting signalling through the full-length 
cell surface GH-R (Isl?izaka-Ikeda et a/., 1993; Silva et a/., 1993). Additionally, a 
disulphide-linked fonn of the GH-R can be detected within seconds of GH binding, 
and GH-R's that are precipitable by phosphotyrosine antibodies in response to human 
GH are enriched in this disulphide-linked form (Frank et a/., 1994). These fmdings all 
indicate that" GH initiates its signal cascade by activating a protein complex including 
at least· a GH-R dimer and JAK2 in a mixture of covalent and non-covalent 
associations. 
The GH-R protein exists in two molecular mass forms; the full length receptor and a 
smaller soluble GH binding protein (GHBP), which circulates in the blood and binds 
to GH, and is homologous to the extracellular domain of the GH-R. There have been 
two mechanisms proposed for the production of the GHBP ; (1) it is due to alternative 
splicing of a single primary transcript, and (2) it is due to specific proteolysis of the 
membrane receptor. In most species, as only a single mRNA transcript (-4.5 kb) has 
been identified by Northern Blot analysis, the second mechanism has been suggested 
to explain the production of G~P. The biological functions of this GHBP remain to 
be clarified. It could act as a reservoir· for GH in the circulation. Decreased 
degradation and metabolic clearance of GH has been reported in a rat model when GH 
is bound to the GHBP (Baumann et a/., 1988). Alternatively, the binding protein 
could serve to block GH actions, preventing further binding to membrane receptors 
(Lim et a/., 1990). 
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1.3.6 Growth hormone signalling .. 
The GH induced intra~ellular signal pathway is not yet fully understood. As stated 
above, it has, been shown' both by mutational analysis and by X-ray crystallography 
that a GH molecule binds to two receptor molecules (Cunningham et al., 1991; De 
Vos et al., 1992), and that hormone-mediated receptor dimerisation is necessary for 
generation of an activated receptor (Fuh et al., 1992). The GH-R may be internalised 
following bin.ding of the ligand, but the role of internalisation in signal transduction, if 
any, is unknown (Roup as & Herington, 1989). Even though the receptor lacks an 
intrinsic tyrosine kinase domain, tyrosine phosphorylation of several proteins in 
response to GH (Tornqvist et al., 1991 ; Anderson, 1992; Campbell et al., 1993), 
including the GH-R complex (Carter-Su et al., 1989) has been reported. 
Phosphorylation of other cellular proteins may therefore be one mechanism by which 
GH transmits an intracellular signal (Wang et al., 1993). 
It has been shown that the GH-R in cells associates with a separate tyrosine kinase, 
called Janus tyrosine kinase-2 (JAK-2), which is a member of cytosolic tyrosine 
kinases. This kinase was initial~y shown in 3T3-F442A cells to be able to associate 
with the occupied GH-R, resulting in activation of JAK2 kinase and tyrosine 
phosphorylation of the GH-R (Argetsinger et al., 1993). JAK2, and the other 
members of the Janus tyrosine kinase family, has two kinase-like domains (Ihle et al., 
1994). Studies using mutated GH-R showed that the proline-rich Box 1 motif of the 
cytoplasmic domain is primarily required for the association of 1AK2 with GH-R and 
GH-dependent activation of JAK2 (Vanderkuur et al., 1994). However, the N-
terminal quarter of the cytoplasmic domain of the GH-R appears to augment the 
interaction with 1AK2. It has been suggested using mutational studies (Vanderkuur et 
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al., 1994) that at leaSt one of the tyrosyl residues present in the N-terminal half of the 
cytoplasmic domain o.fthe GH-R is phosphorylated by JAK2. JAK2 has also been 
shown to associate with' the erythropoietin receptor (Witthuhn et al., 1993), 
interleukin-3 receptor (Silvennoinen et al., 1993) and the prolactin receptor (Lebrunet 
al., 1994). 
It has been 'revealed using pre-adipocyte cell lines that at least three pathways are 
involved in' the' intracellular signalling cascades activated by GH ; activation of 
mitogen-activated protein (MAP) kinase and p90rsk (Moller et al., 1992; Anderson, 
1992) ; activation of p70S6K (Anderson, 1993) ; and activation and translocation of 
, , 
STAT -1 ~ignal !ransducers and ~ctivators of !ranscription) (Roupas & Herington, 
1994; Waters et al., 1994; IhIe & Kerr, 1995), but whether these systems are involved 
in the chronic metabolic effects of GH in mature adipocytes or not is unknown. 
STAT proteins are a family of cytosolic transcription factors, which are the products 
of multiple genes and alternative splicing. These are phosphorylated by members of 
the JAK family of tyrosine kinases (see Lamb et al., 1996). STAT proteins undergo 
tyrosine phosphorylation in th~ cytoplasm, followed by translocation to the nucleus 
where variations in the complexes formed with other transcription factors confer 
specificity of interaction with different DNA response elements (Hunter et al., 1993). 
GH phosphorylates and causes nuclear accumulation of STATlcx. (Kilgour & 
Anderson, 1994; Meyer et al., 1994). Phosphorylation of STAT 1 by GH results in the 
formation of complexes that can interact with the sis-inducible element (SIE) of c-fos 
(Meyer et al., 1994). STAT1 is a subunit of the ISGF3 complex, which comprises a 
48-kDa DNA-binding component, an 84/91-kDa protein and a 113-kDa protein, 
termed p48, p84, p91 and p113, respectively. These protein subunits of ISGF3 are 
25 
localised in the cytoplasm of unstimulated cells. Formation of the complex and its 
migration to the nucleus requires tyrosine phosphorylation of p91/p84 and p113, 
which is mediated by JAK. It has' also been suggested that GH can activate 
STAT3/APRF (acute-phase response factor) .and STAT5IMGF (mammary gland 
factor)' in a cell-specific manner (Meyer et ai., 1994; Gronowski & Rotwein, 1994; 
Campbell et 'ai., 1995; Gouilleux et ai., 1995; Thomas et ai., 1995; Leaman et ai., 
1996; Yi et ai., 1996) .. 
MAP kinases are expressed in all cells, and can be activated by hormones, growth 
. . 
factors, neurotransmitters and other cell stimuli (Anderson, 1992b). The activation of 
MAP kinase requires phosphorylation upon both tyrosine and threonine residues 
(Anderson et ai., 1990; Gomez & Cohen, 1991) by dual specificity MAP kinase 
kinases, or MEKs (Nakielny et ai., 1992; Crews & Erikson, 1992). It has been shown 
that GH induces rapid and transient activation of p44 and p42 MAP kinases and p90rsk 
in 3T3-F442A pre-adipocytes (Anderson, 1992b). To be able to activate the MAP 
kinases, GH seems to require the presence of JAK2, Ras and Raf(Winston & Hunter, 
1995). The S6 kinase, p90rs\ li~s downstream of the p42 and p44 MAP kinases, and 
. 
it has been suggested that protein kinase C (PKC) plays a role in the GH-dependent 
activation of MAP kinases and p90rsk (Anderson et ai., 1992a). 
GH also phosphorylates and activates the S6 ribosomal kinase p70S6K in 3T3-F442A 
cells (Anderson, 1993), which is involved in the regulation of translation via' 
phosphorylation of the S6 ribosomal proteins. Activation of p70S6K is via a MAP 
kinase independent pathway and is thought to involve phosphatidylinositol 3-kinase 
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(PI-3Kinase). Certain second messenger molecules also increase in response to GH 
such as diacylglycerol (DAG) (Catalioto et ai., 1990). 
The studies described above relate to GH signalling in its role as a commitment factor 
for differentiation of 3T3-F442A cells, and to a lesser extent, the acute, insulin-like 
effects of GR. The involvement of these various signalling pathways in the chronic 
effects of GH is not fully resolved, but studies with sheep adipocytes using inhibitors 
such as rapamycin and PD98059 suggest that neither p70S6K nor MAP kinase are 
involved with chronic related effects of GH (see section 1.3.3). However, anti-
lipogenic, insulin-antagonistic effects of GH appear to involve both protein serine 
kinases and phophatases (Vernon, 1996) by use of the inhibitors H7, staurosporine and 
okadaic acid. Chronic exposure to phorbol ester partly attenuated the antilipogenic 
effect of GH, suggesting the involvement of one or more isoforms of PKC (Vernon, 
1996). Studies carried out by Borland et aZ. (1994) showed that the inhibition of 
lipogenesis in sheep adipose tissue by GH required polyamines. The effects of 
polyamines include a role in gene transcription (Scalabrino et ai., 1991; Sjoholm, 
1993), activation of a number <;>f protein kinases and phosphatases (Morgan, 1990) 
and enhancing hormone binding to plas~a membrane receptors (Pedersen et ai., 
1989). Studies using actinomycin D, an inhibitor of gene transcription, implicated a 
protein with a half-life of less than 3 hours in the inhibition of lipogenesis by GH 
(Borland et ai., 1994). 
27 
1.4 Tumour necrosis/actor alpha 
The cytokine family is a large group of polypeptides which includes interleukins (IL) 
1-10, tumour. necrosis factors (lNF) (a. and 13) and interferons. They have numerous 
and diverse actions on many cell types, but are' most noted for their effects on cells of 
the immune system (Hopkins, 1990; Dinarello, 1990). 
The INF "family" includes two structurally and functionally related proteins, INFa 
or cachetin (Carswell et ai., 1975; Beutler et ai., 1985) and 1NFj3 or lymphotoxin 
(Williams & Granger, 1968; Ruddle & Waksman, 1968). INFa is produced mainly 
by neutrophils, activated lymphocytes, macrophages, natural killer cells, astrocytes, 
endothelial cells, smooth muscle cells, adipocytes and some transformed cells, 
whereas INFj3 is a product of lymphoid cells (Vilcek & Lee, 1991). There is around 
30% amino acid residue homology between them, and they bind to the same cell 
surface receptors, producing a vast range of similar, but not identical, effects. These 
effects include the ability to kill certain tumour cells directly, from which their name 
derives. The TNFs have a central role in initiating (together with IL-l) the cascade of 
other cytokines and factors that make up the immune system's response to infection 
and sometimes to cancer. This response is critical in the successful resolution of 
infectious and metastatic diseases, but can occur in an uncontrolled manner. thereby 
damaging the host. The most dramatic example of this is septic shock following 
infection by Gram-negative bacteria (Tracey et ai., 1987). and administration ofINFa 
or TNFj3 at sufficiently high levels can reproduce virtually all of the symptoms of 
septic shock in otherwise healthy animals and humans. Over-production of TNF has 
been implicated as playing a role in a number of pathological conditions, including 
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cachexia (progressive wasting) (Beutler et aZ., 1985; Oliff, 1988), autoimmune 
disorders (Pujol-Borrell et al., 1987) and meningococcal septicemia (Waage et aZ., 
1987). 
Mature human TNFa is a polypeptide of 157 amino acid residues, with mouse, rat and 
rabbit TNFci having one amino acid less (Vilcek & Lee, 1991). Human TNF(3 has a 
higher molecular mass than TNFa (25-kDa and 17-kDa, respectively) under 
denaturing conditions due to extra amino acid residues and from N-glycosylation 
(Aggarwal et aZ., 1984; Aggarwal ~t al., 1985). Human TNFa shows no N-
glycosylation, but murine TNFa is N-glycosylated (Vilcek & Lee, 1991). The 
biologically active native forms of both TNFs are non-covalently linked trimers (Jones 
et al., 1989; Eck & Sprang, 1989; Eck et aZ., 1992). TNFa occurs as a secreted, 
soluble form and as a membrane-anchored form. TNFa has a long precursor sequence 
with both hydrophilic and hydrophobic domains, and apparently occurs as a 
membrane-bound form from which the soluble 17-kDa factor is derived by cleavage 
of the extracellular domain (Kriegler et aZ., 1988; Luettig et aZ., 1989; Perez et aZ., 
1990). Current evidence suggests that the membrane-anchored form of TNFa that 
exists on the surface of macrophages and / or monocytes, in addition to serving as a 
reservoir for release of soluble TNFa, has cytotoxic activity (Kriegler et aZ., 1988; 
Luettig et aZ., 1989; Perez et aZ., 1990), and may also play an important role in 
intercellular communication (Aversa et aZ., 1993; Macchia et aZ., 1993). 
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1.4.1 Tumour necrosis/actor alpha and adipose tissue 
Fatty acids are essential to lymphocyte function, both as fuel and as precursors for the 
. . 
synthesis of lipid-based messenger molecules (Calder, 1995). Nearly all major lymph 
nodes are embedded in adipose tissue (Yoffey.& Courtice, 1970) and.most peripheral 
adipose depots contain one or more lymph nodes (pond, 1996). Adipocytes have 
recently been found to share a range of signal molecules with lymphoid cells, 
including macrophage colony-stimulating factor (Levine et a/., 1998) and INFo. 
(Argiles et a/., 1997). The two types of INFo. receptors have been found on 
adipocytes. Type II receptors to TNFa. are present continuously on adipocytes around 
. . 
the popliteal lymph node, and type I receptors increase on these cells within 30 
minutes of lipopolysaccharide (a known elicitor of TNFa. (Old, 1985» being injected 
into a rat's lower leg, and on those around other nodes within 24 hours (MacQueen & 
Pond, 1998). These experiments reveal that the capacity of adipocytes to respond to 
this cytokine is prompted by immune stimulation, and can be highly localised to the 
perinodal adipocytes. This is true in the case of guinea pigs and rats, however its 
occurrence in other species is uncertain. 
. 
It has been shown that lipolysis in adipose tissue explants from around major lymph 
nodes increased up to 3-fold when incubated for 48 hours with mixtures of 
macrophages and lymphocytes with or without a mitogen (pond & Mattacks, 1995). 
However, the same conditions produced minimal change in the glycerol released from 
explants from the perirenal depot, which lacks lymph nodes, and only small increases 
in samples taken from sites remote from lymph nodes in other depots. This indicates 
that the site-specific properties of adipose tissue around the lymph nodes equip the 
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tissue to nourish or regulate (or both) the metabolism of the lymphoid cells in the 
nodes. Adaptive loc~ interactions with peripheral lymph nodes might be a major 
. . 
reason for the evolution among mammals of the partitioning of adipose tissue into so 
many small depots (pond, 1978). 
Recent studies have shown that TNFa. can play an important role in obesity and 
diabetes in addition to its well-known role in cachexia (Hotamisligil & Spiegelman, 
1994; Hotamisligil et al., 1994; Hotamisligil et al., 1995). lNFa., which is 
synthesised by many cell types, including adipose cells, is a pleiotropic factor that 
. . 
exerts a variety of effects on adipocytes, including thermometabolism, lipogenesis and 
lipolysis. Collectively, these metabolic effects modulate body fat mass. It has also 
recently been reported that TNFa. can directly induce adipocyte apoptosis in cell 
culture (Qian et al., 1998; Porras et al., 1997; Prins et al., 1997). Qian et al. (1998) 
have recently shown that TNFa. plays a role in leptin-induced lipolysis in adipocytes, 
and that leptin, a protein whose synthesis is localised in adipose tissue (Zhang et al., 
1994) and which reduces fat depot size by reducing food intake and increasing energy 
expenditure (Halaas et al., 1997), regulates 1NF expression in adipose tissues. 
1NFa. causes a decrease in the activity of lipoprotein lipase (LPL) (Fried & Zechner, 
1989; . Griinfeld et al., 1989), a decrease in the expression of the glucose transporter 
GLUT4 (Stephens & Pekala, 1991) and an increase in HSL (Patton et al., 1986). The 
regulation of these and other genes could affect the adipocyte insulin sensitivity and 
lipid accumulation. Therefore, the production of 1NFa. by adipose tissue could be a 
local regulator of fat size, and the overproduction of TNFa. in adipocytes of obese 
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animals could represent a fonn of "adipostat", i.e., a nonnal homeostatic mechanism 
designed to limit adipocyte size in the face of overconsumption (Spiegelman et a/., 
. . 
1993; Spiegelman & Hotaniisligil, 1993). 
1.4.2 . Tumour necrosis factor alpha and lipid metabolism 
lNFa. has a wide variety of effects on lipid metabolism. It decreases the activity of 
LPL in adipose tissue both in vivo (Semb et a/., 1987; Evans & Williamson, 1988) and 
in vitro (Price et a/., 1986; Kawakami et a/., 1987). LPL is secreted by adipocytes and 
is one of the key enzymes involved in lipogenesis. 1NFa. also stimulates hepatic lipid 
synthesis (Feingold & GrUnfeld, 1987; Feingold et a/., 1989), which may be the main 
cause for hypertriglyceridaemia that follows lNF administration (Chajek-Shaul et a/., 
1989; GrUnfeld & Feingold, 1991), and increases glucose uptake by peripheral tissues 
(Evans et a/., 1989b), hepatic uptake.of amino acids (Warren et a/., 1987; Argiles et 
ai., 1989; Argiles & LopeZ-Soriano, 1990), and skeletal muscle proteolysis (Argiles et 
ai., 1992; Llovera et ai., 1993). 1NF and interleukin-6 also mobilise fatty acids from 
the periphery, which are re-esterified into triglyceride in the liver (Feingold & 
Staprans, 1990; Nonogaki et a/., 1995). The net result is increased secretion of very 
low density proteins (VLDL) by the liver, resulting in a sustained increase in 
triglyceride levels (Feingold & GrUnfeld, 1987; Feingold et a/., 1991, 1992). TNFa. 
and interleukin-l have both been shown to inhibit glucose transport in adipocytes 
(Hauner et a/., 1995), and consequently to decrease the availability of substrates for 
lipogenesis. No direct action of lNFa. has been shown on de novo lipogenesis in 
adipose tissue of starved rats (Feingold & GrUnfeld, 1987), however 1NFa. has been 
shown to decrease ACC (a key. lipogenic enzyme) during pre-adipocyte differentiation 
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by a decrease in its mRNA (pape & Kim, 1988). Disorders in lipid metabolism like 
hypertriglyceridemia are observed as a consequence of infection, and cachexia, 
, , 
manifested by loss of muscle and so fat, is observed in man under conditions in which 
circulating TNF a. can be measured. 
1.4.3 Tumour necrosis factor alpha and lipolysis 
There have been.' conflicting reports published on the effects of TNFa. on the lipolytic 
system in primary adipocytes and established cell lines. In 1987, Rofe and colleagues 
found that TNFa. did not stimulate basal lipolysis in isolated rat adipocytes, although 
, ' 
TNFa. did increase the response to adrenaline after 1 hour incubation (Rofe et 01., 
1987). However, it has been reported by Green et 01. (1994) that TNFa. chronically 
caused an increase in basal lipolysis in rat epididymal adipocytes, with the effects of 
TNFa. only being seen after 6 hours of incubation. However, no change in either the 
response to isoproterenol or expression of HSL was observed (Green et 01., 1994). 
Very recent studies by Green show that TNFa. appears to stimulate basal lipolysis in 
rat adipocytes by decreasing the inhibitory G-protein, Gj, concentrations, thus 
blocking the inhibitory action'of endogenous adenosine (Gasic et 01., 1999). Chronic 
exposure to TNFa. has also been shown to increase basal lipolysis in newly-
differentiated human adipocytes in cell culture (Hauner et ai., 1995); as with the 
studies by Green et 01. (1994), TNFa. was required to be present for over 6 hours for 
any effects to be seen on the lipolytic rate. 
Studies using differentiated cells from the clonal cell line 3T3-F442A also showed 
that 1NFa. increased basal lipolysis after an incubation period of 8 hours (Hardardottir 
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et al., 1992; Feingold et al., 1992). These studies found that TNFa. appeared to 
stimulate prostaglandin (PO) synthesis (Hardardottir et al., 1992) and that the 
. . 
presence of indomethacin (an inhibitor of PO synthesis) prevented the increase in 
. . 
basal lipolysis induced by TNFa. (Feingold et al., 1992), suggesting that the lipolytic 
actions of TNFa. are mediated by PO. Indomethacin can also act as a PP ARy agonist 
(Lehman et al., 1997), which could account, in part at least, for the findings (Feingold 
et al., 1992) described above. However, POE2 is a potent inhibitor of basal and 
hormone-induced lipolysis in adipocytes (Kather, 1981; Richelsen et al., 1984; 
Richelsen, 1987), which contradicts these fmdings. 
Other studies using 3T3-Ll adipocytes have shown that TNFa. chronically (minimum 
of 6 hours incubation) increases basal lipolysis (Souza et al., 1998a). These studies 
show that the PPARyagonist, a thiazolidinedione (TZD) rosiglitazone (BRL49653), 
reduces the ability of TNFa. to stimulate basal lipolysis in 3T3-Ll adipocytes; 
rosiglitazone had no effect on basal lipolysis or isoproterenol-stimulated lipolysis in 
the absence of TNFa. (Souza et al., 1998a). This may be one of the mechanisms which 
enables TZDs to increase systematic insulin sensitivity. TNFa. was also found to 
cause a large decrease in the expression of perilipin A and a smaller reduction in the 
expression of HSL; an effect which was partially blocked by rosiglitazone (Souza et 
al., 1998a). Overexpression of perilipin resulted in prevention of TNFa. to increase 
lipolysis in the 3T3-L1 adipocytes, but had no effect on isoproterenol-stimulated 
lipolysis or on isoproterenol-induced migration of perilipins from the lipid droplet 
(Souza et aI., 1998b). This suggests that TNFa. regulates lipolysis, in part at least, by 
decreasing perilipin protein levels at the lipid droplet surface (Souza et al., 1998b). 
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The reasons for why TNFa appears to use different mechanisms for modulation of 
lipolysis in the different systems used is not clear. What is apparent is that TNFa 
increases b~al lipolysis, -but only after several hours of incubation, although the 
length of time varies between the systems. Green et al. (1994) found no effect of 
TNFa on HSL levels in rat adipocytes, but Souza et al. (1998a) found that incubation 
with TNFa results in a decrease in HSL levels in 3T3-Ll adipocytes, although the 
effect was small.' However, Green did not investigate the effect ofTNFa on perilipin, 
and the effects of TNFa on isoproterenol-stimulated lipolysis were not looked at by 
Souza. Therefore their results may not be inconsistent. However, the studies by 
Feingold et al. (1992) conflict with those of Green (Green et al., 1994), as PG's 
inhibit lipolysis and TNFa stimulates lipolysis. 
1.4.4 Tumour necrosis/actor alpha and insulin resistance 
TNFa is also an important mediator of insulin resistance in obesity and diabetes 
through its ability to inhibit the tyrosine kinase activity of the insulin receptor (IR), 
and tyrosine phosphorylation of one of its substrates, insulin receptor substrate-l 
(IRS-I). This effect is obserVed in various cell lines such as adipocytes, fibroblasts, 
hepatocytes and myeloid cells (Feinstein et al., 1993; Hotamisligil et al., 1994b; 
Peraldi et al., 1996). Treatment of cultured murine adipocytes with TNFa was shown 
to induce serine phosphorylation of IRS-I (Kanety et al., 1995; Hotamisligil et al., 
1996) and convert IRS-l into an inhibitor of the IR tyrosine kinase activity in vitro 
and in intact cells (Hotamisligil et al., 1996). This effect is dependent upon the 
phosphorylation of IRS-l and is reversible by dephosphorylation of IRS-l by alkaline 
phosphatase. This mechanism appears to by the one by which TNFa induces insulin 
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resistance in animals'. TNFa. is expressed at a higher level in the adipose tissue from 
genetically obese rodents (Hotamisligil et al., 1993; Hofinann et al., 1994). After 
, . 
infusion of anti-TNFa. binding protein, insulin sensitivity improves (Hotamisligil et 
al., 1993), owing to improved IR tyrosine kinase activity (Hotamisligil et al., 1994). 
This indicates that overexpression of TNFa. in adipocytes is in part responsible for 
insulin resistance in animal (Hotamisligil et al., 1993; Hofmann et al., 1994; Hamann 
et al., 1995) and human obesity (Hotarnisligil et al., 1995; Kern et al., 1995). 
1.4.5 Tumour necrosis/actor alpha receptor 
Tumour necrosis factor receptors (TNF-R) have been detected on a wide variety of 
normal tissues and cell lines sensitive or resistant to TNFa. (Kull et al., 1985; Baglioni 
et al., 1985; Tsujimoto et al., 1985; Creasey et al., 1987). There have been two 
immunologically distinct TNF receptors identified ; 55kDa (Loetscher et al., 1990; 
Schall et al., 1990) and 75kDa (Smith et al., 1990; Dembic et al., 1990), each of 
which binds TNFa. and TNF13 with a similar affinity (Loetscher et al., 1990; Smith et 
al., 1990). Both receptors have clear sequence similarity in their extracellular 
domains, where they both contain ~ characteristic 6-cysteine consensus motif repeated 
. 
four times. In contrast, their cytoplasmic region sequences are entirely unrelated, 
suggesting different modes of signalling and function (Dembic et al., 1990; Loetscher 
et al., 1990; Schall et al., 1990; Smith et al., 1990). The receptors are glycoproteins 
with a single membrane-spanning hydrophobic segment. Based mostly on their 
similarities in their extracellular domains, these receptors belong to a receptor 
superfamily which includes the low-affinity nerve growth factor receptor and the 
FAS-antigen or APO-l (Nagata, 1993; Smith et al., 1994). Most of the known TNF 
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responses occur by the activation ofp55 lNF~R (Wiegmann et ai., 1992), and this has 
been confirmed in vivo. Mice deficient for the p55 TNF-R were resistant to 
lipopolysaccharide or'toxic shock, yet proved compromised in their ability to clear 
intracellular bacteria like' Listeria monocytoge~es (Pfeffer et ai., 199.3; Rothe et ai., 
1993). However, thymocyte proliferation is associated with the p75 ~-R (Tartaglia 
et ai., ~991), and cytotoxicity may be a function of p75 lNF-R acting alone or 
together.with p55 TNF-R (Heller et ai., 1992; Grell et ai., 1993). There is no evidence 
that the TNF receptors possess intrinsic tyrosine kinase activity, unlike some major 
growth factor receptors. A comparison of the intracellular sequences of the two TNF-
R's shows no obvious sequence similarity to known tyrosine- or serine/threonine-
kinase encoding sequences. Both receptors are rich in serine and threonine residues, 
which may serve as sites of phosphorylation by other cellular kinases. The p55 TNF-
R also contains a tyrosine residue, a possible phosphorylation site for heterologous 
tyrosine kinase. 
In addition to the receptors and ligands, two soluble 1NF inhibitory proteins have 
been discovered and shown to be truncated extracellular regions of the two receptors 
(Olsson et ai., 1989; Engelmann et ai., 1990; Seckinger et ai., 1990). 
The active form of both TNFa and TNFP appears to be the trimeric molecule. Both 
factors crystallise in the trimeric form' (Hakoshima & Tomita, 1988; Jones et 01., 
1989; Eck & Sprang, 1989; Eck et ai., 1992). Trimeric TNFa and TNFP have also 
been detected in solution, and recombinant TNFa and TNFP were found to combine 
in solution with soluble TNF receptors to form complexes in which three receptor 
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molecules bind to one TNFa or TNFf3 trimer (Loetscher et al., 1991b; Schoenfeld et 
al., 1991). It has been suggested that one receptor interacts with sites on two adjacent 
subunits, and that the lNF trimer thus has three spatially distinct but equivalent 
receptor-binding sites. 
1.4.6 Tumour necrosis factor alpha and signal transduction 
Phosphorylation of several distinct proteins has been shown to occur within minutes 
after the exposure of cells to TNF (Schutze et al., 1989; Robaye et al., 1989; Marino 
et al., 1989; Kronke et al., 1991), which is probably due to the activation of several 
major cellular kinases. Evidence suggests that TNFa and interleukin-l f3 employ the 
sphingomyelin pathway to effect signal transduction by their receptors. This pathway 
is initiated by hydrolysis of a neutral plasma membrane sphingomyelin to cerami de by 
the action of sphingomyelinase (SMase) (Kim et al .. 1991). Ceramide serves as a 
second messenger, stimulating a serine/threonine membrane-bound 97 -kDa cerami de-
activated protein kinase to transduce the cytokine signal (Liu et al., 1994), in part 
through mitogen-activated protein (MAP) kinases and transcription factors such as 
nuclear factor (NF)-KB and activating protein AP-l. NF-KB and AP-l activation by 
TNF depends upon the activities of Ras and Raf(Finco & Baldwin, 1993), and/os and 
jun (Brenner et al.. 1989), respectively. These factors mediate the induction of many 
proteins central to inflammatory processes and immune responses, such as cytokines, 
cell-adhesion molecules, growth factors, metalloproteinases, and other proteins that 
participate in the production ofPG's, leukotrienes and nitrogen oxide (Angel & Karin, 
1991; Baldwin, 1996).TNF reportedly also activates the 42- and 44-kDa MAP 
kinases and increases their tyrosine phosphorylation, as well as their ability to 
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phosphorylate the standard substrate myelin basic protein (MBP) (Vietor et a/., 1993). 
The phosphorylation and activation of the 42-kDa MAP kinase by TNF parallels an 
increase in cellular sphingomyelin hydrolysis and the addition of both bacterial SMase 
or . cell-permeable ceramide analogues activa~e the p42 MAP kin~e in a time-
dependent manner, similar to TNF (Raines et a/., 1993). Therefore, both the 
ceramid~-activated kinase and the MAP kinases are activated by TNF and ceramides. 
Activation of MAP kinases leads to distinct cellular responses mediated by 
phosphorylation of specific target substrates (Marshall, 1994). 
Arachadonic acid (AA) release by TNF occurs in a number of cell lines, mediating 
increases in both the secreted 14-kDa (Oka & Arita, 1991) and the cellular 85-kDa 
(Hoeck et a/., 1993) phospholipase (PL) A2, which are enzymes known for the 
production of AA by cells. cPLA2 is selective for AA (Lin et a/., 1992), and provides 
a source for the production of biologically active lipid mediators such as PG's and 
leukotrienes. TNF alone induces phosphorylation of cPLA2, but when calcium is 
present there is a marked increase in cPLA2 activity. In combination with calcium-
mobilising agents at sites of inflammation, the released AA could serve both a 
regulatory function and have pro-inflammatory action. cPLA2 is phosphorylated on 
serine residues by PKC and the p42 MAP kinase, and the MAP kinase-mediated 
phosphorylation is essential for receptor-induced cPLA2 activation (Lin et a/., 1993; 
Nemenhoff et a/., 1993). Growth factors induce MAP kinase activity through a signal 
cascade of signal transfer reactions including ras and rat proteins, and the. 
·serine/threonine MAP kinase kinases (Thomas, 1992). Since the TNF / SMase 
initiated protein phosphorylation cascade stimulates a MAP kinase pathway and the 
p42 MAP kinases activate cPLA2, it is conceivable that the ceramide-activated protein 
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kinase is an intermediate in the MAP kinase action pathway, particularly if c-Raf 
could serve as a substrate for cerarnide-activated protein kinase (Liu et al., 1994). It 
has also been reported that the p38 MAP kinase pathway is activated in TNF-treated 
cells, which has a crucial but selective role in gene induction, such as synthesis of 
interleukin-6 and granulocyte macrophage colony-stimulating factor. (Beyaert et al., 
1996). 
Within minutes after binding to the p55 lNF-R, 1NF stimulates the production of 
diacylglycerol (DAG) from membrane phospholipids by activation of phospholipase C 
(PLC). Phosphatidylcholine (PC) is hydrolysed by phosphatidylcholine-specific PLC 
(PC-PLC), which results in DAG generation. The DAG generated by PC-PLC 
appears central to the activation of at least two other signalling enzymes, protein 
kinase C (PKC) (Brenner et al., 1989; Kronke et al., 1991) and acidic SMase. The 
activation of PKC by this pathway is probable as a release of Ca2+ from internal 
stores, an increase in PLD activity, and an increase in inositol 1,4,5-triphosphate 
levels have not been seen after lNF treatment. PKC mediates a number of lNF 
actions, including the induction .ofjun andfos proteins that are components of the AP-
I transcription factor (Brenner et al., 1989). There is also evidence for a rapid 
increase in cyclic AMP levels and resulting PKA activation (Zhang et al., 1988). The 
activation of the acidic SMase, C-type phospholipase, causes a breakdown of 
sphingomyelin to produce ceramides. Although the presence of phorbol esters causes 
downregulation ofPKC, they do not alter the SMase activity, indicating that the action 
of DAGs on SMase is independent of its effects on PKC (Kolesnick, 1987). The 
cerarnide produced from the breakdown of sphingomyelin acts as a second messenger, 
mediating a number of cellular responses (Hannum, 1994). While ceramide produced 
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by neutral SMase at or within the plasma membrane seems to trigger a plasma 
membrane-associated kinase (Liu et al., 1994), ceramide produced by the acidic 
SMase is associated with 'the endolysomal compartments and therefore may have 
different consequences. 
Another claSs of enzymes that are strongly activated by TNF are the stress-activated 
protein kinases '(SAPK; Kyriakis et al., 1994) or c-jun N-tenninal kinases (JNK; 
Derijard et al., 1994). SAPKlJNK are potentially induced by environmental stresses, 
such as inhibitors of protein synthesis, inflammatory cytokines, changes in osmolarity, 
, . 
heat shock and UV irradiation (Kyriakis et al., 1994; Derijard et al., 1994), and have 
been implicated in the induction of programmed cell death (Xia et al., 1995; Santana 
et al., 1996; Verheij et al., 1996). However, several studies have recently 
demonstrated that SAPKlJNK activation by p55 TNF-R is mediated through the 
protein, TNF-R-associated factor 2 (TRAF2) , and that it occurs in a non-cytotoxic 
manner (Liu et al., 1996; Natoli et al., 1997; Reinhard et al., 1997). Additional 
studies are required to fully elucidate the function of SAPKlJNK in the signal 
transduction pathway initiated ~y p55 TNF-R. 
1.5 Insulin 
The insulin molecule consists of two polypeptide chains, A (21 amino acids) and B 
(30 amino acids), connected by two disulphide bridges. This' two-chain structure has 
been present throughout evolution, but major variations in the sequence are observed 
between species. Insulin is formed from a biosynthetic precursor of a higher 
molecular weight called pro insulin, which originates in the pancreas. 
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Insulin is among the most potent of anabolic agents, promoting the synthesis and 
storage of carbohydrates, lipids and proteins, and inhibiting their degradation and 
release into the circulatiorr. The physiological actions of insulin are characterised by a 
wide variety of cellular effects, including modulation of glucose and amino acid 
transport, activities of key enzymes in intermediary metabolism, rates of protein DNA 
and RNA synthesis, transcription . of specific genes, and cellular growth and 
differentiation; regulation of lipid metabolism in adipose tissue by insulin is described 
in section 1.2.5. It is very unlikely that a single mechanism accounts for all the 
actions of insulin, and therefore different biochemical pathways are required for the 
regulation of cellular metabolism and growth. 
1.5.1 The insulin receptor 
The insulin receptor is present in. virtually all vertebrate tissues, although the 
concentration varies from as few as 40 receptors on circulating erythrocytes to more 
than 200,000 receptors on adipocytes and hepatocytes. The receptor gene is located 
on the short arm of human chromosome 19, is more than 150 kilobases in length, and 
contains 22 exons which enco~e a 4.2-kb cDNA (Seino et al., 1990). The insulin 
receptor (IR) is a heterotetrameric transmembrane glycoprotein comprised of two 
extracellular a subunits and two transmembrane ~ subunits linked by disulphide 
bonds. The a subunits contain the insulin-binding domain, while the transmembrane 
~ subunits function as a tyrosine-specific protein kinase that undergoes 
autophosphorylation following insulin binding (for reviews, see White & Kahn, 1994; 
Cheatham & Kahn, 1995). Three tyrosine residues in the tyrosine kinase domain of 
the receptor (1158, 1162 and 1163) are phosphorylated in trans by the reciprocal half-
receptor (Lammers et al., 1990). To propagate the signal, the autophosphorylated 
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receptor binds directly to proteins containing Src homology domains (SH2 proteins). 
The binding of SH2 proteins depends on the amino acid sequence surrounding the 
tyrosine autophosphorylation site in the receptor (Cantley et al., 1991). 
Phosphorylation of all three tyrosines appears to be necessary to allow full activation 
of the receptor's tyrosine kinase activity towards other substrates, and to allow normal 
signalling to 'downstream effectors (Murukami & Rosen, 1991). Autophosphorylation 
activates the tR kinase (Zick et al., 1983) and enables it to phosphorylate endogenous 
proteins, including IR substrate-l (IRS-I) (Sun et al., 1991), IRS-2 (Sun et al., 1995) 
and Shc (pronk et al., 1993). These, in turn, are linked to downstream signal 
transduction molecules, eventually culminating in cellular biological responses (White 
& Kahn, ·1994; Cheatham & Kahn, 1995; Saltiel, 1996; Waters & Pessin, 1996). 
The unoccupied a.-subunit of the IR. inhibits the tyrosine kinase activity of the ~­
subunit. Removal of the a.-subunits by proteolytic cleavage or deletion mutagenesis, 
or certain point mutations in the a.-subunit, relieve this inhibition. Insulin and 
epidermal growth factor (EGF) receptors may use similar mechanisms for ligand 
regulation, since the IR kinase domain (intracellular) linked to an EGF binding 
domain (extracellular) via the transmembrane domain is stimulated by EGF (Riedel et 
al., 1989). The external ligand binding domain of the IR is linked to the tyrosine 
kinase by a single transmembrane segment, which has a broad tolerance for structural 
changes or substitutions (Frattali et a/., 1991; We et al., 1990). However, the IR is 
constitutively activated by substitution of the transmembrane segment from the 
oncogene v-erbB-2, which contains V al664 ~Glu mutation (Cheatham et al., 1993) ; an 
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analogous point mutation (Val938~Asp) in the transmembrane segment of the IR also 
partially activates the receptor kinase (Longo et al., 1992). 
Proteins known to associate with IRS-l are, phosphatidylinositol 3-kinase (the lipid 
kinase; PI-3Kinase), Grb2 (an adapter protein which associates with the guanine 
nucle<?tide exchange factor Sos), syp (a phosphotyrosine phosphatase) and nck (a 
linker protein) (Skolnik et al., 1993; robe et al., 1993; Kuhne et al., 1993; Lee et al., 
1993). 
1.5.2. Insulin and signal transduction via PI-3kinase 
Unlike many other receptor tyrosine kinases, the phosphorylated tyrosine residues on 
the receptor itself do not appear to act primarily as docking sites for Src homology 2 
domain-containing signal transduction proteins. The insulin and insulin-like growth 
factor-l receptors phosphorylate one or more substrate proteins with a molecular mass 
of approximately 185-kDa. Further characterisation of the 185-kD~ substrate(s) 
resulted in the cloning of IRS-l (Sun et al., 1991). IRS-l contains multiple tyrosine 
residues in YMXM or YXXM. motifs suitable for interaction with Src homology 2 
(SH2) domain-containing proteins (Shoelson et al., 1992; Sun et al., 1993). IRS-l 
also contains over 30 potential serine/threonine phosphorylation sites in motifs 
recognised by various kinases. A pleckstrin homology (PH) domain is important for 
association of IRS-l with the IR (Yenush et al., 1996). IRS-l and She also contain a 
phosphotyrosine binding domain which recognises the NPXy960 sequence of the IR 
(Heetal., 1995; Gustafsonetal., 1995; Isakoffetal., 1996; Ecketal., 1996). Several 
specific signalling molecules that interact with tyrosine-phosphorylated IRS-l have 
been identified, including PI-3Kinase, phospholipase Cy (PLCy), growth factor 
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receptor-bound protein 2 (Grb2), SH2-containing phosphotyrosine phosphatases 
(SHPTP), and Ras GTJ>ase (Backer et al., 1993; Skolnik et al., 1993; Lee et al., 1993; 
Xiao et al., 1994; Yamauchi et al., 1995). 
A family of PI-3Kinases phosphorylates the inositol ring at the D-3 position to give 
PI-3-phosphate from PI, PI-3,4-bisphosphate from PI-4-phosphate, and PI-3,4,5-
triphosphate' from PI-4,5-bisphosphate (Whitman et al., 1988; Auger et al., 1989). PI-
3Kinase is a heterodimer consisting of 85-kDa (a.-p85) and 11O-kDa (PlIO) subunits. 
Cloning of these subunits has revea1e~ that the a.-p85 is an adapter subunit containing 
two SH2 domains and one SH3 domain (Otsu et al., 1991; Skolnik et al., 1991; 
Escobedo et al., 1991), while the plIO subunit has catalytic activity (Hiles et al., 
1992; Hu et al .• 1993). It is the presence of the SH2 domains and their demonstrated 
ability to bind phosphotyrosine that has led to this form of PI-3Kinase being strongly 
implicated in insulin action in target tissues. It has been shown that IRS-1 associates 
with the SH2 domain of the 85-kDa regulatory subunit of PI-3Kinase (Myers et al., 
1992), and that this association results in the activation of PI-3Kinase because of 
occupancy of the SH2 domains,o(p85 by the tyrosine-phosphorylated protein (Myers 
et al., 1992). 
Activation of PI-3Kinase appears to be necessary for the metabolic effects of insulin, 
including stimulation of glycogen synthesis (Shepherd et al., 1995; Nave et al., 1996; 
Frevet & Kahn, 1997). glucose transport (Cheatham et al., 1994; Okada et al., 1994; 
Herbst et al., 1995; Holman & Kasuga, 1997). inhibition of lipolysis (Stagsted et al., 
1993; Okada et al., 1994; Moule et al., 1995), stimulation of lipogenesis (Vernon & 
Lindsay-Watt, 1995), and activation of ACC (Stagsted et al., 1993; Okada et al., 
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1994; Moule et al., '1995; Travers, et al., 1996) but not pyruvate dehydrogenase by 
insulin (Kilgour & Vernon, 1987). There is experimental evidence for protein kinase 
B (PKB) being an element of the signalling cascade leading from PI-3Kinase to 
activation of glycogen synthesis and glucose transport in isolated, rat adipocytes, 
various cell culture models, and human skeletal muscle (Cross et al., 1995; Hurel et 
al., 1996; Shepherd et al., .1997). PI-3Kinase activation results in the production of 
PtdIns(3,4,5)P3 and Ptdlns(3,4)P2. The binding of the pleckstrin homology domain of 
PKB to these phosphoinositides both recruits PKB to the plasma membrane and 
directly and / or indirectly stimulates its kinase activity, via phosphorylation by the 
membrane-associated protein kinases, PDK1I2. Activated PKB phosphorylates 
substrate proteins resulting in a variety of biological effects, possibly including 
stimulation of glycogen synthesis, by inhibiting glycogen synthase kinase-3 (GSK3) 
by serine phosphorylation via PKB .(Cross et al., 1995), the translation of certain 
mRNAs (Welsh et al., 1994, 1998) and GLUT4 translocation. 
p70S6 kinase phosphorylates elongation factor-l (EF-l) and ribosomal protein S6, and 
activation of PI-3Kinase is thought to be upstream of p70S6 kinase activation and 
hence mRNA translation (Cheatham et al., 1994), resulting in insulin stimulation of 
translation elongation (Chang & Traugh, 1997). There is also evidence suggesting 
that there is PI-3Kinase-independent activation of p70S6 kinase by insulin (Hara et al., 
1995). 
1.5.3 Insulin and signal transduction via MAP kinases 
Grb2 is a small cytoplasmic protein that contains two SH3 domains and one SH2 
domain that binds to Tyr89S in IRS-I. Grb2 acts as an "adapter molecule" that links 
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the guanine nUcleotide exchange factor for p21 ras, tenned mSOS (homologous to the 
Drosophila protein, so~-of-sevenless (SOS)), to tyrosyl phosphoproteins like the EGF 
receptor and IRS-1 (Simon et al., 1993; Li et al., 1993). The binding of Grb2/mSOS 
to IRS-1 mediates the insulin stimulation of. p21 ras. Ras binds directly to Raf-1 
serine/threonine kinase, which in turn activates MAP kinase by phosphorylation and 
activation of MAP kinase kinase (MEK; Crews & Erikson, 1993). 
She, another substrate of the IR kinase (pronk et a/., 1993), has three different 
isofonns of 46-, 52-, and 66-kDa. It has been shown to interact directly with Grb2 
after being phosphorylated by the IR (Sasaoka et a/., 1994). Therefore, there are at 
least two pathways by which activation of Ras might occur; that is, IRS-1 and She. 
MEK causes the activation of the p42 and p44 MAP kinases by threonyl- and tyrosyl-
phosphorylation (Ray & Sturgill, 19~8). MAP kinases are a conserved family of 
serine/threonine kinases that are activated in all eukaryotic cells in response to a wide 
range of signals (Lenonnand et a/., 1993; Marshall, 1995). MAP kinases then 
phosphorylate and activate p90rsk (Haystead et a/., 1990). MAP kinase itself 
translocates into the nucleus ul?on activation by a number of mitogens, where it is 
thought to phosphorylate transcription factors such as p62TCF, leading to stimulation 
of activating protein-1 (AP-1) activity. However, it is likely that a large fraction of the 
activated enzyme remains cytoplasmic, and contributes to some metabolic processes. 
MAP kinase catalyses the rephosphorylation of upstream proteins in the pathway, such 
as Sos, causing the desensitisation ofp21ras activity (Waters et al., 1995). 
A central role for MAP kinase in growth factor and insulin signalling is probable 
because MAP kinase can phosphorylate a large number of target substrates in vitro, 
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including p90 S6 kID.ase (Sturgill et al., 1988), MAPKAP kinase-2 (a kinase that 
phosphorylates glycogen synthase at Ser7 ; Stokoe et al., 1992), EGF receptor 
(Takishima et al., 1991), PIA2 (Lin era/., 1993), tyrosine hydroxylase (Sutherland et 
al., 1993a), PHAS-l (Lin et al., 1994), protein tyrosine phosphatase 2C (peraldi et al., 
1994), stathmin (Leighton et al., 1993) and the transcription factors c-myc, c-jun, c-
los, p62TCF, NF-IL6 and ATF-2 (Nishida & Gotoh). The role of MAP kinase in the 
metabolic effect 'of insulin, however, is uncertain (Denton & Tavare, 1995). 
1.6 Phosphodiesterases (PDEs) 
In adipocytes, the intracellular concentrations of cyclic AMP are controlled by the 
complex coordinate regulation of both adenylate cyclase and cyclic AMP PDE 
activities. Changes in intracellular cyclic AMP greatly affect the metabolic status of 
the cell. Enzyme activity that catalyses the hydrolysis of cyclic AMP and cyclic GMP 
was described almost immediately after the discovery that cyclic nucleotides exist in 
the cell. In fact, the demonstration of enzymatic degradation of cyclic nucleotides by 
PDEs formed part of the criteria that these compounds act as second messengers. 
Within a few years it became apparent that more than one enzyme was able to catalyse 
the hydrolysis of cyclic AMP and cyclic GMP. We now know that many different 
PDEs selectively catalyse the hydrolysis of purine 3',5' nucleoside monophosphates to 
5' -nucleoside monophosphates. By catalysing the degradation of cyclic AMP and 
cyclic GMP, cyclic nucleotide PDEs are critical determinants in regulating 
intracellular concentrations and, consequently, biological effects of these important 
second messengers. PDEs are now thought of as mediators of "cross-talk" between 
different second messenger signalling systems (see Beavo & Houslay, 1990). 
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PROPERTIES OF POE FAMILIES 
FAMILY (specific inhibitor) Km eDNA/isozyme name intracellular regulatory properties 
1 Ca£~ /calmodulin-sensitive cGMP=<cAMP PDE1A11A1, 1A2 Ca£~, calmodulin 
(Methoxymethyl-IBMX) PDE1B/181 Phosphorylation by . 
PDE1C/1C1, 1C2, 1C3, 1C4, 1C5 cAMP-kinase (PKA), CaM-kinase 
2 cGMP-stimulated cGMP<cAMP PDE2AI2A 1. 2A2 cGMP 
Positive cooperativity 
Non-catalytic binding sites 
3 cGMP-inhibited cAMP=cGMP PDE3A13A1 cGMP 
(lonotropicJvasodiiator drugs. PDE3B/3B1 Phosphorylation by 
e.g., cilostamide. milrinone. cAMP-kinase (PKA) or 
Enoximone, Imazodan, insulin-activated kinases 
LY195115 (Indolidan» 
4 cAMP-specific cAMP«cGMP PDE4A14A1, 4A5, 4A8 cAMP (gene expression) 
(Rolipram, RO 2~1724) PDE4B/4B1, 482 Phosphorylation by 
PDE4C/4C1 cAMP-kinase (PKA) 
PDE4D/4D1. 4D2, 403, 404 
5 cGMP-specific 
(Dipyridamole, Zaprinast) cGMP«<cAMP PDE5A15A1 
6 cGMP-specific cGMP<<<cAMP PDE6A16A1 Transducin (G-protein) 
Photoreceptor PDE6B/6B1 Phosphorylation by 
cGMP-binding cGMP-kinase 
7 Non-catalytic binding sites 
cAMP-specific cAMP«cGMP PDE7A17A1.7A2 
rolipram-insensitive 
8 cAMP-specific cAMP«cGMP PDE8 cAMP 
IBMX-insensitive 
(Dipyridamole) 
9 cGMP-specific cGMP<<<cAMP PDE9A1 
10 cAMP/cGMP cAMP«cGMP PDE10A 
Table.1.1. Properties of POE families (adapted from Manganiello et al. (1995) Cell. Signal., 7.445-455) 
In individual cells, cyclic nucleotide hydrolysis is a highly regulated process, usually 
dependent on the coordinated and integrated activities of several structurally related 
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PDE isoenzymes. Cyclic nucleotide PDEs are a multi enzyme family in which at least 
14 distinct genes encode over 20 different isoforms. These isoforms have been 
classified into ten families according to their substrate specificity, sequence 
similarities and regulatory sites (see table 1.1) (Thompson, 1991; Torphy et al., 1993; 
Bolger, .1994; Manganiello et al., 1995; Beavo, 1995; Conti et al., 1995; Dent & 
Oiembycz, 1995; Houslay & Milligan, 1997; Souness & Rao, 1997; Fisher et al., 
1998; Soderling et aI., 1998a,b; Soderling et al., 1999). Although, sometimes, 
specific PDEs are highly concentrated in single types of cells, multiple PDEs are 
usually present in most cells, in different amounts, proportions and subcellular 
locations. Some PDE forms are specific for cAMP, such as the PDE3, PDE4 and 
PDE7 families. Members of the PD~l and PDE2 families can hydrolyse both cAMP 
and cOMPo This chapter will focus on what are currently believed to be the major and 
key cAMP-hydrolysing PDEs of adipocytes, namely PDE3 and PDE4. 
1.6.1 Structure andfunction of PDEs 
Members of PDE families are products or distinct, but related, genes. PDEs share a 
common structural domain pattern, all containing conserved catalytic domains (-25-
40% amino acid identity) of -270 amino acids, usually in the C-terminal portion of 
the enzymes (Charbonneau et al., 1986; Charbonneau, 1990). The seven known 
families of PDEs that can hydrolyse cAMP (PDE-l,-2,-3,-4,-7,-8 and -10) have a 
central core region of -330 amino acids containing the active site. The N-terminal 
regulatory domains are divergent which accounts for the distinctive regulatory 
properties unique to the individual families, Le. putative Ca2+ -calmodulin binding 
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sites, membrane-associated domains, allosteric non-catalytic cGMP-binding sites, 
putative phosphorylati.on sites for Ca2+ -, insulin-, cAMP- and cGMP-dependent 
protein kinases (Charbonneau et al., 1986; Beavo, 1988; Beavo & Houslay, 1990; 
Beavo & Reifsnyder, 1990; Charbonneau, 1990; Conti et al., 1991; Bentley & Beavo, 
1992; Nicholson et al.,1991; Thompson, 1991; Torphy & Undem, 1991; Giembycz, 
1992; Hall, 1993). 
1.6.2 PDEs and adipocytes 
Although sometimes specific PDEs are highly concentrated in single types of cells, 
multiple PDEs are usually present in most cells, in different amounts, proportions and 
subcellular locations. The PDE3 family has two different gene products that have 
currently been identified (Meacci et al., 1992; Taira et al., 1993). PDE3A has been 
identified in smooth muscle, platelets (MacPhee et al., 1986; Alvarez et al., 1986; 
LeBon et al., 1992; Degerman et al., 1995) and cardiac tissue. POE3B is mainly 
located in adipocytes (Kono et al., 1975; Degerman et al., 1987; Anderson et al., 
1989) and liver (Pyne et al., 1987; Boyes & Loten, 1988), although both PDE3A and 
PDE3B are found in lower amount in other tissues. In liver (Pyne et al., 1987; Boyes 
& Loten, 1988) and adipocytes (Kono et ~/., 1975; Degerman et al., 1987; Anderson 
et al., 1989), PDE3B is predominantly membrane-associated. PDE3 has high affinity 
for both cAMP and cGMP, and low concentrations of cGMP can inhibit the hydrolysis 
of cAMP by this enzyme. 
The POE4 isoforms are widely expressed in many tissues. They have a high affinity 
for cAMP, but practically no activity with cGMP as substrate. However, unlike 
POE3, cGMP does not bind to PDE4 with high affinity. PDE4 is the largest PDE 
50 
family, with 4 different genes having been identified in hwnan and rat. All of these 
genes are reported to encode more that one alternatively spliced mRNA transcript. It 
has been shown that increaSed PDE4 activity in the mouse can be responsible for one 
form of diabetes insipidus (Homma et al., 1991). 
It has recently been shown by MacKenzie and colleagues that the cAMP-specific 
PDE4A5 can be activated by stimulation of p70 S6 kinase via a GH-controlled PI-
3Kinase pathway in 3T3 pre-adipocytes (MacKenzie et al., 1998). This identified a 
role for the PDE4 phosphodiesterases in regulating the ability of GH to stimulate 
differentiation of 3T3-F442A cells (MacKenzie et al., 1998). However, PDE3 
isoform inhibitors did not enhance differentiation to adipocytes (MacKenzie et al., 
1998). Elks and Manganiello have also shown that PDE4, and not PDE3, inhibitors 
enhance differentiation to adipocytes (Elks & Manganiello, 1985) in 3T3-Ll 
fibroblasts. They also showed that PDE3, but not PDE4, inhibitors played an 
important role in regulating lipolysis in the mature adipocytes (Elks & Manganiello, 
1985). This suggests that the differences in response to these selective PDE inhibitors 
reflects compartmentalisation of cAMP signalling between a pool controlled by PDE3 
activity and another pool controlled by PDE4 activity. Studies on other cell types also 
support this notion (Faux & Scott, 1996; Erdogan & Houslay, 1997; Houslay & 
Milligan, 1997). 
1.6.3 PDEs and lipid metabolism 
Insulin and catecholamines playa major role in the acute regulation of adipose tissue 
lipolysis (Arner, 1988).· One important effect of the insulin signal is to mediate 
activation of membrane-associated cGMP-inhibited PDE (PDE3). This leads to a 
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reduction in cAMP,' which results in a decrease in cAMP-dependent protein kinase 
(PKA) and a reduction. in phosphorylation, which attenuates HSL activity, the rate-
. . 
limiting enzyme in the regtilation of lipolysis (Beebe et al., 1985; Londos et al., 1985; 
Elks & Manganiello, 1985; Nilsson et al., 1986; Schmitz-Peiffer et al .• 1992; Eriksson 
et al., 1995; Manganiello et ai., 1995). This reduction in HSL activity can occur by 
the downregulation of l3-adrenoceptors (Engfeldt et al., 1988) or activation of cAMP 
phosphodiesterase (PDE) (Manganiello & Vaughan, 1973). 
During recent years, a number of studies have supported the idea that insulin-induced 
phosphorylation and activation of PDE3 is critical to the antilipolytic and 
antiglycogenolytic effects of insulin in adipose tissue (Manganiello et ai., 1991; 
Manganiello et al., 1992), although this has mainly been based on in vitro findings. 
Hagstrom-Toft and colleagues presented a report on the effects on lipolysis in human 
adipose tissue in vivo of nonselective and selective (PDE3) inhibition of PDE (Arner 
et al., 1993) found using a microdialysis method, showing that PDE3 inhibition with a 
selective inhibitor stimulates lipolysis, but not to the same extent as a nonselective 
PDE inhibitor. This suggests ~at other PDE isofonns are involved in the regulation 
of lipolysis. The antilipolytic effects of insulin have been shown to be abolished by 
using nonselective PDE inhibitors (Fain & Rosenberg, 1972; Makino et al., 1992). 
This was also observed using a selective inhibitor of PDE3 (Smith et al., 1991; 
Manganiello et al., 1991; Manganiello et al., 1992), whereas. the inhibition of PDE4 
did not inhibit antilipolysis by insulin (Schechter, 1984; Gabbay & Lardy, 1986). In 
liver, insulin has been reported to cause the activation of both the PDE3 "dense 
vesicle" and also a PDE4 isofonn (Heyworth et al., 1983). This indicated that 
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multiple PDEs may be involved in ~e ability of insulin to regulate cAMP signalling 
processes (HouSlay & Kilgour, 1990). 
The mechanism whereby insulin activates PDE3 is still not fully understood. 
However, rapid regulatory changes in cAMP can be elicited by the phosphorylated 
POE3 enzymes (Manganiello et al., 1982; Kilgour et al., 1989; Houslay & Kilgour, 
1990; Degerman et al., 1990; Manganiello et al., 1991; Smith et al., 1991; 
Manganiello et al., 1995) and isoforms of POE4 enzymes (Marchmont & Houslay, 
1980; Sette et al., 1994). Early studies with PDE3 indicated that both an increase in 
cyclic AMP by isoproterenol and insulin resulted in the phosphorylation/activation of 
POE3, and that the effect was more than additive (Smith & Manganiello, 1988; Smith 
et al., 1991) suggesting cross-talk between the two signal transduction pathways. An 
insulin-sensitive PDE3 serine kinase. was then identified (Shibata & Kono, 1990a; 
Shibata & Kono, 1990b; Smith et al., 1992; Lopez-Aparacio et al., 1993). This kinase 
was not a substrate for direct phosphorylation by the activated insulin receptor (Lopez-
Aparacio et al., 1993), but possibly belonged to a family of protein serine kinases 
regulated by upstream kinases/phosphatases involved in insulin receptor-mediated 
signal transduction cascades. Based on the deduced amino acid sequence of adipocyte 
POE3 (Taira et al., 1993), Rascon et a/. (1994) found that a probable site for 
phosphorylation ofPDE3 by PKA was Ser427, but this was in a cell-free system. Rahn 
et al. (1996) then showed that a single' site in PDE3 (Ser302) was phosphorylated in 
adipocytes incubated with isoproterenol and/or insulin. There was some confusion as 
to whether PKA and insulin resulted in phosphorylation of different sites or the same 
site on PDE3. The reason for the discrepancy is probably due to adipocyte PDE3 
being membrane-bound. It is possible that ser427 is usually inserted in the membrane, 
S3 
and therefore not subject to phosphorylation. in intact cells. In the cell-free system 
(Rascon et al., 1994), ser427 is exposed, and can therefore be phosphorylated. 
. . 
Data was then published showing effects of pretreatment of adipocytes with the PI-
3kinase inhibitor, wortmannin. Wortmannin is known to inhibit the antilipolytic 
action of insulin (Okada et al., 1994), as well as other effects of insulin and other 
growth factors, like regulation of cell growth (Myers & White, 1993; Parker & 
Waterfield, 1993; White & Kahn, 1994; Van Hom et al., 1994; Keller & Lienhard, 
1994). Pre-treatment of adipocytes with wortmannin inhibited 
phosphorylation/activation of PDE3B, blocked insulin-induced activation of a kinase 
that phosphorylates PDE3B (Rahn et al., 1994) and the antilipolytic action of insulin 
(Okada et al., 1994; Rahn et al., 1994). However, the components in the signalling 
pathway between PI-3Kinase and P~E3B, including the kinase responsible for the 
phosphorylation of PDE3B, had not been identified. Wijkander and colleagues 
(Wijkander et al., 1998) have now shown that PKB is responsible for the 
phosphorylation ofPDE3B in vitro. This has since been found by others (Kitamura et 
al., 1999), and is consistent with one site on PDE3 being phosphorylated by insulin 
and PKA (Serine 302). 
Longer-term changes in cAMP levels, through up-regulation, have also been 
described as adaptive responses to c~onic increases in intracellular cAMP levels 
(Thompson, 1991; Conti et al., 1995a). This has been described in particular detail 
for splice variants arising from the PDE4D gene (Sette et al., 1994; Conti et al., 
1995a; Conti et al., 1995b), where short PDE4Dl splice variants are upregulated, 
suggesting distinct promoter regions. 
S4 
The diversity among' PDE isoforms may provide unique mechanisms for regulating 
the amplitude ari.d duration of cyclic nucleotide levels in particular cells. Targeting of 
, . 
specific cell types by selective inhibitors for different splice variants may provide a 
. , 
pharmacological approach to the treatment of a wide variety of metabolic disorders. 
1.7 Objectives 
The aim·ofthis study was to further elucidate the mechanisms whereby GH exerts its 
chronic effect on adipose tissue metabolism, in particular the effect of GH on 
lipolysis. 
A study by Green et al. (1994) had shown that TNFa chronically increases basal 
lipolysis in rat epididymal adipocytes: an effect that is similar to that of GH. Borland 
et ai, (1994) had implicated a protein with a half-life of less that 3 hours in the 
regulation of lipolysis and lipogenesis by GH. This raised the possibility that TNFa 
might mediate the chronic metabolic effects of GH on adipose tissue, an analogous 
system to the mediation of the mitogenic effects ofGH by IGF-l. Initial studies using 
ovine adipose tissue explants. inyolved the investigation if TNFa could be this 
putative secreted protein. However, TNFa did not appear to mimic the effects of GH 
on isoproterenol-stimulated lipolysis in this system, and therefore I concluded that 
TNFa was not the protein involved in GH regulation oflipolysis and lipogenesis. 
Previous studies in the laboratory on the mechanism of GH action had used inhibition 
of signal transduction components in an explant system. More specific effects could 
be observed by using an antisense approach, but this required the use of a cell culture 
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system rather than adipose tissue explants. The next objective of the study was then to 
determine the sUitability of an ovine adipose cell culture system for investigating the 
molecular basis of the lipolytic effects of GH; in particular the inhibitory effects of 
"GH on adenosine inhibition of lipolysis. The "lipolytic system partially developed in 
primary ovine adipocytes, but only a very small response to adenosine "was observed 
under SUb-optimum conditions. This response to adenosine was considered too small 
to investigate the effects of GH. However, by manipulating the differentiation 
conditions, I significantly improved both cell differentiation and the lipolytic response 
and sensitivity to isoproterenol, but there was no improvement in response to 
adenosine. 
As ovine primary adipocytes only had a small response to adenosine, the suitability of 
the murine cell line, 3T3-F442A, was investigated for determining the molecular basis 
of the lipolytic effects of GH. However, although the lipolytic system did develop in 
differentiated 3T3-F442A adipocytes and response to isoproterenol was observed, no 
significant effect of adenosine was measured in this system either. This line of 
investigation was not pursued further. 
Therefore, I decided to investigate the effects of GH and insulin on the lipogenic 
system in 3T3-F442A adipocytes instead. This was with a view to extending previous 
observations by others (Millar, 1998)" in the laboratory on the roles of specific 
isoforms of PKC on the modulation of lipogenesis by insulin and GR. The main 
objective was to determine the role of PKC isoforms in the modulation of the effect of 
insulin and GH on the lipogenic enzyme, ACC, and its mRNA, total ACC, proportion 
of active ACC. However, the effect of the hormones on lipogenesis, and especially 
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ACC, was considered to be too small to investigate the roles of specific PKC 
isoforms, despite trying many different ways of improving the hormone effects. 
. . 
A possible explanation for the poor response ~o insulin could be that the lipogenic 
system was not being "switched off' in the absence of stimulant, so isoproterenol was 
added to the 3T3-F442A adipocytes to decrease lipogenesis. Isoproterenol did reduce 
the rate of lipogenesis, but the effect of insulin was still small. Therefore, modulation 
of the effect of specific PDE isoforms on lipogenesis was explored as an alternative. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals and reagents 
General laboratory chemicals were purchased from Sigma Chemical Company (poole, 
Dorset, UK), Gibco BRL (Renfrewshire, Scotland), BDH (poole, Dorset, UK) or 
Calbiochem (Nottingham, UK), unless otherwise stated. 
Tissue . culture plastic was obtained from Corning Costar Corporation 
(Buckinghamshire, UK) or Greiner Labortechnik Ltd. (Dursley, UK). Tissue culture 
media, antibiotics, collagenase (typ~ II) and serum were obtained from Life 
Technologies (Paisley, Scotland), Sigma Chemical Company (Poole, Dorset, UK) or 
Labtech International (Uckfield, East Sussex, UK). Pentex Ex-cyte III was purchased 
from Bayer Corporation (Basingstoke, Hampshire, UK). 
Bovine growth hormone was a generous gift given by Monsanto Europe, B-11S0 
(Brussels, Belgium). 
e4C]-acetate and [U-14C]_glucQse. were obtained from ICN Pharmaceuticals, Inc . 
. 
(Hertfordshire, UK) and sodium[14C]bicarbonate was purchased from Arnersham 
International pIc (Buckinghamshire, UK). Scintillation cocktails and vials were 
purchased from Packard (Berkshire, UK) or ICN Pharmaceuticals, Inc (Herts, UK). 
2.1.2 Preparation of bovine serum albumin 
The bovine serum albumin (BSA) used for all the tissue or cell culture and relevant 
experiments was fraction V, essentially fatty acid-free. This was dialysed prior to use 
to remove contaminants such as citrate and pyruvate, as described by Hanson & 
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Ballard (1968). A 10% BSA solution made up in 0.9% NaCI solution was dialysed 
against 0.9% NaC1. a~ 40 C for a period of 3 days. The 0.9% NaCI solution was 
changed 5 t~es over this period, with a minimum of 4 hours between each change. 
The BSA was finally dialysed for a minimum of 4 hours against distilled water before 
being lyophilised, and the dry powder was stored at 40C until required. 
2.1.3 eel/lines ' 
3T3-F442A cells were generously provided by Dr. Howard Green (Harvard Medical 
School, USA) 
2.1.4 Sheep 
Sheep were all Finn x Dorset cross-breds. Wether (castrated male) lambs of 1 month 
old to 9 months old were used. 1Jte animals were given hay, with water freely 
available, and a cereal mix (the amount depending on age); young lambs were left to 
feed naturally with their mothers, for at least 4 weeks before slaughter. Lactating 
sheep were killed after 18 days of lactation, and were fed on hay and a cereal mix, as 
described previously, prior· to slaughter (Vernon et al., 1981). Sheep were 
anaesthetised with an intrajugular injection of 10-30 ml of Sagatal (May & Baker, 
Dagenham, Essex, UK) depending on age, administered by Dr. R.G. Vernon. The 
animals were exsanguinated when unconscious, and samples of adipose tissue were 
removed. These were then placed in a 'sterile isotonic saline at 37°C and taken to the 
laboratory immediately. 
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2.1.5 Rats 
Male Wistar rats (A .. Tuck and Son, Rayleigh, Essex, UK) were fed on standard 
pelleted rat chow ad libitum (CRM 'diet, Labsure, Poole, UK), with water freely 
available. Rats of similar age and weight (150-180g) were used for experimental 
purposes. Rats were anaesthetised by an intraperitoneal injection of O.9ml Sagatal 
plus O.lml Hypnorm (May & Baker, Dagenham, Essex, UK), administered by Dr. 
R.O. Vernon. The animals were exsanguinated when unconscious, and samples of 
adipose tissue were removed. These were then placed in isotonic saline at 370 C and 
taken to the laboratory immediately. 
2.2 Methods 
2.2.1 Tissue culture 
2.2.1.1 Preparation of ovine explant tissue 
Pieces of either subcutaneous or popliteal ovine adipose tissue (approximately 20mg) 
were cut with sterilised scissors, after the removal of blood vessels and connective 
tissue. Tissue explants giving a total weight of around 100mg were maintained in 
culture at 370 C for 22 hours jn.an atmosphere of 95% air, 5% CO2• The tissue 
explants were cultured in 24 well plates in 2mls of Medium 199 containing Earle's 
salts, L-glutamine and 25mM Hepes (PH 7.3) and supplemented with 2mM acetate 
(PH 7.3) and antibiotics (penicillin G, 60/lglrnl ; streptomycin sulphate, lOO/lglml ; 
neomycin sulphate, 10/lglml) (Vernon & Finley, 1988). The tissue was then 
transferred to fresh medium for a further 24 hour period, containing the relevarit 
additions for the experiments, as described in the results chapters. 
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2.2.1.2 Preparation'o/rat explant tissue 
Pieces of rat epididymal adipose tissue (approximately 15mg) were cut with sterilised 
, , 
scissors, after the removal' of blood vessels and connective tissue. Tissue explants 
giving a total weight or' around 100mg were, maintained in culture, at 37°C for 22 
hours in an atmosphere of 95% air, 5% C02. The tissue explants were cultured in 24 
well plates in 2mls of Medium 199 containing Earle's salts, L-glutamine and 25mM 
Hepes (PH 7.3) and supplemented with 2mM acetate (PH 7.3) and antibiotics, as with 
the sheep explant culture. The tissue was then transferred to fresh medium for a 
further 24 hour period, containing the relevant additions for the experiments, as 
described in the results chapters. 
2.2.2 Cell culture 
2.2.2.1 Preparation 0/ ovine pre-adipocytes 
Pieces of subcutaneous ovine adipose tissue (approximately 20mg) were cut with 
sterilised scissors, after the removal of blood vessels and connective tissue, in Kreb's 
Ringer's bicarbonate medium (1.2mM CaCh, 120mM NaCI, 5mM KCI, 1.5mM 
KH2P04 and 25mM NaHC03) supplemented with Imglml D-glucose, 2mM acetate, 
25mM Hepes (PH 7.4), and 3% BSA (the Ringer's bicarbonate medium was gassed 
for 20 minutes with 5% CO2, 95% O2). The explants were subjected to digestion with 
collagenase. The collagenase digest was made up in Ringer's bicarbonate medium 
supplemented with Imglml D-glucose, 2mM acetate, 25mM Hepes, 4% BSA and 
Imglml collagenase, and filtered through a 0.451Jlll filter into a conical tissue culture 
flask. The tissue explants were washed in Ringer's bicarbonate medium and 
transferred to the flask containing the collagenase digest, before being placed in a 
shaking water bath at 370 C for 1 hour. After the digestion, the digest was filtered into 
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sterile SOml tubes using coarse mesh and a siliconised funnel, and the adipocytes were 
allowed to float to the upper layer of the digest. The infranatant was removed to fresh 
. . 
tubes, and centrifuged at·room temperature for 5 minutes at 2800 rpm in an MSE 
benchtop centrifuge, to give a pellet of stromovascular cells and red blood cells. The 
supernatant was removed, and the pellet was resuspended in 30mls of :warm Hank's 
Balanced Salt Solution without Calcium or Magnesium (HBSS). The cells were 
centrifuged and 'resuspended twice more as previously, but the cells were only in 
20mls of HBSS the last time. The cell suspension was filtered through a fine mesh, 
and 40).LI of the filtered cell suspension was removed to count cell number using a 
haemocytometer. The cell suspension was centrifuged for 5 minutes at 2800 rpm, and 
the pellet resuspended in the appropriate amount of proliferation medium to give a cell 
number of 3xlOs cells/ml. The proliferation medium consisted of Medium 199 
containing Earle's salts, L-glutamine and 25mM Hepes (PH 7.3) and supplemented 
with 2mM acetate (PH 7.3), antibiotics (Penicillin G, 60J..lg/ml ; streptomycin sulphate, 
100).Lg/ml) and 20% Newborn Calf Serum (NCS). 16mls of proliferation medium and 
4mls of cell suspension were added to a 75cm2 tissue culture flask to give a final cell 
concentration of 0.6xl0s cells/ml. 
2.2.2.2 Culture of ovine pre-adipocytes 
24 hours after the preparation of the pre-adipocyte cells, the cells were washed with 
HBSS and the medium was replaced with fresh proliferation medium. This was 
repeated every 48 hours thereafter until the cells had reached 80% confluence 
(detennined visually) before they entered growth arrest. If required, the cells were 
passaged using 1m! of 0.25% trypsin / EDT A solution, and were transferred to 24 well 
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plates at a density of 0.6x10s cells/ml in 2mls proliferation medium. The medium 
was replaced with fresh proliferation medium every 48 hours. 
2.2.2.3 Differentiation of ovine pre-adipocytes. 
For conversion to adipocytes, the ovine pre-adipocytes were grown to confluence in 
the 24 well' plates. Two ,day confluent cultures were induced to differentiate by 
replacing the proliferation medium with differentiation medium. This medium 
consisted of DuIbecco's Modified Eagle's Medium (DMEM) I Ham's F12 
supplemented with penicillin (60J.!g/ml), streptomycin (100J.!g/ml) and typically Ex-
cyte III (1% v/v), Insulin (10ng/ml) and TJ (2nM) , unless otherwise stated. The 
medium was only replaced with fresh medium every 4 days. 
2.2.2.4 Culture of 3T3-F442A pre-adipocytes 
3T3-F442A pre-adipocytes were cultured in Dulbecco's Modified Eagle's Medium 
(DMEM) containing 2mM glutamine and supplemented with 100units/ml penicillin, 
100J.!g/ml streptomycin (penlstrep) and 10% (v/v) Newborn Calf Serum (NCS) 
(growth medium). The cell we!e grown in a 90%02:10%C02 atmosphere at 370 C . 
. , 
Stock cultures were passaged routinely at approximately 80% confluence using 1ml of 
0.25% trypsin I EDTA solution. For experimental purposes, pre-adipocytes were 
seeded at O.lxl06 cells, and grown to confluence in 24 well plates, unless stated 
otherwise. The growth medium was changed every 48 hours. 
2.2.2.5 Differentiation of 3T3-F442A pre-adipocytes 
To convert the 3T3-F442A pre-adipocytes to adipocytes, the pre-adipocytes were used 
between passages 6 and 14, and grown to confluence. Two day confluent cultures 
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were induced to differentiate by replacing the growth medium with DMEM containing 
2mM glutamine, sup~lemented with penistrep, 10% Foetal Calf Serum (FCS) and 
5J.iM insulin (28.7Jlg/ml) (differentiation medium). The differentiation medium was 
replaced with fresh differentiation medium every 72 hours. Under these conditions, at 
least 80% of the pre-adipocytes converted to adipocytes by day 8. 
2.2.3 Procedures using ovine and rat explant tissue 
2.2.3.1 Lipolysis assay 
Ovine or rat adipose tissue explants were prepared (as described earlier), and the rate 
of lipolysis of either fresh tissue or after tissue culture. was measured as glycerol 
release during a 3 hour incubation period at 37°C in 2.5mls Ringer's bicarbonate 
medium supplemented with Img/ml D-glucose, 2mM acetate, 25mM Hepes (PH 7.4) 
and 3% BSA (dialysed and fatty acid free) as described by Vernon & Finley (1985). 
The incubation medium was supplemented with honnones and other agents, as 
described in the results chapters. After the 3 hour incubation period, 1 ml of the 
medium was removed and transferred to NA5 tubes containing 120JlI of 45% (w/v) 
perchloric acid (on ice) to deproteinise it. This was followed by a 15 minute 
centrifugation period at 2500 rpm in an MSE benchtop centrifuge. 800Jll of the 
supernatant was removed and transferred to LP4 tubes containing 85JlI 5M KOH and 
170JlI of saturated KHC03. These were then mixed and centrifuged again for 15 
minutes at 2500 rpm. Following this step, 800Jll of the supernatant was removed to 
fresh LP3 tubes and stored at -20°C prior to the detennination of glycerol content. 
The weight of the tissue explants from each sample was recorded by blotting them and 
weighing them prior to them being discarded. 
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2.2.3.2 Glycerol assay 
Glycerol concentration was measured as described previously (Aitchison et al., 1982). 
The samples were defrosted mid centrifuged for 15 minutes at 2500 rpm in an MSE 
benchtop centrifuge. After this period, 30J.11 of each supernatant was placed in 
triplicate into a 96 well plate, and 200J.d of assay mix was added to each well. This 
consisted of 13.5ml of 0.25M triethanol ammonium chloride buffer (PH 7.5), 2.49ml 
of2mglml NAD, 2.71ml of 5mglml ATP, 24SIlI of 1M MgCh, 12111 of Triton X-I00 
(10%), 212J,11 of Imglml Diaphorase, 20J,11 of 10mglmi Glycerol-3-phosphate 
dehydrogenase (G-3-PDH), SOSIlI. of distilled water and. Smg of (3-
{4,5dimethylthiosal-2-yl }-2,5-diphenyl-tetrazoliumbromide] (MTT). The assay mix 
was made up in a light-protected bottle containing a magnesium flea, and was stirred 
at 40C. Glycerol levels were determined by the addition of 50J,11 of glycerol kinase 
(4units/ml) to each well, and the plates were incubated at room temperature for 45 
minutes in the dark. After this period, the plate was read at 600nm absorbance on a 
Titertek plate reader. Glycerol levels were calculated from a glycerol standard curve 
that was measured on each 96 well plate over a concentration range of 2nm to 20nm. 
For tissue explants, the number of adipocytes per gram of tissue was determined, as 
described in section 2.2.6. The rate of glycerol release was expressed as Ilffiol 
glycerol / hr / l06cells. 
2.2.3.3 Lipogenesis assay 
Adipose tissue explants were prepared (as described previously) and various 
hormones and I or other agents were added to the culture medium, as indicated in the 
results chapters. The rate of lipogenesis of fresh tissue and tissue after culture was 
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determined by measUring the amount of 14C-Iabelled sodium acetate incorporated into 
the cell lipid over a 2 hour period, using the method described by Vernon & Finley 
(1988). Prior to the measurement of the rate of lipogenesis, the tissue was transferred 
'to 24 well plates containi~g 2.5ml of fresh cul~e medium. 100J.lI of 2.5 J.lCilml [14C]_ 
acetate was added to each of the wells for a 2 hour period. The ti1lsue was then 
removed from the medium, blotted on filter paper, and weighed. To obtain blank 
values, .100ill of 2.5J.lCilml [14C]-acetate was added to 3 wells containing tissue 
explants for one. minute before the tissue was blotted and the dry weight taken. The 
tissue was then transferred to a glass mini-scintillation vial, and the samples were 
dissolved in a scintillation cocktail comprising of 2ml of toluene plus 4ml of opti-
fluor scintillants. The samples were vortexed for 10 seconds each, and counted in a 
Packard 1600~R liquid scintillation analyser. To obtain a value for total counts, 10J.lI 
of medium was removed from 4 wells at random and transferred to glass mini-
scintillation vials. 4m1 of emulsifier safe was added and the total counts were counted 
in a Packard 1600 TR liquid scintillation analyser. The number of adipocytes per 
gram of tissue was determined, as described in section 2.2.6. The rate of lipogenesis 
was expressed as nmol acetate i~corporated / hr / 106cells. 
2.2.4 Procedure using ovine adipocyte cells 
2.2.4.1 Lipolysis assay 
Differentiation medium was removed from the wells, the cells, were washed once with 
0.5ml of PBS, and the medium was replaced with Iml Ringer's bicarbonate medium 
supplemented with Imglml D-glucose, 2mM acetate, 25mM Hepes (PH 7.4) and 3% 
BSA (dialysed and fatty acid free). The rate of lipolysis was measured as glycerol 
release during a 3 hour incubation period at 37°C in a modification of the method 
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described by Vernon & Finley (1985). After the 3 hour incubation period, 800)..l1 of 
the medium was removed and transferred to NA5 tubes containing 96)..l1 of 45% (w/v) 
. . 
perchloric acid (on ice) .. to deproteinise it. This was followed by a 15 minute 
centrifugation period at 2500 rpm in an MSE benchtop centrifuge. 600)..l1 of the 
supernatant was removed and transferred to LP4 tubes containing 64)..l1 5M KOH and 
128J..lI of saturated KHC03. These were then mixed and centrifuged again for 15 
minutes at 2500 rpm. Following this step, 600)..l1 of the supernatant was removed to 
fresh LP3 tubes and stored at -200 C prior to the determination of glycerol content 
(section 2.2.3.2). 
2.2.4.2 Determination of cell numher 
After the medium had been removed for the lipolysis assay, the cell number was 
determined for each well by detaching the cells using 0.25% trypsin / EDT A solution 
for 1 minute, resuspending the cells in 20ml of proliferation medium, and counting the 
cell number using a haemocytometer. 
2.2.5 Procedure using 3T3-F442A adipocyte cells 
2.2.5.1 Lipolysis assay 
Differentiation medium was removed from the cells and replaced with differentiation 
medium minus FCS and insulin 8 days after the induction of adipogenesis, unless 
stated otherwise. After an overnight period, growth hormone (100ng/ml) and / or 
insulin (100ng/ml) were added to the medium for either 24 hours or 48 hours, as 
indicated in the results chapters. Prior to the measurement of the rate of lipolysis, the 
medium was removed, the cells washed once with 0.5ml of PBS, and the rate of 
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lipolysis was measured as glycerol release during a 3 hour incubation period at 370 C 
in Iml Ringer's bicarbonate medium supplemented with Img/ml D-glucose, 2mM 
acetate, 25mM Hepe~ (PH 7.4) and 3% BSA (dialysed and fatty acid free). The 
amount of glycerol released was determined as ~n section 2.2.3.2. 
2.2.5.2 Lipogenesis assay /14Cjacetate 
Differentiation medium was removed from the cells and replaced with differentiation 
medium minus FCS and insulin 8 days after the induction of adipogenesis, unless 
stated otherwise. After an overnight period, growth hormone (100ng/ml) and I or 
insulin (100ng/ml) were added to the medium for either 24 hours or 48 hours, as 
indicated in the results chapters. Prior to the measurement of the rate of lipogenesis, 
the medium was removed, the cells washed once with O.5ml of PBS, and the medium 
replaced with freshlml of fresh D~EM (4.5g/l glucose, unless otherwise stated), 
containing 2mM glutamine and supplemented with 100 units/ml penicillin and 
100Jlg/ml streptomycin (pen/strep). The rate of lipogenesis was determined by 
measuring the amount of 14C-Iabelled sodium acetate incorporated into cell lipid over 
a 4 hour period (unless indicated otherwise), using a modification of the method 
described by Vernon & Finley (1988). I·JlCilml [14C]-acetate + 2mM cold sodium 
acetate were added to the medium for a 4 hour period, after which time the medium 
was removed, the cells were washed once before being lysed by the addition of GIT 
buffer (O.IM EDTA pH 8.0, containing SM guanidine. thiocyanate, Melford 
Laboratories Ltd., Suffolk, UK). To obtain blank values, 100Jll of IJlCilml [14C]-' 
acetate + 2mM cold acetate were added to 3 wells containing cells for one minute 
before the medium was removed and the cells were lysed. Lysates were transferred to 
I.Sm1 eppendorf tubes, and lipids were extracted by the addition of an equal volume 
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of water-saturated chloroform. The samples were mixed well and centrifuged at 
10,000g for 5 minutes in an eppendorf centrifuge (5402). The upper aqueous layer 
was carefully removed and kept separate for the determination of DNA content. The 
. . 
lipid-containing chloroform layer was transferr~d to a glass mini-scintillation vial and 
allowed to dry overnight. Samples were then dissolved in a scintillation cocktail 
comprising of Iml of toluene scintillation fluid and 4ml ofEcoLite (lCN). To obtain a 
value for total counts, 10J.l.l of medium was removed from 4 wells at random and 
transferred to glass mini-scintillation vials. 4ml of emulsifier safe was added. The 
samples were counted in a Packard 1600 TR liquid scintillation analyser, and the rate 
of lipogenesis was expressed as ~ol acetate incorporated / hr / mg of DNA. The 
amount of DNA was determined, as described in section 2.2.5.4. 
2.2.5.3 Lipogenesis assay /uCjgluco$e 
Differentiation medium was typically removed from the cells and replaced with 
differentiation medium minus FCS and insulin 8 days after the induction of 
adipogenesis, unless stated otherwise. After an overnight period, growth hormone 
(100ng/ml) and / or insulin (100nglml) were added to the medium for either 24 hours 
or 48 hours, as indicated in the results chapters. Prior to the measurement of the rate 
of lipogenesis, the medium was removed, the cells washed once with 0.5ml of PBS, 
and the medium replaced with freshlml of fresh DMEM (4.5g/1 glucose, unless 
otherwise stated), containing 2mM glutamine and supplemented with 100 units/ml 
penicillin and 100J.l.g/ml streptomycin (pen/strep). The rate of lipogenesis was 
determined by measuring the amount of 14C-labelled D-glucose incorporated into the 
fatty acids of cell lipid over a 4 hour period, using a modification of the method 
described by Christie et al. (1970). 0.1 J.l.Cilml [14C]-glucose was added to the 
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medium for a 4 hour period, after which time the medium was removed and the cells 
were lysed by the addition of GIT buffer. To obtain blank values, O.IJ.1Cilml e4C]-
. . 
glucose added to 3 wells ·containing ·cells for one minute before the medium was 
. . 
removed and the cells were lysed. Lysates were transferred to 1.5ml eppendorf tubes, 
and lipids were extracted by the addition of an equal volume of water-saturated 
chloroform .. The samples were mixed well and centrifuged at 10,000g for 5 minutes 
in an eppendorf centrifuge (5402). The upper aqueous layer was carefully removed 
and kept separate for the determination of DNA content. The lipid-containing 
chloroform layer was transferred to a glass mini-scintillation vial and allowed to dry 
overnight, prior to the glucose extraction. Once the lipid was dry, 3ml of 5% H2S04 ; 
95% Methanol was added and the samples were mixed well, the pressure being 
released from the vials occasionally. The tubes were sealed with tape and were 
incubated at 80°C for 2 hours, vorte~ing every 30 minutes. The vials were removed 
from the oven, and the samples were allowed to cool before being transferred to 15ml 
plastic centrifuge tubes. 2m1 of distilled water and 2 ml of petroleum ether (40-60oC) 
were added to each sample, and after vortexing, they were centrifuged at 1500 rpm for 
15 minutes at 15°C in a Beckman Benchtop centrifuge. The upper phase was 
transferred to a glass scintillation vial, and'the extraction was repeated, combining the 
upper phases for the 2 extractions. The solvent was removed using a nitrogen line, 
then the scintillation cocktail of Iml of toluene scintillation fluid and 4m1 of EcoLite 
(lCN) was added to the vials. To obtain a value for total counts, 10J.11 of medium was 
removed from 4 wells at random and transferred to glass mini-scintillation vials. 4ml 
of emulsifier safe was added. The samples were counted in a Packard 1600 TR liquid 
scintillation analyser, and the rate of lipogenesis was expressed as J.1Mol glucose 
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incorporated I hr I mg DNA. The amount of DNA was determined, as described in 
section 2.2.5.4 .. 
2.2.5.4 DNA assay 
The amount of DNA present was determined according to the method of Labarca & 
Paigen (1980) using calf thymus DNA as the standard. The upper aqueous layer 
samples retained from the lipogenesis assays and ACC assay were used as the samples 
for the DNA assay. 25J.l.l of each sample was added to 975J.l.l of DNA assay buffer 
(2M NaCI, O.lM NaH2P04), and the standard was made up to lml, with a 
concentration range of OJ.l.g/ml, O.25J.l.g/ml, O.5J.l.g/ml, IJ.l.g/ml, 2J.l.g/ml to 5J.l.g/ml. 
Standards and samples were incubated with 500J.l.I of 3J.l.g/ml Bisbenzimine (Fluka 
Chemicals, Dorset, UK) to give a fmal concentration of I J.l.g/ml Bisbenzimine. After 
30 minutes, the fluorescence was .read in a Perkin-Elmer LS-5 luminescence 
spectrometer (excitation 360nm, emission 475nm). 
2.2.5.5 Acetyl CoA carboxylase (ACC) assay 
Differentiation medium was re~oved from the cells and replaced with differentiation 
medium minus FCS and insulin 8 days after the induction of adipogenesis. After an 
overnight period, growth hormone (IOOng/ml) and I or insulin (IOOng/ml) were added 
to the medium for either 24 hours or 48 hours, as indicated in the results chapters. 
Following the chronic and I or acute treatment of 3T3-F442A adipocyte cells with 
hormones, as indicated in the results chapters, total activation and the proportion of 
active acetyl CoA Carboxylase (ACC), the rate-limiting enzyme in fatty acid 
synthesis, present in the' adipocytes was determined using a modification of the 
method of Borland et al. (1994). For this purpose, the 3T3-F442A adipocytes were 
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grown in 6 well tissue culture plates. To prepare the samples, medium was removed 
from the wells· and the cells were washed twice with ice-cold Phosphate Buffered 
Saline (PBS). 4 wells of each· 6 well. plate were scraped into 1ml of homogenising 
·buffer (PH 7.4), consistmg of 300mM sucros~, 30mM Tris, 1mM EDTA and 1mM 
GSH (reduced glutathionine), using a plastic rod, and the homogenate was passed 
through. a 26 gauge needle ~everal times. This was then centrifuged for at 14,000 rpm 
for 1 minute at 4°C in an eppendorf centrifuge (S402), and the supernatant was 
transferred to a fresh eppendorf tube. The sample was assayed for ACC activity 
immediately. 
To measure the initial ACC activity in each sample, O.IM NaF was also included in 
the homogenising buffer. The samples were prepared one at a time, and assayed for 
ACC activity immediately. IS0J.11. of each sample was transferred to a glass 
scintillation vial which contained 8S0J.11 of assay mix with or without acetyl CoA. The 
assay mix consisted of 100J.11 of200mM Tris / HCI (PH 7.S), 200J.11 of 100mM MgCh, 
200J.11 of 1mM EDTA, 100J.11 of200mM citrate (PH 7.S), S0J.11 of SOmg/ml BSA, 1OJ.11 
of 100mM GSH, 100J.11 of 7S~ ATP (PH 7.S), 2SJ.11 of sodium[14C]bicarbonate 
(2J.1Cilml NaH14C03 made up in 500mM sodium bicarbonate at a ratio of 1 :40), 20J.11 
of 4.2SM sodium fluoride, plus or minus 50J.11 of 3.6mg/ml acetyl CoA, and made up 
to 8S0J.11 with distilled water. The (+) acetyl CoA samples were done in triplicate and 
the (-) acetyl CoA samples were done individually. The assay mixes were stoppered 
in the glass scintillation vials, and stored at 40 C until immediately prior to the assay~ 
then only the vials required for one homogenate were placed in a water bath at 37°C. 
The homogenate was prepared as described above, and 150J.11 was transferred to each 
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vial for 90 seconds.' The reaction was stopped by adding 200J.lI of 6N HCI to each 
vial, after which time the vials were transferred to a heating block at 65°C for 75 
minutes. After the samples had cooled, 10mls of emulsifier safe was added to each 
vial, and the samples were counted in a Packar4 1600 TR liquid scintillation analyser. 
To mea$ure the total ACC activity in each sample, the homogenates were prepared as 
described above; but no NaF was present in the homogenising buffer and the samples 
were pre-incubated in assay mix at 37°C prior t~ addition of acetyl CoA. The amount 
of ACC activity was expressed as picomole / minute / mg DNA. The amount of DNA 
was determined, as described in section 2.2.5.4. 
2.2.6 Determination of mean cell volume and numher of adipocytes per gram of 
tissue 
Rat or ovine tissue explants were prepared as described earlier (sections 2.2.1.1 and 
2.2.1.2). The explants were added to 5ml of a collagenase digest mix of 1mg/ml 
collagenase (type II) and 40 mglml BSA made up in Medium 199, and were left at 
37°C for between 5 and 7 hours, without shaking (to minimise disruption of the cells). 
After passing through a sieve, samples (5~1) of cell suspension were transferred to a 
warm haemocytometer, and the diameter of 100 cells was measured using a Projectina 
microscope at X 145 magnification. An estimate of the number of cells per gram 
tissue was obtained by dividing the totai lipid content of the tissue (see section 2.2.7) 
by the mean cell volume and multiplied by lipid density (taken to be 0.915). 
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2.2.7 Determination of lipid content of ovine and rat adipose tissue (Folch 
Extraction) 
Rat or ovine tissue explaIJ.ts were prepared as described earlier (sections 2.2.1.1 and 
2.2.1.2). Tissue pieces were blotted and wei~ed, before being added to 30 ml glass 
centrifuge tubes containing 2 drops of IN HCI and 8ml of chlorofonn I methanol 
(1:1). 1.be tubes were shaken and left at room temperature overnight, after which time 
4ml of ~hlorofonn was added. The tubes were shaken again and left for a minimum 
period of 2 hours. 3ml of 0.88% KCI was then added to the tubes and the tubes were 
shaken again before being centrifuged at 2500 rpm for 15 minutes. The upper phase 
was removed and the lower phase was taken to dryness using a rotary evaporator. The 
remaining lipid was then re-dissolved in 3ml of chlorofonn, filtered into a weighed 
glass scintillation vial and placed on a heating block at 6SoC under an airline to 
remove the chlorofonn. After the vials had been left to cool they were weighed again. 
The difference in weight of the vial gave the lipid weight. 
2.2.8 Statistical analysis 
Each group of observations was obtained from a different animal (rats and sheep). 
Each observation was obtained from 3 replicates. Results are presented as means +1-
S.E.M. and statistical analysis was by Student's t-test for either paired or unpaired 
observations, using Analysis of Variance (ANOVA) or REsidual Maximum 
Likelihood (REML ; Patterson & Thompson, 1971), as indicated in the text. 
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CHAPTER THREE 
THE EFFECT OF TUMOUR NECROSIS FACTOR 
ALPHA (TNFa) ON LIPOLYSIS AND 
LIPOGENESIS IN o VINE ADIPOSE TISSUE 
IN VITRO 
3.1 Introduction 
Lipolysis is under complex and acute endocrine control. The rate-limiting enzyme 
. . . 
hormone-~ensitive lipase (HSL) can be phosphorylated and activated by cAMP-
dependent protein kinase A (pKA), so changes' in adenylate cyclase (AC) activity are 
closely .connected with the control of lipolysis (Belfrage, 1985). Growth hormone 
(GH) is' thought to alter lipolysis via indirect mechanisms by altering the maximum 
response or sensitivity of adipocytes to acutely acting lipolytic or antilipolytic agents. 
Chronic treatment with bovine GH in vivo increases the lipolytic response of adipose 
tissue to catecholamines in vitro in rats (Vernon et al., 1987) and sheep, and in vivo in 
cows (McCutcheon and Bauman, 1986; Peters, 1986; Sechen et al., 1990). Chronic 
treatment with bovine GH in vivo or in vitro reduces the response to the antilipolytic 
effects of the adenosine analogue PIA in rat (Vernon et al., 1987; Doris et al., 1994) 
and bovine (Lanna et al., 1992) adipose tissue in vitro. The mechanism whereby GH 
chronically regulates lipolysis and lipogenesis is not resolved. Studies by Borland et 
al. (1994) have implicated a protein with a very short half-life that is possibly a 
secreted protein. 
The cytokine Tumour Necrosis Factor alpha (TNFa) is produced and secreted by 
adipocytes. It has been published by Green et al. (1994) that TNFa chronically causes 
an increase in lipolysis in rat epididymal adipocytes like that' of GH. This raised the 
. possibility that TNFa might be this putative secreted protein. so initial studies were 
carried out comparing the effect of GH and TNFa on lipolysis and also lipogenesis in 
ovine and rat adipose tissue explants. 
75 
3.2 Experimental procedure 
3.2.1 Lipolysis assay-: ovine and rat adipose tissue explants 
Ovine subcutaneous or popliteal adipose tissue explants or rat adipose tissue explants 
were prepared, as described in sections 2.2.1.1 and 2.2.1.2, and cultured in Medium 
199 for 24 hours in 24 well plates. The explants were then transferred to fresh 
Mediuni 199 that either had no additions (con), growth hormone added (gh ; 
lOOng/nil) or Tumour Necrosis Factor alpha added (TNFa (murine, unless stated 
otherwise) ; 20nglml or SOng/ml, as indicated). These were left at 37°C for a further 
24 hours, after which time the tissue Was transferred to 2.5mls of Ringer's bicarbonate 
medium (+ 3% BSA + Img/ml glucose + 2mM sodium acetate + 25mM Hepes) for 3 
hours at 370 C. This contained either no additions (basal), + adenosine deaminase (ad 
; 8~g/ml), ad + isoproterenol (isop ; lO-sM) or ad + isop + PIA (lOOnM, unless 
otherwise indicated). After the 3 'hour incubation period, Iml of medium was 
removed and assayed for glycerol content, as described in section 2.2.3.2. 
3.2.2 Lipogenesis assay: ovine adipose tissue explants 
Ovine adipose tissue explants -were prepared, as described in section 2.2.1.1, and 
cultured in Medium 199 for 24 hours in 24 well plates. The explants were then 
transferred to fresh Medium 199 that either had no additions (con), growth hormone 
added (gh ; 100ng/ml), insulin added (ins ; 100ng/mI) or murine Tumour Necrosis 
Factor alpha added (TNFa ; 20ng/ml or SOng/mI, as indicated). These were left at 
370 C for a further 24 hours, after which time the tissue was transferred to 2.5m1s 
Medium 199 containing O.IJ.1Cilml of [14C]-sodium acetate to give a final 
concentration of 2.6mM acetate. After a 2 hour period at 370 C, the tissue was 
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removed from the m~dium, and the rate of lipogenesis was assessed, as described in 
section 2.2.3.3. 
3.2.3 Statistical analysis 
Results are expressed as the means +/- S.E.M., and statistical analysis was by analysis 
of variance CANOY A), unless stated otherwise. 
3.3 Results· 
3.3.1 Effects of growth hormone on lipolysis in ovine subcutaneous adipose tissue 
The lipolytic effects of GH were determined in primary cultures of ovine 
subcutaneous adipose tissue. After 48 hours incubation, there was an increase in the 
rate of lipolysis in both unstimulated and catecholamine-stimulated tissue explants, as 
shown in Figure 3.1. Analysis of variance shows that GH significantly increased the 
rate of lipolysis overall, also shown in Figure 3.1 CP<O.05). GH alone had a tendency 
towards causing an increase in the rate of lipolysis, which is in accordance with 
previous fmdings (Vernon et al., 1987; Watt et al., 1991). 
The experiment shown in Figure 3.2 indicates that GH also has a tendency to diminish 
the inhibition effect of PIA on lipolysis, as found previously (Vernon et al., 1991b; 
Doris et al., 1994). 
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Effect of Growth Hormone on basal and stimulated lipolysis in 
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ovine subcutaneous adipose tissue 
4 
-tn 
-Q) 
(,) 
U» 
~3 
-l!! 
.c 
M 
-'0 DdayO 
~ !::lcon 
-CD ~gh 
tn 
ca 
CD 
Q) 
... 
-1 e 
CD (,) 
~ 
C) 
0 
Figure 3.1. Subcutaneous adipose tissue was removed from the sheep and tissue 
explants were cultured in Medium 199. After 24 hours, Growth Hormone (gh ; 100ng/ml) 
was added for a further 24 hour period prior to !he measurement of the rate of lipolysis 
(con = control). The explants were washed and the medium was changed to Ringer's 
Bicarbonate medium, with either no addition (basal), adenosine deaminase (ad ; 8~ml) 
or ad + isoproterenol (isop ; 10·5M). After a 3 hour incubation period, medium was 
removed and assayed for gly.cerol content, which is a measure of the rate of lipolysis. 
Day 0 tissue was assayed at the time the tissue was removed from the sheep. Results 
are the means of 8 observations, + S.E.M. 
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Figure 3.2, Subcutaneous adipose tissue was 'removed from the sheep and tissue 
explants were cultured in Medium 199. After 24 hours, Growth Hormone (gh : 100ng/ml) 
was added for a further 24 hours prior to the measurement of the rate of lipolysis (con = 
control). The explants were washed and the medium was changed to Ringer's 
Bicarbonate medium, with adenosine deaminase (8j.LQ/ml) + isoproterenol (10·oM) + 
various concentrations of PIA, as indicated. After a 3 hour incubation period, medium 
was removed and assayed for glycerol content. Day 0 tissue was assayed at the time 
. the tissue was removed from the sheep. Results are the means of 6 observations, 
+/- S.E.M. 
3.3.2 Effects of tumour necrosis factor alpha (TNF a) on lipolysis in ovine 
subcutaneous adipose tissue 
The chronic effects of the cytokine, TNFa, on lipolysis were investigated to determine 
whether it produced similar effects to GH in primary cultures of ovine subcutaneous 
adipose tissue. Murine TNFa appeared to cause a slight increase in basal lipolysis, as 
shown in Figure 3.3, but the effect was not significant TNFa also had no effect on 
catecholamine-stimulated lipolysis. GH caused a decrease in the ability of PIA to 
inhibit lipolysis, as shown in Figures 3.4 and 3.5 (P<0.05). TNFa had also tended to 
decrease response to PIA, the percent. inhibition being intermediate between that of 
GH and the control value (see Figures 3.4 and 3.5). 
The concentration of TNFa was increased from 20 ng/ml to 50 ng/ml to investigate 
whether this altered the TNFa effect" on the rate of lipolysis. However, the TNFa 
effect did not significantly change, as shown in Figure 3.6. The effect of murine 
TNFa was compared with the effect of human TNFa to test ifTNFa from a different 
species had a greater effect on the rate of ovine lipolysis. Figure 3.7 shows that there 
was no obvious difference between the two TNFa from different species. 
3.3.3 Hormone effects on lipolysis measured at two regions in ovine popliteal 
adipose tissue 
Studies on ovine popliteal adipose tissue explants were undertaken to investigate if 
. the distance from the lymph node caused variation in the effect ofTNFa on the rate of 
lipolysis (see introduction, chapter 1, section 1.4.1). TNFa had no effect on basal, 
catecholamine-stimulated or PIA-inhibited lipolysis in adipose tissue from "near" 
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Effect of Growth Hormone and TNFa on lipolysis in ovine 
. subcutaneous adipose tissue 
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Figure 3.3. Subcutaneous adipose tissue was removed from the sheep and tissue 
explants were cultured in Medium 199. After 24 hours, either Growth Hormone (GH ; 
100ng/ml) or murine TNFa. (20ng/ml) 'were ad~ed for a further 24 hour period prior to the 
measurement of the rate of lipolysis (CON = control). The explants were washed and 
the medium was changed to Ringer's Bicarbonate medium, with either no additions 
(basal), adenosine deaminase (ad; 8j.Lg/ml) +/- isoproterenol (isop ; 10-5M) +/- PIA 
(100nM), as shown. After a 3 hour incubation period, medium was removed and 
assayed for glycerol content. Results are the means of 7 observations + S.E.M. 
Effect of Growth Hormone and TNFa on the inhibition of lipolysis 
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Figure 3.4. Subcutaneous adipose tissue was removed from the sheep and tissue 
explants were cultured in Medium 199, After 24 hours, either Growth Hormone (GH ; 
100ng/ml) or murine TNFa. (20ng/ml) were add~d for a further 24 hour period prior to the 
measurement of the rate of lipolysis (CON = control). The explants were washed and 
the medium was changed to Ringer's Bicarbonate medium, with adenosine deaminase 
(ad; 8f.L9/ml) + isoproterenol (isop ; 1 O~M) + various concentrations of PIA, as 
indicated. After a 3 hour incubation period, medium was removed and assayed for 
glycerol content. Results are the means of 4 observations, +/- S.E.M. 
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Figure 3,5, Adipose tissue was removed from ovine subcutaneous tissue and explants 
were cultured in Medium 199. After 24 hours, 'either Growth Hormone (GH : 
1 DOng/ml), or murine TNFa. (20ng/ml) were added for a further 24 hour period prior to 
the measurement of the rate of lipolysis (CON = control), The explants were 
washed and the medium was changed to Ringer's Bicarbonate medium, containing 
either adenosine deaminase' (8~/ml) + isoproterenol (10-sM) or ad + isop + PIA 
(100nM), After a 3 hour incubation period, medium was removed and assayed for 
glycerol content. Results are the means of 7 observations + S.E.M. 
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Figure 3.6. Subcutaneous adipose tissue was removed from the sheep and tissue 
explants were cultured in Medium 199. After 24 hours. either Growth Hormone (GH ; 
100ng/ml) or murine TNFex. (2Dng/ml or 50ng/ml) were added for a further 24 hour 
period prior to the measurement of the rate of,lipolysis (CON - control). The 
explants were washed and the medium was changed to Ringer's Bicarbonate medium 
with either no additions (basal) . adenosine deaminase (ad; 81J.g/ml) +1- isoproterenol 
(isop ; 1 D·oM) +1- PIA (100nM). as shown. After a 3 hour incubation period. medium 
was removed and assayed for glycerol content. Results are the means of 2 
observations. 
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Figure 3.1. Subcutaneous adipose tissue was removed from the sheep and tissue 
explants were cultured in Medium 199. After 24 hours, either Growth Hormone (GH ; 
100ng/ml), murine-derived TNFa. (?Ong/ml) or human-derived TNFa. (20ng/ml) were 
added for a further24 hour period prior to the measurement of the rate of lipolysis 
(CON = control) . The explants were washed and the medium was changed to 
Ringer's Bicarbonate medium, with adenosine deaminase (8f.Lg/ml) +1- isoproterenol 
(isop ; . 10~M) +1- PIA (100nM), as shown. After a 3 hour incubation period, medium 
was removed and assayed for glycerol content. Results are the means of 2 
obseNations. 
(lOmm or less) or "far" (greater than lOmm) from the lymph node, as is shown in 
Figure 3.8. In contras~ growth hormone increased basal lipolysis in both "near" and 
"far" adipose tissue, and decreased the 'response to PIA in "far" but not "near" ovine 
adipose tissue explants. GH had no significant effect on response to isoproterenol. An 
increase in the concentration of TNFa. had no apparent effect on the rate of lipolysis 
or the inhibitory effects of PIA on lipolytic rate (results not shown). 
Some site-specific differences were observed, however. The response of the adipose 
tissue to isoproterenol was greater in the "far" depots than in the "near" depots, and 
. . 
being further away from the lymph node resulted in an increased tendency towards 
increased basal lipolysis. As shown in Figure 3.9, the response to PIA was greater in 
"far" than in "near".. This suggests that although "near" does not respond to TNF a, 
there appears to be some differences. with "far" that could be due to proximity to 
lymph nodes. 
3.3.4 Effects of growth hormone and TNFaon lipolysis in rat adipose tissue 
explants 
The chronic effects of both GH and TNFa on lipolysis in rat adipose tissue explants 
were investigated. After 48 hours incubation, there was an increase in the rate of 
lipolysis in both unstimulated and catecholamine-stimulated primary tissue explants, 
as shown in Figure 3.1 O. Neither hormone had a significant effect on the rate of 
lipolysis. Figure 3.11 shows that both GH and TNFa. tended to diminish the" 
inhibitory effect of the adenosine analogue, PIA, on lipolytic rate (P=O.07 for TNFa). 
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,Figure 3.8. Popliteal adipose tissue was removed from the sheep and tissue 
explants from (a) within a 1 cm radius from the lymph node ("nearj, and (b) more 
than 1, cm radius from the lymph node ("farj were cultured in Medium 199. A~er 
24 hours, either Growth Honnone (GH ; 100ng/ml) or TNFa. (20ng/ml) were added 
to the medium for a further 24 hour period prior to the measurement of the rate of 
lipolysis (CON = control). The explants were washed and the medium was 
changed to Ringer's Bicarbonate medium, with either no additions (basal), 
adenosin'e deaminase (ad ; 8~ml) +1- isoproterenol (isop ; 10-5M) +/- PIA 
(1 OOnM), as shown. After a 3 hour incubation period, medium was removed and 
assayed for glycerol content. Results are the means of 4 observations, + S.E.M. 
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Figure 3,9, Popliteal adipose tissue was removed from the sheep and tissue 
explants from (a) within a 1cm radius from the .lymph node C'near'), and (b) more 
than 1 cm radius from the lymph node ("far'1 were cultured in Medium 199. After 
24 hours, either Growth Hormone (GH ; 100ng/ml) or TNFa. (20ng/ml) were added 
to the medium for a further 24 hour period prior to the measurement of the rate of 
lipolysis (CON = control). The explants were washed and the medium was 
changed to Ringer's Bicarbonate medium, with adenosine deaminase (ad; 
8~/ml) + isoproterenol (isop ; 10-5M) +1- PIA (100nM). After a 3 hour incubation 
period, medium was removed and assayed for glycerol content. Results are the 
means of 4 observations, + S.E.M. 
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Figure 3.10. Adipose tissue was removed from the rat fat pads and tissue explants 
were cultured in Medium 199. After 24 hours, either Growth Hormone (GH ; 
100ng/ml), or murine TNFo. (20ng/ml) were added for a further 24 hour period prior to 
the measurement of the rate of lipolysis (CON = control). The explants were 
washed and the medium was changed to Ringer's Bicarbonate medium, containing 
either no additions (basal), adenosine deaminase (ad ; 8~/ml) +/- isoproterenol 
(isop; 10-5M) +/- PIA (100nM), as indicated. After a 3 hour incubation period, 
medium was removed and assayed for glycerol content. Day 0 tissue was assayed 
at the time the tissue was removed from the rat. Results are the means of 6 
observations + S.E.M. 
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Figure 3.11. Adipose tissue was removed from the rat fat pads and tissue explants 
were cultured In Medium 199. After 24 hours, 'either Growth Hormone (GH ; 
1 OOng/ml) , or murine TNFa. (20ng/ml) were added for a further 24 hour period prior to 
the measurement of the rate of lipolysis (CON = control). The explants were 
washed and the medium was changed to Ringer's Bicarbonate medium, containing 
either adenosine deaminase (8J.L9/ml) + isoproterenol (10-5M) or ad + isop + PIA 
(100nM). After a 3 hour incubation period, medium was removed and assayed for 
glycerol content. Results are the means of 6 observations + S.E.M. 
1.3.5 Hormone effects on the rate of lipogenesis in ovine subcutaneous adipose 
tissue explants 
Studies on ovine subc~taneous adipose- tissue explants were undertaken to investigate 
- -
the chronic effects on GR, insulin and lNFa ()n lipogenesis. Figure 3.12 shows that 
GH caused a reduction in lipogenic rate, while chronic exposure to insulin resulted in 
a large increase in lipogenesis. Chroiuc incubation with lNFa alone and lNFa plus 
GH together did not _ alter the lipogenic rate significantly. However, inclusion of 
TNFa with insulin resulted in a reduction (P<O.Ol) in lipogenesis (see Figure 3.12). 
There was no apparent different effect on the rate of lipogenesis in the absence or 
presence of GH or insulin when the concentration of lNFa. was increased from 20 
nglml to 50 nglml (results not shown). 
1.1.6 Hormone effects on lipogenesis in subcutaneous adipose tissue explants of 
lactating sheep 
The effects of dexamethasone, insulin and lNFa were investigated on the rate of 
lipogenesis in subcutaneous adipos~ tissue explants from lactating sheep, after both 24 
. 
hours and 48 hours incubation of the hormones with the tissue explants. GH 
abolishes the effects of insulin and dexamethasone after a 48 hour period, so this 
study was to determine if 'INFo. had a similar effect. After 24 hours incubation with 
insulin and dexamethasone, there was a slight increase in the rate of lipogenesis, as 
shown in Figure 3.13. 'INFo. had no effect on lipogenesis by itself, and it did not' 
reduce stimulation of lipogenesis by insulin and dexamethasone. After a further 24 
hours incubation, there was a much greater increase (p<0.001) in lipogenesis in the 
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presence of insulin and dexamethasone. Again, there was no effect on lipogenic rate 
by the presence ofTNFa.. However, TNFa. did cause inhibition of the stimulation of 
. . 
lipogenesis by insulin and· dexamethasone (P<O.OOl), reducing the level to half that 
seen in the absence ofTNFa.. 
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Figure 3.12. Subcutaneous adipose tissue was removed from the sheep and tissue 
explants were cultured in Medium 199. After 24 hours, the medium was replaced by 
fresh medium, with either no additions (con), Growth Hormone (gh ; 100ng/ml), 
Insulin (ins; 100ng/ml) added +/- TNFa. (20ng/ml). These hormones were present in 
the medium for 24 hours prior to the measurement of the rate of lipogenesis. This 
was determined by measuring the amount of 14C-labelled sodium acetate 
incorporated into the tissue explants over a 2 hour period. Results are the means of 
5 observations, + S.E.M. 
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Figure 3.13. Subcutaneous adipose tissue was removed from the sheep and tissue 
explants were cultured In Medium 199. After 24 hours, the medium was replaced by 
fresh medium, with either no additions (con), dexamethasone (dex ; 100ng/ml) and/or 
Insulin (ins; 100ng/ml) and/or TNFa. (20ng/ml) added. These hormones were 
present In the medium for either 24 or 48 hours prior to the measurement of the rate 
of lipogenesis. This was determined by measuring the amount of 14C-labelled 
sodium acetate incorporated into the tissue explants over a 2 hour period. Results 
are the means of 4 observations + S.E.M. 
3.4 Discussion 
GH has acute, insulin-like effects and chronic insulin-antagonistic effects on adipose 
tissue. GH a~ts chronically on adipose tissue to enhance the rate of lipolysis and to 
decrease the rate of lipogenesis and to antagonise insulin stimulation of lipogenesis 
both in vivo and in vitro. However, mechanisms by which GH achieves its effects are 
still not fully" understood. 
It has been shown that loss of the acute insulin-like effects of GH and the 
development of enhanced lipolysis in rat adipocytes are both prevented by the addition 
. . 
of the transcription inhibitor, Actinomycin D (Goodman et al., 1987; Goodman, 
1993). Inhibition of lipogenesis by GH in sheep adipose tissue is also prevented by 
Actinomycin D (Borland et aI., 1994), which indicates that it requires transcription of 
at least one gene. Borland et al. (1994) also observed that the product(s) of gene 
transcription muSt have a relatively short half-life (less than 3 hours), but as yet it 
(they) remains unidentified. This prompted the investigation into whether the 
cytokine lNFa. could be the protein involved, as its effects appeared to be similar to 
those ofGH on adipose tissue meta~olism (Green et al., 1994; Gasic et al., 1999). 
Green and colleagues found that incubating primary rat epididymal adipocytes with 
TNFa. resulted in a 2.7-fold increase in the rate of basal lipolysis (Green et al., 1994). 
This effect required a minimum of 6-12 hours to become apparent, and was maximal 
by 24 hours incubation, which is comparable with the time course observed for GH to 
increase lipolysis (Gorin et al., 1990). I found that TNFa. incubation with the primary 
ovine subcutaneous tissue explants had no effect on either basal lipolysis or 
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catecholamine-stimulated lipolysis in ovine subcutaneous tissue, whereas GH had a 
tendency to increase lipolysis in both stimulated and unstimulated explants, as seen 
previously (e.g. Dori~ et al., 1994). Culture with GH also resulted in a decrease in 
response to PIA. TNFa. appears to attenuate the effect of PIA on sheep adipose tissue, 
but the effect is smaller than that of GH. Green and colleagues had found that 1NFa. 
had an attenUating effect on PIA inhibition of lipolysis in rats, although no significant 
effect was 'observed on isoproterenol-stimulated lipolysis (Gasic et 01., 1999). 
Chronic incubation with rat epididymal explant tissue showed that after 48 hours 
incubation, either in the presence or absence of additions, the rate of lipolysis was 
generally greatly increased, and so differences due to 1NFa. and GH were difficult to 
detect. Rat adipose tissue shows a much greater stimulation of lipolysis by adenosine 
deaminase (removal of adenosine) than is observed in ovine adipose tissue. Both GH 
and 1NFa. (consistent with Gasic et 01., 1999) had a tendency to reduce the response 
to PIA in rat explants, but the effect was not great. Overall, 1NFa. is less effective in 
changing lipolysis in sheep adipocytes than GH. 
Pond and colleagues have previously demonstrated that, in guinea pigs, adipose tissue 
around lymph nodes has properties which enables it to participate in local interactions 
with lymph node lymphoid cells (Pond & Mattacks, 1995; Mattacks & Pond, 1997). 
Lipolysis increased more than 3-fold in adipocytes near to the node when cultured 
with lymph node lymphoid cells in vitro, whereas lipolysis from adipose tissue further 
away from the node in the same depot barely doubled. Almost all lymph nodes are 
embedded in adipose tissue (Yoffey et 01., 1970) which is protected from the general 
mobilisation of fat reserves observed during starvation or fever (Pond, 1996a,b), and 
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most peripheral adip'ose tissue depots contain at least one lymph node (pond, 1996a). 
Both the lipolytic, response and fatty acid composition of triacylglycerols from 
popliteal adipose tiss~e varies' with distance from the lymph nodes in guinea pigs 
(Pond, 1996a). Cytokine's often mediate interactions between lymphoid cells and the 
immune system and other cell types. TNFa. is a cytokine produced ,by many cell 
types, including adipocytes. Type II INFo. receptors are present continuously on 
adipocytes around the popliteal lymph node, and it has been shown that endotoxin 
(lipopolysaccharide) injection results in the appearance of INFo. type I receptors and 
enhanced lipolysis on adipocytes near the lymph node, but not from further away in 
, ' 
rat adipose tissue (MacQueen & Pond, 1998; Pond & Mattacks, 1998). However, the 
results in this chapter indicate that there are no differences in the ability of TNFa. to 
stimulate basal, or catecholamine-stimulated lipolysis in adipose tissue from either 
near or far from the lymph node in ovine popliteal tissue explants. It has also been 
found that there are no changes in fatty acid composition with distance from the 
lymph node in popliteal adipose tissue from sheep, which is consistent with my 
findings 01 emon & Pond, 1997). There appear to be some differences between 
"near" and "far", however. Ovine ,adipose tissue from "near" the lymph node showed 
a smaller increase in response to isoproterenol, and a diminished response to PIA. 
I 
This presumably reflects the proximity to the lymph node. 
Although chronic exposure to INFo. only appeared to result in a slight change in 
lipolysis in ovine and rat adipose tissue explants, I found that TNFa did cause a 
reduction in insulin stimulation of lipogenesis. INFo. did not appear to have any 
effects by itself, but it did block the effects of insulin in ovine subcutaneous adipose 
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tissue explants. It has previously been shown that in 3T3 adipocytes, 1NFa. inhibits 
lipoprotein lipaSe synthesis (Semb et a/., 1987), as well as ACC (pape & Kim, 1988), 
fatty acid-binding proteinaild glycerol phosphate dehydrogenase (Torti et a/., 1985) 
and fatty acid synthase (Pekala et a/., 1983) synthesis. All these enzymes are involved 
in fat synthesis. It has been shown that the presence of 1NFa. results.in peripheral 
insulin resistance in rats (Lang et al., 1992) and humans (Van der Poll et a/., 1991). 
Treatment of 3T3-F442A adipocytes with 1NFa. leads to downregulation of GLUT4 
mRNA (Stephens & Pekala, 1991) and downregulation in expression of GLUT4, the 
insulin stimulable glucose transporter, in rat 3T3-Ll adipocytes (Stephens & Pekala, 
1991). The TNFa. gene has been shown to be overexpressed in skeletal muscle in 
diabetic subjects (Saghizadeh et a/., 1996), as well as a high correlation being found 
to exist between levels of TNFa. mRNA, body mass index and circulating insulin 
levels in adipose tissue of obese subjects (Kern et a/., 1995), which supports the role 
of the cytokine in the induction of a generalised state of insulin resistance. 1NFa. can 
decrease the tyrosine kinase activity of the insulin receptor (IR) (Hotamisligil et a/., 
1996), and treatment of cultured murine adipocytes with TNFa. induces serine 
phosphorylation of IRS-I, converting it into an inhibitor ofIR tyrosine kinase in vitro, 
and attenuating IR signalling. This has also been observed in other cell types. The 
production of 1NF a. by adipose tissue could be a local regulator of fat size, and the 
overproduction of TNFa. in adipocytes of obese animals could represent a form of 
"adipostat", i.e. a normal homeostatic mechanism designed to limit adipocyte size in 
the face of overconsumption (Spiegelman, 1993 ; Spiegelman & Hotamisligil, 1993). 
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At the onset of lactation, the rate of lipogenesis increases greatly in mammary epithelial 
cells (Vernon & Flint, 1983), while it decreases in adipose tissue (Vernon, 1988), in 
part due to reciprocal changes in the amount of the regulatory enzyme acetyl CoA 
carboxylase and its mRNA in adipose tissue (Kim & Tae, 1994). This facilitates the 
targeting of the precursors for fatty acid synthesis to the mammary gland to satisfy the 
increased metabolic demand created by the requirement to synthesise and secrete milk. 
Insulin increases both the gene transcription and therefore the amount and the 
activation status of the enzyme (refer to chapter 1, section 1.5), while catecholamines 
decrease the activation status. Lactation alters the ability of adipocytes to respond to 
insulin, catecholamines and adenosine (Vernon, 1988). In vitro studies with adipose 
tissue from rats and sheep showed that insulin stimulation of lipogenesis was decreased 
during lactation (Burnol et al., 1986; Vernon & Finley, 1988), although not all aspects 
of insulin action are impaired. There was a small increase in stimulation of lipogenesis 
in the adipose tissue from lactating sheep when insulin was present for 24 hours, 
although the stimulation was less than that observed in tissue from non-lactating sheep, 
as seen in previous studies (Burnol et al., 1986; Vernon & Finley, 1988). However, 
after a prolonged exposure to insulin and dexamethasone in subcutaneous adipose 
tissue from lactating sheep, there was a great increase in stimulation of lipogenesis, 
consistent with previous results (Vernon & Finley, 1988). TNFa. reduced this increase 
in stimulated lipogenesis after 48 hours by half TNFa. inhibits many enzymes involved 
in fatty acid synthesis, including ACC synthesis (Pape & Kim, 1988) and lipoprotein 
lipase synthesis (Semb et al., 1987), which is consistent with the observations seen 
here. However, the effect of TNFa. is much smaller than that found with GH, which 
completely inhibits the increase in lipogenesis by insulin and dexamethasone in adipose 
tissue from lactating sheep (Vernon & Finley, 1988). 
Thus, TNFa does not appear to be the putative secreted protein involved in GH 
regulation of lipolysis and lipogenesis in adipose tissue. I found that the effects of 
TNFa on basal lipolysis in rats and sheep were similar to those found by Green, and it 
also had similar effects to GH on inhibition of insulin-stimulated lipogenesis, but TNFa 
did not mimic all the effects of GH on adipose tissue metabolism, and its effects were 
quantitatively less than those of GH. 
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CHAPTER FOUR 
DEVELOPMENT OF THE LIPOLYTIC SYSTEM IN 
o VINE PRE-ADIPOCYTES IN VITRO 
4.1 Introduction 
Elucidating the role of growth hormone (GH) in animal growth and development has 
been the goal-of endocrinoiogists since Evans & Long (1921) observed that injections 
of crude hypophysial extracts promoted the growth of rats. Purification of the GH 
molecule (Li & Evans, 1944) and the molecular cloning of the GH cDNA (Miller et 
al., 1980) have pennitted extensive investigations into the effects of GH on 
physiological processes. 
It is well established that GH regulates lipid and glucose metabolism in vivo 
(Jeanrenaud, 1965; Schwartz & Eden, 1985; Cameron et al., 1987; Evock et al., 
1988), with adipose being the key target tissue. However, the mechanism through 
which GH modulates lipid accumulation remains unclear. Attempts to identify critical 
biochemical events regulated by GH have involved a variety of experimental 
approaches, including tissue explant or isolated cell culture systems (Watt et al., 1991; 
Vernon et al., 1995; Doris et al., 1998), whole animal studies (McCutcheon & 
Bauman, 1986; Peters, 1986; Sechen et al., 1990; Doris et al., 1996), and a 
combination of whole animal -treatments with GH followed by in vitro explant 
cultures (Vernon et al., 1987; Lanna et al., 1992; Doris et al., 1994; Doris et al., 
1996). Such studies have shown that GH decreases lipogenesis, both by decreasing 
expression of lipogenic genes and by antagonising enzyme activation by insulin, and 
also enhances lipolysis. Effects of GH on lipolysis are complex, but a major 
. mechanism appears to involve the attenuation of the ability of antilipolytic factors 
such as adenosine and prostaglandins to inhibit the process (Chapter 1, section 1.3.3). 
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However, it is not yet fully understood how these effects of GH on adipocyte cells are 
mediated, although it appears that the intracellular signalling pathways involved differ 
from those mediating the 'commitm·ent to differentiate' effects of the honnone 
(Chapter I, section 1.3.4). The initial objective of this study was to detennine the 
suitability of an ovine adipocyte cell culture system for investigating the molecular 
basis of the· lipolytic effects of GH, in particular the inhibitory effects of GH on 
adenosine inhibition of lipolysis. 
4.2 Experimental procedure 
4.2.1 Preparation of ovine adipocytes 
Pre-adipocyte cell preparations were made from ovine subcutaneous adipose tissue by 
digestion with collagenase, as described in section 2.2.2.1. The pre-adipocytes were 
cultured in proliferation medium (consisting of Medium 199 containing Earle's salts, 
L-glutamine and 25mM Hepes (PH 7.4) and supplemented with 2mM acetate (PH 
7.3), antibiotics (penicillin G, 60Jlg/ml ; streptomycin sulphate, IOOJlg/ml) and 20% 
Newborn Calf Serum) in 24 well plates until they were confluent, which takes 
approximately 7 days. The cells were then washed once with Hanks Balanced Salt 
Solution (HBSS) and the medium was changed to differentiation medium (Dulbecco's 
MEM I Ham's F12 , supplemented with penicillin (60J.lg/ml) and streptomycin 
(IOOJlglml)). Initial studies included insulin (1.6Jlglml), the lipid supplement ex-cyte 
(1% v/v) and T3 (2nM) in the differentiation medium. Later studies also included 
. dexamethasone (IOnM) and rosiglitazone (BRL 49653 ; lOOnM), as indicated. 
Control cells were still cultured in the proliferation medium. 
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4.2.2 Lipolysis Assay 
10 days after the indu~tion of cell differentiation (unless stated otherwise), the cells 
were washed,and the medi~ was changed to 1 ml of Ringer's Bicarbonate medium 
(+3% BSA + Img/ml D-glucose + 2mM sodium acetate + 25mM Hepes, pH 7.4) ; 
cells were incubated for 3 hours at 370 C. This contained either no addition (basal), 
adenosine deaminase (ad; 8J.1g/ml), ad + different concentrations of isoproterenol, as 
indicated (isop ; 10-12M - 104 M), or ad + isop + PIA (100nM). After the 3 hour 
incubation period, 800J.lI of medium was removed and assayed for glycerol content, as 
described in section 2.2.3.2. The n~ber of cells per well was ~etermined using a 
haemocytometer. 
4.2.3 Statistical Analysis 
Data were analysed by Restricted Maximum Likelihood (REML ; Patterson & 
Thompson, 1971). Each value contributing to a mean came from a different sheep, 
with the number of sheep being indicated in each figure legend. 
4.3 Results 
4.3.1 Determination of experimental conditions required to achieve the optimal 
rate of lipolysis in primary ovine adipocytes 
A time course study was carried out to investigate the optimal time to measure the rate 
of lipolysis after the induction of cell differentiation to adipocytes, as seen in Figure 
4.1. This shows that the basal rate of lipolysis increased with time. At the early 
stages of differentiation, there was no isoproterenol-stimulation of lipolysis. 
However, as cell differentiation increased the response to isoproterenol developed, 
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Time course data for the development of lipolysis in ovine 
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Figure 4.1 . Pre-adipocyte cell preparations were made from ovine subcutaneous 
adipose tissue by digestion with collagenase. The digest was then subjected to 
centrifugation to separate pre-adipocytes from the adipocyte fraction. The 
pre-adipocytes were cultured in proliferation medium in 24 well plates until they reached 
confluence, then the medium was changed to differentiation medium, which was 
supplemented with Ex-cyte, T3 and insulin. Various days after the onset of 
adipocyte differentiation, the cells were washed and the medium changed to Ringer's 
Bicarbonate medium (3% BSA + 2mM sodium acetate + 1 mg/ml D-glucose + 25mM 
Hepes, pH 7.4), with either no additions (basal), adenosine deaminase (ad) or 
adenosine deaminase + isoproterenol (10-5M) (ad+isop) . After a 3 hour incubation 
period, medium was removed and assayed for glycerol content, which is a measure or 
the rate of lipolysis. The number of cells per well was determined using a 
haemocytometer. Results are the means of between 5 and 11 observations. 
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Figure 4.2. Pre-adipocyte cell preparations were made from ovine subcutaneous adipose 
tissue by digestion with collagenase . . The digest was then subjected to centrifugation to 
separate the pre-adipocytes from the adipocyte fraction. The pre-adipocytes were cultured 
in proliferation medium in 24 well plates until they reached confluence, then the medium 
was changed to differentiation medium, which was supplemented with Ex-cyte, 
T3 and insulin. 10 days after the onset of cell differentiation, the cells were washed and 
the medium changed to Ringer's Bicarbonate medium (+ 3% BSA + 1 mg/ml D-glucose + 
2mM sodium acetate + 25mM Hepes, pH 7.4), containing adenosine deaminase 
and various concentrations of isoproterenol. After a 3 hour incubation period, medium was 
removed and assayed for glycerol content, which is a measure of the rate of lipolYSiS. The 
number of cells per well was detennined using a haemocytometer. Results are the 
means of between 8 and 15 observations and were analysed using REML; effect of 
isoproterenol was Significant, P<O.05. 
with the greatest isoproterenol stimulation of lipolysis being observed 10 days after 
the onset of differentiation. 
The isoproterenol dose response curve in ovine adipocytes was found, as shown in 
Figure 4.2, with isoproterenol having a half maximum of about 10·7M. The maximum 
rate of lipolysis was achieved with 10·sM isoproterenol. 
4.3.2 Effects of PIA on different concentrations of catecholamine-stimulated 
lipolysis in primary ovine adipocytes 
10 days after the onset of differentiation to adipocytes, the adenosine analogue, PIA, 
was incubated with the adipocytes, together with adenosine deaminase and various 
different concentrations of isoproterenol during the lipolysis assay. This was to 
detennine whether the addition of . PIA resulted in inhibition of catecholamine-
stimulated lipolysis. However, as Figure 4.3 indicates, PIA had very little effect on 
stimulated lipolysis. There were marginal effects of PIA at sub-optimal 
concentrations of isoproterenol (1 O·7M-l 0-6M), but the effects were very small (much 
less than with ovine tissue expl~ts, Chapter 3). 
It has previously been observed that the presence of triiodothyronine (T3) decreases 
response to adenosine in rats (Malbon et al., 1988). However, differentiating cells in 
medium containing only insulin and ex-cyte did not increase the PIA inhibition of 
stimulated lipolysis (see Figure 4.4). T3 had no significant effect on the rate of 
catecholamine-stimulated lipolysis itself in the presence of insulin and ex-cyte. 
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The effect of .PIA (100nM) at different concentrations of 
.isoproterenol on lipolYsis in ovine adipocytes 
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Figure 4.3. Pre-adipocyte cell preparations were made from ovine subcutaneous 
adipose tissue by digestion with collagenase. The digest was then subjected to 
centrifugation to separate the pre-adipocytes from the adipocyte fraction. The 
pre-adipocytes were cultured in proliferation medium in 24 well plates until they reached 
confluence, then the medium was changed to differentiation medium, which was 
typically supplemented with Ex-cyte, T 3 and insulin. 10 daysafter the onset of cell 
differentiation, the cells were washed and the medium changed to Ringer's Bicarbonate 
medium, containing adenosine deaminase, various different concentrations of 
Isoproterenol, with or without the addition of 100nM PIA. After a 3 hour incubation 
period, medium was removed and assayed for glycerol content, which is a measure of 
the rate of lipolysis. The number of cells per well was determined using a 
haemocytometer. Results are the means of 4 or more observations, and were analysed 
using REML; PIA effect was significant, P<0.02. 
The effect of PIA (100nM) at different concentrations of 
isoproterenol on lipolysis in ovine adipocytes when cultured 
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Figure 4.4. Pre-adipocyte cell preparations were made from ovine subcutaneous 
adipose tissue by digestion with coliagenase. The digest was then subjected to 
centrifugation to separate the pre-adipocytes from the adipocyte fraction . The 
pre-adipocytes were cultured in prOliferation medium in 24 well plates until they 
reached confluence, then the medium was changed to differentiation medium, which 
was supplemented with Ex-cyte and insulin, but no T 3' 10 days after the 
onset of cell differentiation, the cells were washed and the medium c.hanged to 
Ringer's Bicarbonate medium (+ 3% BSA + 1 mg/ml D-glucose + 2mM sodium 
acetate + 25mM Hepes, pH 7.4), containing adenosine deaminase and various 
different concentrations of isoproterenol, with or without the addition of 100nM PIA. 
After a 3 hour incubation period, medium was removed and assayed for glycerol 
content, which is a measure of the. rate of lipolysis. The number of cells per well 
was determined using a haemocytometer. Results are the means of 3 observations. 
4.3.3 Altering the components o/the differentiation medium/or primary ovine 
pre-adipocytes 
The compon~nts present iIi the differentiation medium for the ovine pre-adipocytes 
were altered in an attempt to improve the rate of catecholamine-stimulated lipolysis 
and produce an inhibitory effect of adenosine on stimulated lipolysis. . The previous 
factors that had been present in the medium were ex-cyte, insulin and T3. The two 
additional factors added were a PPARy agonist called rosiglitazone (BRL 49653) and 
a glucocorticoid analogue, dexamethasone. Various combinations of these 
components were investigated, and the results are shown in Figures 4.5, 4.6 and 4.7. 
. . 
Different combinations of components in the differentiation medium were 
investigated in adipocytes from 6 different sheep. However, some of the initial 
investigations were abandoned due to a poor rate of lipolysis, so only two 
observations were obtained. As the investigation proceeded, different combinations 
of components in the differentiation medium were examined, and so there was an 
incomplete set of data for the 6 different sheep. As there was an overlap in the 
experiments, REML (Restricted Maximum Likelihood ; Patterson & Thompson, 
1971) was used to analyse the data, as this package gives predicted values for missing 
data. Using REML to analyse the data produced several observations. 
Figure 4.5 shows all the means for unstimulated and stimulated lipolysis for 
individual combinations of components in the differentiation medium. There was no 
difference in the rate of lipolysis between basa1levels and the presence of adenosine 
deaminase for any combination of additions. Similarly, there was no difference 
between isoproterenol-stimulated lipolysis in the presence or absence of PIA. 
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However, there waS a very significant difference between unstimulated and 
isoproterenol-stimulated lipolysis for all combinations (P<O.OOI). Looking at the five 
. . 
different components individually, addition of ex-cyte, insulin and rosiglitazone had 
significant, positive effects (P<O.OOOI in each. case), while the presence of T3 was 
inhibitory (P<O.OOl). In the absence of insulin, it was observed that the majority of the 
cells did· not survive. 
The REML analysis also indicated that there were significant (P<O.OI) interactions 
between components in the differentiation medium on their effects in isoproterenol-
stimulated lipolysis. In the presence of insulin, dexamethasone and ex-cyte act in 
synergy. Individually with insulin, the rates of lipolysis were low, but when they were 
present together, the rate of lipolysis increased 2-3 fold. This gave a similar rate to 
when rosiglitazone and insulin were present together. A synergistic effect of 
dexamethasone and ex-cyte was also found in the presence of rosiglitazone and 
insulin; this combination resulted in the greatest rate of isoproterenol-stimulated 
lipolysis. As shown in Figures 4.5 and 4.6, the addition ofT3 had an inhibitory effect 
on the maximum rate of lipoly~is found with insulin, ex-cyte, dexamethasone and 
rosiglitazone, but the presence of T 3 did not have any significant effect with any of the 
other combinations tested (insulin plus either ex-cyte, dexamethasone or 
rosiglitazone) (i.e. when lipolysis is not at its highest rate). 
Differentiation in the presence of insulin, ex-cyte, dexamethasone and rosiglitazone' 
not only markedly increased the maximum rate of isoproterenol-stimulated, the 
adipocytes became much more sensitive to isoproterenol (EDso = 2xIO-9M) (EDso was 
1O-
7
M after culture with ex-cyte plus insulin plus T3); the addition ofT3 had no effect 
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on the EDso value 'of isoproterenol. However, no inhibitory effect of PIA was 
observed on stimulated lipolysis using any of the combinations of components tested, 
, . 
when low or high rates o(lipolysis were measured (Figures 4.5, 4.7), or when sub-
optimal concentrations of isoproterenol were present (Figure 4.7). 
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The effect on lipolysis of adding different components to the differentiation medium in ovine adipocytes 
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Figure 4.5. Pre-adipocyte cell preparations were made from ovine subcutaneous adipose tissue by digestion with collagenase. The digest was 
then subjected to centrifugation to separate the pre-adipocytes from the adipocyte fraction. The pre-adipocytes were cultured in proliferation 
medium in 24 well plates until they reached confluence, then the medium was changed to differentiation medium. The differentiation medium 
was supplemented with various combinations of insulin, T3 , ex-cyte, dexamethasone and rosigJitazone, as indicated. 10 days after the onset. 
of cell differentiation, the celiS were washed and the medium was changed to Ringer's Bicarbonate medium (+ 3% BSA + 1 mg/ml D-glucose + 
2mM sodium acetate + 2SmM Hepes, pH 7.4), containing either nothing (basal), adenosine deaminase (ad) or adenosine deaminase + 
isoproterenol (10·5M) (ad+isop). After a 3 hour ~ncubation period, medium was removed and assayed for glycerol content, which is a 
measure of the rate of lipolysis. The number of cells per well was determined using a haemocytometer. Results are the means of between 2 
and 6 observations. Results were analysed lI.sing REML. 
KEY: 0 = dexamethasone (10nM), E = ex-cyte (10/0vlv), I = insulin (1.6~g/ml), R = rosiglitazone (100nM) 
T = triiodo-L-thyronine (2nM) 
The effect of either. omitting or including T 3 in the 
differentiation. medium on lipolysis in ovine adipocytes 
.!!! 
180 
160 
·140 
B '120 
co 
o 
:!:: 100 ' 
~ 
.c 80 ~ 
~ 60 
::1. 40 
20 
0 +-IO-'-1~O~-9~~8--~7-'-'6-'-5'-' 
isoproterenol concentration (10-xM) 
-EI 
--.-- EIT 
--..-EIRD 
-M-ETIRD 
KEY: D = dexamethasone (10nM), E= ex-cyte (1%v/v), 
I = insulin (1.6f,1g/ml), R = rosiglitazone (100nM), 
T = triiodo-L-thyronine (2nM) 
Figure 4.6. Pre-adipocyte cell preparations were made from ovine subcutaneous 
adipose tissue by digestion with collagenase. The digest was then subjected to 
centrifugation to separate the pre-adipocytes from the adipocyte fraction. The 
pre-adipocytes were cultured in proliferation m.edium in 24 well plates until they 
reached confluence, then the medium was changed to differentiation medium. 
The differentiation medium contained either ex-cyte+insulin +/-T 3, or ex-cyte+ 
insulin+dexamethasone+rosiglitazone+/-T3, as shown in the key. 10 days after 
the onset of cell differentiation, the celfs were washed and the medium was 
changed to Ringer's Bicarbonate medium, (+3% BSA + 1 mg/ml D-g!ucose + 2mM 
sodium acetate + 25mM Hepes, pH 7.4), containing either nothing (basal), 
adenosine deaminase (ad) or ad+isoproterenol concentrations (1 a-10M - 10-4M). 
After a 3 hour incubation period, medium was removed and assayed for glycerol 
content, which is a measure of the rate of lipolysis. The number of cells per well 
was determined using a haemocytometer. Results are the means of 3 
observations for EI+/-T and 4 observations for EIDR+/-T. 
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Figure 4.7. Pre-adipocyte cell preparations were made from ovine subcutaneous 
adipose tissue by digestion with collagenase. The digest was then subjected to 
centrifugation to separate the pr~-adipocytes from the adipocyte fraction . The 
pre-adipocytes were cultured in proliferation "':!edium in 24 well plates until they 
reached confluence, then the medium was changed to differentiation medium. 
The differentiation medium contained ex-cyte+ insulin+dexamethasone+ 
rosiglitazone+I-T3• as shown in the key. 10 days after the onset of cell 
differentiation, the cells wer~ washed and the medium was changed to Ringer's 
Bicarbonate medium, (+3% BSA + 1 mg/ml D-glucose + 2mM sodium acetate + 
25mM Hepes, pH 7.4), containing either adenosine deaminase (ad)+isoproterenol 
concentrations (isop ; 1 0·10M - 10-5M) or ad+isop concentrations+ PIA (100nM). 
After a 3 hour incubation period, medium was removed and assayed for glycerol 
content, which is a measure of the rate of lipolysis. The number of cells per well 
was determined using a haemocytometer. Results are the means of 4 
observations. 
4.4 Discussion 
Initial studies showed ,that some, but not all, of the features of the lipolytic system 
develop with differentiation of ovine primary pre-adipocytes. Unstimulated and 
catecholamine-stimulated lipolysis in the ovine adipocytes developed ,with time after 
the ons~t of cell differentiation, with it reaching its maximum level after 10 days of 
differentiation when using ex-cyte, T3 and insulin to induce cell differentiation. This 
is consistent' with previous studies by Soret et al. (1999), who used morphological 
criteria and the activity of the marker enzyme, glycerol 3-phosphate dehydrogenase 
(GPDH), to assess the amount of diff~rentiation in ovine adipocytes. Under similar 
conditions, these studies showed that GPDH activity and the amount of lipid droplets 
within the cells reached a maximum by about day 10 of differentiation. Soret et al. 
(1997) have also shown that differentiation was associated with an increase in the rate 
of fatty acid synthesis (lipogenesis) from acetate which was paralleled by an increase 
in the activity of acetyl CoA carboxylase, both increasing to a maximum at around 1 D 
days of differentiation. When sensitivity of the differentiated ovine adipocytes to 
isoproterenol was measured, the EDso value was 10-7M isoproterenol (1 DOnM), which 
was less sensitive than had previously been measured in ovine subcutaneous tissue 
explants (EDso=21nM) (Vernon et al., 1995). However, the concentration of 
isoproterenol to produce the maximum rate of stimulated lipolysis was the same as 
observed previously in explants (IO-sM). 
Although the ovine pre-adipocytes were being induced to differentiate under these' 
conditions, and the rate of catecholamine-stimulated lipolysis increased with time 
after differentiation, no significant inhibition of stimulated lipolysis was observed in 
the presence of the adenosine analogue, PIA, unlike the effects observed in vivo or in 
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explant tissue culture' (Doris et al., 1996, 1998). It is known that hyperthyroidism in 
rats results in a decreased response to adenosine which is, at least partly, due to a 
, . 
decrease in adenosine receptor number (Malbon et al., 1988). However, when the 
ovine pre-adipocytes were differentiated in the. presence of insulin and lipid only in 
the differentiation medium, there was still no significant inhibitory effect .of PIA. 
More recent studies have shown that the inclusion of rosiglitazone and 
dexamethasone, along with ex-cyte, T3 and insulin enhances differentiation of ovine 
pre-adipocytes (Soret et ai., 1999). The stromal-vascular fraction of adipose tissue 
contains endothelial cells, mast cells and blood cells, in addition to adipocyte 
precursor cells at different stages of development (Flint & Vernon, 1993). These 
precursor cells ~an be induced to proliferate and differentiate in vitro in chemically 
defined media. For cell differentiation to proceed, the committed pre-adipocyte first 
enters a growth arrest phase. Expression of numerous genes undergoes chronological 
changes, mainly at the transcription level, and genes inhibitory to adipogenesis are 
repressed. The transcription factors CCAAT/enhancer binding protein alpha (CIEBP) 
and peroxisome proliferation-activated receptor gamma (PP ARy), which is largely 
adipocyte-specific, have been shown t~ transactivate adipocyte-specific genes. 
PPARy is expressed at low, but detectable, levels in pre-adipocytes, and its expression 
rapidly increases after the onset of differentiation, with maximum levels of expression 
being attained in mature adipocytes (Brun et al., 1996; Chawla & Lazar, 1994). It is 
activated by arachadonic acid metabolites and also thiazolidinedione drugs such as' 
rosiglitazone (BRL49653) (Spiegelman, 1998). Recent studies show that 
rosiglitazone enhances differentiation of human (Adams et al., 1997) and bovine 
(Ohyama et al., 1998), as well as ovine (Soret et al., 1999) pre-adipocytes. It has 
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previously been found that the presence of lipid stimulated differentiation of ovine 
pre-adipocytes "(Broad & Ham, 1983) and of rat pre-adipocytes (Bj5mtorp et a/., 
" " 
1980). Dexamethasone is "a glucocorticoid analogue, and has been found to enhance 
" " 
differentiation in ovine (Broad & Ham, 1983; Casteilla et a/., 1991; Vierck et a/., 
1996; Soret et a/., 1999) and bovine (Aso et a/., 1995) pre-adipocytes. 
In this study, different combinations of dexamethasone, ex-cyte, T3, rosiglitazone and 
insulin were included in the differentiation medium for ovine pre-adipocytes to try and 
increase the activity of the lipolytic system and hopefully induce a response to 
adenosine (pIA). The combination of insulin, ex-cyte, rosiglitazone and 
dexamethasone resulted in a 10-fold or so increase in maximum lipolytic rate and a 
50-fold increase in sensitivity to the J3-adrenergic agonist isoproterenol compared with 
the initial combination tried (insulin, ex-cyte, T3). 
With respect to individual components, it was immediately apparent that the cells 
showed little differentiation in the absence of insulin, as had previously been observed 
(Aso et a/., 1995; Adams et a/., 1996; Soret et a/., 1999), and so insulin was included 
in all further studies. Rosiglitazone result~d in a large increase in the rate of lipolysis 
with every combination that was tested, and this effect appeared to reflect a general 
improvement of differentiation, due to it being a potent agonist of the transcription 
factor PPARr (Lehmann et al., 1995; Krey et a/., 1997)." Chronic exposure of 
differentiated 3T3-Ll cells to rosiglitazone had no effect on isoproterenol-stimulated 
lipolysis (Souza et a/., 1998). However, rosiglitazone had a much greater effect on 
lipolysis and also lipoge"nesis in ovine cells than was observed on GPDH activity 
(Table 4.1). 
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The presence of ex-cyte always resulted in an increase in the rate of lipolysis with all 
combinations tested (insulin + dexamethasone, insulin + rosiglitazone, and insulin + 
. . 
rosiglitazone + dexamethaSone). The possibility that the effect of ex-cyte was due to 
providing fatty acid and hence ligand for PPARr appears to be .excluded by it 
enhancing lipolysis in the presence of rosiglitazone. 
It has also' previously been shown that prolonged exposure to dexamethasone 
increases response and sensitivity to p-adrenergic agonists in both rats and sheep, at 
least in part by increasing the number of p-adrenergic receptors (Vernon, 1992). 
. . 
Dexamethasone caused an increase in the rate of lipolysis in the present study, but this 
was only apparent when ex-cyte was also present (insulin + ex-cyte, insulin + ex-cyte 
+ rosiglitazone); dexamethasone had no effect when combined with insulin and 
rosiglitazone in the absence of ex-cyte. This suggests there is a synergy between ex-
cyte and dexamethasone, but the molecular basis for this is unknown. 
T3 did not have an effect on development of the lipolytic system under most 
conditions investigated (ex-cyte . + ins14in, dexamethasone + insulin, insulin + 
rosiglitazone). However, T3 resulted in a substantial decrease with lipolytic response 
to isoproterenol when insulin, ex-cyte, rosiglitazone and dexamethasone were also 
present in the differentiation medium. This effect of T3 was unexpected, as 
hyperthyroidism Increases whereas hypothyroidism decreases response to 
. isoproterenol in rat adipose tissue, and hypothyroidism decreased the lipolytic 
response to catecholamines in neonatal lambs. Futhermore, T3 causes over a 2-fold 
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increase in 133-adrenoceptor concentration in differentiating 3T3-F442A adipocytes 
due to an increase in ~e half-life of 133-adrenoceptor mRNA (El Hadri et 01., 1996). 
However, despite improving the rate of pre-adipocyte differentiation, improving 
sensitivity of the adipocytes to isoproterenol, and greatly enhancing the rate of 
, , 
catecholamine-stimulated lipolysis hi the ovine adipocytes, no significant effect of 
PIA was observed for any of the combinations of components present, or in the 
presence of sub-optimal concentrations of catecholamines. Hypothyroidism in rats 
increases response to adenosine and prostaglandins (Malbon et aL, 1988; Vernon et 
01., 1991), while chronic incubation of sheep adipose tissue with dexamethasone 
increased response to adenosine (PIA) in sheep adipose tissue (Vernon et 01., 1991). 
Nevertheless, neither the addition of dexamethasone nor removal of T 3 from the 
medium induced a response to PIA in the present system. This suggests that the 
adenosine Al receptors are either not present or not functional in the differentiated 
ovine adipocytes. It has been shown that in the clonal cell line Ob1771, the adenosine 
stimulatory (with respect to adenyl cyclase) A2 receptors are present in higher 
quantities in pre-adipocytes, and the inhi?itory Al receptors are present in higher 
quantities in the mature adipocyte, but only from day 16 after the induction of cell 
differentiation (B0l'glwn et 01., 1996). These studies also showed that PIA had an 
inhibitory effect on isoproterenol-stimulated lipolysis 16 days after differentiation 
(B0l'glum et 01., 1996). Ravid & Lowenstein (1988) found that 3T3-F442A pre-
,adipocytes appeared to express only stimulatory CA2) adenosine receptors, and that 
inhibitory (AI) adenosine receptors were only expressed after the onset of 
differentiation. However, an effect of PIA on cyclic AMP activity was only measured 
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at later stages of differentiation (from day 11 onwards) (Ravid & Lowenstein, 1988). 
Elks et al. (1987) also found that PIA had an inhibitory effect on isoproterenol-
stimulated lipolysis iIi the. differentiated 3T3-Ll cell line, although lipolysis was not 
measured prior to 9 days after differentiation. A response to PIA. was found on 
lipolysis in hamster adipose adipocytes 8 days after differentiation (Saulnier-Blache et 
al., 1990. However, Mersmann et al. (1997) have found that no inhibitory adenosine 
receptors are present in suckling pigs at early stages of development, and so they seem 
to play no role in the modulation of adipocyte lipid metabolism in the young pig. 
Therefore, it seems that the inhibitory adenosine Al receptors are not present in very 
early stages of adipocyte differentiation, and that the time of their expression in the 
differentiating adipocytes depends on species, as response to adenosine develops at 
different intervals depending on the cell culture system. A few studies were 
undertaken to measure response to adenosine in the ovine primary adipocytes at later 
stages of differentiation (day 15), but no effect of PIA was observed. However, the 
cells had been induced to differentiate under sub-optimum conditions (ex-cyte + 
insulin + T3). 
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Comparison between GPDH activity and lipolytic rate in the 
presence of different additions to the differentiation medium of 
primary ovinE!· subcutaneous pre-adipocyte cells 
GPDH lipogenesis glycerol release 
(nmollminlmg protein) ~nmoI/3hrs/1 06cells~ {/:moIl3 hrs/106ceIlS~ 
additions to 
culture medium 
Ex-cyte. 53 601 20 
Rosiglitazone 66 1806 64 
Dexamethasone 61 270 16 
Table 4.1. A comparison of the effects of dexamethasone, rosiglitazone and ex-cyte on 
GPDH activity and the rate of lipolysis in pre-adipocytes from suckling lambs and 
fattening sheep. Differentiation was induced by the addition of insulin (1.6J..Lg/ml) and 
T3 (2nM), with or without ex-cyte (1% vlv), dexamethasone (10nM) and rosiglitazone 
(100nM), as indicated. GPDH activity, rate of lipogenesis and lipolytic rate were 
assessed after 10 days of differentiation. Values for GPDH activity are taken from 
Soret et a/. (1999) and values for the rate of lipogenesis are unpublished observations 
(Soret & Vernon). 
CHAPTER FIVE 
LIPOLYSIS AND LIPOGENESIS IN THE 3T3-F442A 
MURINE ADIPOCYTE CELL LINE 
5.1 Introduction' 
The mechanisms whereby growth hormone (GH) and insulin regulate adipocyte 
metabolism have not yefbeen fully elucidated. It is well established that GH acts 
chronically to decrease adiposity in animals' by several mechanisms, including a 
decrease in lipogenesis and an increase in lipolytic rates (Boyd & Bauman, 1989; 
Vernon' & Flint, 1989; Goodman, 1993). It has previously been shown that GH acts 
, , 
chronically by itself· to decrease the rate of lipogenesis and to antagonise insulin 
stimulation of lipogenesis in adipose tissue from various species (Nyberg & Smith, 
1977; Vernon, 1982; Walton & Etherton, 1986; Etherton et al., 1987). These 
adaptations are observed both in vivo and in vitro (Bauman & Vernon, 1993; Etherton 
et ai., 1993). In addition to its chronic insulin-antagonistic effects, GH also has an 
acute insulin-like effect in adipocytes (Vernon & Flint, 1989; Goodman, 1993), 
although the physiological significance of this is uncertain as it is only observed when 
adipocytes have not been exposed to GH for a period (Vernon & Flint, 1989; 
Goodman, 1993). GH also promotes differentiation of several pre-adipocyte cell 
lines, including 3T3-F442A cells (Green et ai., 1985). 
The rate of lipogenesis is regulated by a number of enzymes. Acetyl eoA carboxylase 
(ACC) is the most important of these enzymes, and is subject to both chronic and 
acute control. It exists in both active and inactive states, with insulin and 
catecholamines causing an increase and decrease to the activation status of the . 
enzyme, respectively, while insulin also acts chronically to increase gene transcription 
and therefore the amount of ACC (Vernon, 1992). 
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Several murine fibroblast cell lines (for example, 3T3-F442A and 3T3-Ll) have the 
capacity to undergo dit:ferentiation into cells which exhibit most of the morphological 
(Green & K~hinde, 1976;' Kuri-Harcuch & Wise, 1978) and biochemical (Kuri-
Harcuch & Green, 1977; Wise & Green" 1978; Pairault & Green , 1979) 
characteristics of normal adipocytes. These cell lines were clonally isolated from 
Swiss 3T3 cells derived from disaggregated 17 to 19 day mouse embryos (Green & 
Meuth, 1974; Green & Kehinde, 1975; Green & Kehinde, 1976). Extensive studies 
using these pre-adipocyte cell lines indicate that they represent a reasonable model of 
the process of adipocyte differentiation in vivo. It has been shown previously that the 
3T3-F442A adipocytes provide a versatile in vitro model for analysis of cellular 
events'resulting in hormonal changes in lipogenic and lipolytic rates (Goodman & 
Schwarz, 1974; Schwarz, 1980; Schwarz et ai., 1985). As the ovine adipocytes did 
not appear to show any response to adenosine, a key target of the lipolytic action of 
GH (see chapter 4), the 3T3-F442A adipocyte cells were utilised to further elucidate 
the molecular actions of GH and also insulin on adipocyte metabolism. 
5.2 Experimental procedure, 
5.2.1 Culture of 3T3-F442A pre-adipocytes 
3T3-F442A pre-adipocytes were induced to proliferate in culture, as described in 
section 2.2.2.4. Two-day confluent pre-adipocytes were induced to differentiate, as 
described in section 2.2.2.5. 8 days after the onset of cell differentiation, unless stated 
otherwise, the insulin and FCS were removed from the medium. 
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5.2.2 Lipolysis assay 
After an overnight period of serum and insulin removal, hormones were added to the 
, , 
medium for a 24 hour or' a 48 hour' period, unless stated otherwise. The rate of 
lipolysis was measured, as described in section 2.2.5.1. 
5.2.3 Lipogenesis assay , 
After an overnight period of serum and insulin removal, insulin (100 ng/ml) and / or 
growth hormone (100 ng/ml) were added to the medium for a 24 hour or a 48 hour 
period prior to the measurement of the rate of lipogenesis. 14C-acetate incorporation 
into adipocyte lipid was determined, as described in section 2.2.5.2. 14C-glucose 
incorporation into adipocyte fatty acids was determined, as described in section 
2.2.5.3. The rate of lipogenesis was expressed as lJ.Illol. acetate or glucose 
incorporated / 4 hours / mg DNA. The amount of DNA present was determined, as 
described in section 2.2.5.4. 
5.2.4 Acetyl CoA carboxylase (ACC) assay 
Following the overnight perio~ of insulin and serum removal from the 3T3-F442A 
adipocyte differentiation medium, and th~chronic treatment of the adipocytes with 
hormones, as indicated in the results section 5.3, the proportion of active ACC was 
determined, as described in the figure legends and section 2.2.5.5, and the amount of 
ACC activity was expressed as picomol. / minute / mg DNA, as described in section 
2.2.5.4. 
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5.2.5 Statistical an'alysis 
Results are expressed ~ means +/- S.E.M., and the statistical analysis was by analysis 
, , 
of variance (~OVA), unless stated otherwise. 
5.3 Results 
5.3.1 Characterisation of the development of the lipolytic system in the murine 
3T3-F442A adipocyte cell line 
3T3-F442A pre-adipocytes were induced to differentiate into mature adipocytes by the 
introduction of 10% Foetal Calf Serum (FCS) and insulin (5J.lg/ml) into the medium, 
after the cells had been maintained at confluence for 48 hours. After a further 8 days 
in the differentiation medium, the serum and insulin were removed. At various time 
intervals at, or after, the serum and insulin removal, the rate of catecholamine-
stimulated lipolysis was assessed over a 3 hour period. This showed that the response 
of the adipocytes to isoproterenol developed over a 48 hour period after the removal 
of serum and insulin, as shown in Figure 5.1. 
Figure 5.2 shows that the opti~um rate of lipolysis was attained with an isoproterenol 
concentration of 10·6M, with the half-maximum concentration being 2 x 10·8M 
isoproterenol. However, although the response of the 3T3-F442A adipocytes to 
catecholamine-stimulated lipolysis developed, no significant inhibitory effects of the 
adenosine analogue, PIA, were apparent on the stimulated lipolytic system, as shown 
in Figure 5.3. 
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Development of the lipolytic response to isoproterenol after the 
removal of serum· and insulin from the differentiation medium 
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Figure 5.1. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5~g/ml), after which time the serum and insulin were 
removed from the medium. At various intervals after the removal of serum, the cells 
were washed and the medium changed to Ringer's Bicarbonate medium (+3% BSA + 
1 mg.ml D-glucose + 2mM sodium acetate + 25mM Hepes), containing adenosine 
deaminase and various concentrations of isoproterenol. After a 3 hour incubation period, 
medium was removed and assayed for glycerol content, which is a measure of the rate 
of lipolysis. The number of cells per well was determined using a haemocytometer. The 
time intervals selected for the measurement of the rate of lipolysis were immediately 
after serum removal (-19hrs), the following day after serum removal ·(day 0), and 24 hours 
and 48 hours after the removal of the serum (24hrs, 48hrs, respectively). Results are the 
. means of between 2 and 5 observations. 
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Figure 5.2. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5Ilg/ml), after which time the serum and insulin were 
removed from the medium. After the cells had been deprived of serum overnight plus an 
additional 24 hours, the cells were washed and the medium changed to Ringer's 
Bicarbonate medium (+3% BSA + 1 mg/ml D-glucose + 2mM sodium acetate + 25mM 
Hepes), containing adenosine deaminase and various concentrations of isoproterenol. 
After a 3 hour incubation period, medium was removed and assayed for glycerol content, 
which is a measure of the rate of lipolysis. The number of cells per well was determined 
using a haemocytometer. Results are the means of 5 observations. 
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Figure 5.3. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5~g/ml), after which time the serum and insulin were 
removed from the medium. At various intervals after the removal of serum (24 hour or 48 
hours after an overnight period with no serum), the cells were washed and the medium 
changed to Ringer's Bicarbonate medium (+ BSA + 1 mg/ml O-glucose + 2mM sodium 
acetate + 25mM Hepes), containing adenosine deaminase (ad), various concentrations 
of isoproterenol and plus or minus PIA (100nM). After a 3 hour incubation period, 
medium was removed and assayed for glycerol content, which is a measure of the rate 
of lipolysis. The number of cells per well was determined using a haemocytometer . 
. Results are the means of between 2 and 5 observations, + S.E.M. 
The chronic effects' of GH and insulin on the rate of stimulated and unstimulated 
lipolysis were investigated over a 24 hour and 48 hour incubation period. Figure 
. . 
S.4(a) shows that the presence of GH for 24 hours results in a small increase (P<O.OS) 
in. the rate of basal and adenosine deaminase-stimulated lipolysis, but has no effect on 
basal lipolysis after 48 hours incubation (Figure S.4(b)). Neither GH or insulin had 
any effect on isoproterenol-stimulated lipolysis at either time, as shown in Figures 
S.4(a) and (b). fusulin does not prevent the effects of GH on either basal or adenosine 
deaminase-stimulated lipolysis over the 24 hour period. PIA did not have any 
significant inhibitory effects on the rate of catecholamine-stimulated lipolysis in the 
presence or absence of exposure to either hormone after either incubation periods. 
5.3.2 Effects of growth hormone and insulin on lipogenesis in 3T3-F442A 
adipocytes 
As the 3T3-F442A adipocytes showed no response to PIA on the rate of 
catecholamine-stimulated lipolysis, it was decided to investigate the effects of GH and 
insulin on the lipogenic system instead, with a view to extending the previous 
observations by others in the laboratory on the roles of specific isoforms of protein 
kinase C on the modulation of lipogenesis by insulin and GH. 
The rate of lipogenesis was assessed over a 4 hour period using 14C-Iabelled sodium 
acetate incorporation into lipid as a marker. Eight days after the induction of 3T3-
F442A differentiation followed by the removal of FCS and insulin for an overnight 
period, insulin and / or GH were added to the medium for a 24 hour incubation period. 
The hormones were removed from the medium immediately prior to the 4 hour period 
of the lipogenesis assay. Incubation with insulin resulted in an increase (P<O.OS) in 
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Figure 5.4. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (Sll9/ml), after which time the serum and insulin were 
removed from the medium. After the cells were serum-starved overnight, the honnones 
Growth Hormone (GH) and I or Insulin (INS) were added to the medium for either (a) 24 
hours or (b) 48 hours prior to the cells being washed and the medium changed to 
Ringer's Bicarbonate medium ( + 3% BSA + 1 mg/ml O-glucose + 2mM sodium 
acetate + 2SmM Hepes). This medium contained either nothing (basal), adenosine 
deaminase (ad), isoproterenol (isop) (10-6M) or PIA (100nM). After a 3 hour incubation 
period, medium was removed and assayed for glycerol content, which is a measurement 
of the rate of lipolysis. The number of cells per well was determined using a 
haemocytometer. Results are the means of 3 or 4 observations, + S.E.M. 
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lipogenesis, while incubation with GH reduced (P<O.05) the rate of lipogenesis, as 
shown in Figure 5.5. However, these honnonal effects were small. 
5.3.2.1 Chronic and acute effects of insulin on the rate of lipogenesis 
In order to try and improve the stimulation of lipogenesis by insulin, it was decided to 
examine the' acute effects .of the honnone. The cells were either incubated with 
insulin for 24 hoUr prior to lipogenesis, or for the 4 hours during the lipogenesis assay, 
or insulin was present throughout. As shown in Figure 5.6, insulin had both acute 
(P<O.Ol) and chronic (P<O.OOl) effects on the rate of lipogenesis in 3T3-F442A 
adipocytes. Addition of insulin during culture and the assay resulted in the highest 
.cP<O.05) rate. However, while having insulin present throughout the chronic and 
acute periods caused a significant increase in the rate of lipogenesis, the effects were 
stilI small. 
5.3.2.2 A comparison of hormone effects when lipogenesis was measured over 
different periods of time 
The rate of lipogenesis was measured over a 2 hour and a 4 hour period, with growth 
honnone and / or insulin being present 24' hours prior to, and during, the lipogenesis 
assay. As can be observed in Figure 5.7, the honnonal effects on the rate of 
lipogenesis in 3T3-F442A adipocytes were linear. 
5.3.2.3 Chronic incubation of growth hormone and / or insulin for 24 hours or 
48 hours prior to the lipogenesis assay 
A comparison between the effects of 24 hours and 48 hours chronic incubation of GH 
and / or insulin on the rate of lipogenesis in 3T3-F442A adipocytes can be seen in 
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Figure 5.5. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5J.1g/ml),· after wh!ch time the serum and insulin were 
removed from the medium. After the cells were serum-starved overnight, the honnones 
Growth Hormone (gh ; 100ng/ml» and I or Insulin (ins; 100ng/ml) were added to the 
medium for 24 hours prior to, but not dUring, the measurement of the rate of 
lipogenesis. This was detennined by measuring the amount of 14C-labelled sodium 
acetate incorporated into the cell lipid over a 4 hour period. Results are the 
means of 16 observations, +1- S.E.M. 
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Figure 5.6. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum, after which time the serum was removed from the medium. After the 
cells had been serum-starved overnight, Insulin (ins; 1 OOng/ml) was added to the 
medium for either 24 hours culture prior to, or 4 hours during, (or both) the measurement 
of the rate of lipogenesis (con = control). This was determined by measuring the 
amount of 14C-labelled sodium acetate incorporated into the cell lipid over a 4 hour 
period. Results are the means of 16 observations, +1- S.E.M. 
The effect of Growth Hormone and Insulin on the rate of 
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Figure 5.7. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5f.Lg/ml), after which time the serum and insulin were 
removed from the medium. After the cells had been serum-starved overnight, the 
hormones Growth Hormone (gh ; 100ng/ml) and 1 or Insulin (ins ; 1 OOng/ml) were added 
to the medium for 24 hours prior to, and during, the measurement of the rate of 
lipogenesis (con = control). This was determined by measuring the amount of 
14C-labelled sodium acetate incorporated into the cell lipid over either a 2 hour period, or 
a 4 hour period. Results are the means of 5 observations, +1- S.E.M. 
Figure 5.8. 3T3-F442A pre-adipocytes were differentiated for 8 days in mediu'!1 
containing se~m and insulin (5~g/ml), after which time the serum and insulin were 
removed" from the medium. After the cells had been serum-starved overnight, the 
hormones Growth Hormone (gh ; 100ng/ml) and/or Insulin (ins; 100ng/ml) were added 
to the medium for either 24 hours or 48 hours plior to, and duling, the measurement of 
the rate of lipogenesis (con = control). This was determined by measuring the 
amount of 14C-labelled sodium acetate incorporated into the cell lipid over a 4 hour 
. . 
peliod. (a) shows the absolute values for the rate of lipogenesis, and (b) shows the 
rates expressed as a percentage of 'no additions' X 100. Results are the means of 11 
observations, +1- S.E.M. 
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Figure 5.8, with the hormones being present during the 4 hour lipogenesis assay. As 
Figure 5.8(a) indicates, lipogenesis was greater after 48 hours incubation in the 
presence and absence of the hormones: However, the relative rate of lipogenesis did 
not increase or decrease in the presence of the hormones after the longer period of 
incubation, as shown in Figure S.8(b). 
5.3.2.4 . Effect of a PI-3Kinase inhibitor on insulin stimulation of lipogenesis 
To assess if insulin was causing an increase in the rate of lipogenesis via the 
phosphatidylinositol 3-kinase (PI-3Kinase) pathway, the 3T3-F442A adipocytes were 
incubated in the presence of the PI-3Kinase inhibitor, L Y29004. As shown in Figure 
5.9, the presence of LY29004 abolished the stimulation of lipogenesis by insulin. 
This indicated that, even although the effects of insulin are smail, insulin is still acting 
to increase lipogenesis via the PI-3Kinase pathway. However, the presence of 
LY29004 reduced the rate of basal lipogenesis, indicating that lipogenesis was already 
increased due to the PI-3Kinase pathway being activated prior to incubation with 
insulin. 
5.3.2.5 Individual experiments to imj,~ove hormone effects on lipogenesis in 
3T3-F442A adipocytes 
In an effort to accentuate the effects of GH and insulin on the rate of lipogenesis, a 
variety of different single experiments were carried out, which are summarised below. 
The experiments were only performed once when it was apparent that no 
improvement in response to insulin was observed. 
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The effect of the PI 3-Kinase inhibitor Ly29004 on the rate of 
lipogenesis in 3T3-F442A adipocytes in the presence and 
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Figure 5.9. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5IJ.g/ml), after which time the serum and Insulin were 
removed from the medium. After the cells had been serum-starved overnight, 
Ly29004 (Iy: 501J.M) and lor Insulin (ins; 100ng/ml) were added to the medium 
for 24 hours culture prior to, and for 4 hours during, the measurement of the rate 
of lipogenesis. This was determined by measuring the amount of 1"C-labelled 
sodium acetate incorporated into the cell lipid over a 4 hour period. Results are 
the means of 4 observations, +1- S.E.M. 
The rate of lipogenesis was assessed either 7 days or 10 days after the induction of 
differentiation, with the insulin and serum having been removed for an overnight 
. . 
period prior to 24 hour hOrnlone incubation. This was to ensure that the hormones did 
. . . 
not have a greater effect on lipogenesis at an earlier stage of cell. differentiation. 
However, both insulin· and GH had greater effects 10 days after the. induction of 
adipocyte differentiation. 
The presence of insulin and serum was initially required in the differentiation medium 
for the 3T3-F442A pre-adipocytes to be induced to differentiate. However, the typical 
insulin concentration present in the medium was high (5!J.g/ml), and this caused 
concern over whether this high concentration of insulin was resulting in the adipocytes 
becoming desensitised to the hormone over the chronic incubation period, thereby 
resulting in increased basal levels (and increased stimulation of PI-3Kinase) and a 
decrease in insulin stimulation of the rate of lipogenesis. The cells were differentiated 
in the presence of different concentrations of insulin, ranging from 0.1 !J.g/ml to 
5 !J.g/ml. The highest concentration of insulin, which was the concentration used 
routinely in the medium, appeared to reduce the overall rate of lipogenesis. However, 
it did not cause a decrease in the chronic response of the adipocytes to insulin or GH. 
It was also decided to investigate the effects of insulin and GH on the rate of 
lipogenesis at various time intervals after serum and insulin removal from the 
differentiation medium to ensure that the hormonal effects on the lipogenic system 
were not being repressed by the serum. The time after serum removal did not appear 
to alter the effects of insulin and GH on the rate of lipogenesis up to 72 hours. After a 
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period without serum'the adipocytesenter apoptosis, so any effects that the absence of 
serum may have on lipogenesis were not investigated after a 72 hour period. 
It had been questioned as to whether trace amounts of serum and insulin remaining in 
the wells after the medium had been changed could cause the effects of the hormones 
to be diminished, and therefore the PI-3Kinase signalling pathway being activated 
already. However, the number of time that the adipocytes were washed with PBS did 
not alter the hormone effects on lipogenesis either. 
The 3T3-F442A pre-adipocytes were differentiated following a protocol by Fleming et 
al. (1998), which had 10% FCS and 5~g/ml insulin present (standard differentiation 
medium). Variations of this medium have been described by different research 
groups. Schwarz and colleagues routinely added the glucocorticoid analogue, 
dexamethasone, and the non-selective phosphodiesterase inhibitor, IBMX, in addition 
to antibiotics and insulin, to the differentiation medium for the first 48 hours after the 
induction of differentiation (modified differentiation medium) (Dietz & Schwarz, 
1991). A comparison of the standard and modified differentiation medium showed 
that the hormone had a greater effect on the rate of lipogenesis when the cells were 
differentiated in the modified medium. However, the overall rate of lipogenesis in the 
presence or absence of hormones was greatly reduced when the cells were induced to 
differentiate in the modified medium. For example, basal lipogenesis was ten times 
higher in cells differentiated in standard rather than modified differentiation medium. 
During the overnight period that serum and insulin were absent from the medium 
prior to the addition of GH and / or insulin, different components like heat-inactivated 
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FCS and the PPARy"agonist, rosiglitazone, were added to the medium in an attempt to 
enhance the honnone effect on lipogenesis. However, none of these additions 
appeared to increase the effects of insulin and OH on the rate of lipogenesis in the 
3T3-F442A adipocytes. 
5.3.2.6" Effects of growth hormone and insulin on the rate of lipogenesis from 
glucose in 3T3-F442A adipocytes: a comparison with acetate 
An investigation was undertaken comparing the rate of glucose incorporation into 
fatty acid with that of acetate, by measuring the rate of lipogenesis (fatty acid 
synthesis) in 3T3-F442A adipocytes using either 14C-Iabelled glucose or 14C-Iabelled 
sodium acetate. The honnones were added to the medium 24 hours prior to, and 
during, the lipogenesis assay. As shown in Figure S.10, OH inhibited lipogenesis 
from acetate and glucose to a similar .extent. However, insulin stimulated lipogenesis 
by a greater degree (P<O.OS) when the amount of glucose incorporation was measured 
compared with acetate incorporation. 
5.3.2.7 Hormonal effects l!n the amount of acetyl CoA carboxylase (ACC) 
activity in 3T3-F442A adipocytes 
The amount of total ACC activity and initial ACC activity was measured in the 
differentiated 3T3-F442A adipocytes after chronic exposure to OH and / or insulin, as 
shown in Figure S.l1 Insulin had no effect on total ACC activity. Incubation with 
OH resulted in a decrease (P<O.OS) in the amount of total ACC activity measured, but 
neither growth honnone nor insulin had any effect on the proportion of ACC in the 
active state. 
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5.3.2.8 Effects of growth hormone and insulin on ACC mRNA levels 
The amount of ACC mRNA was measured after incubation of 3T3-F442A adipocytes 
, . 
for either 24 ,hours or 48 hours with or without insulin and, or, GH. The presence of 
insulin tended to increase the amount of ACC mRNA whereas GH had no apparent 
effect, as shown in Figure 5.12. ACC mRNA was measured by Dr .. M.T. Travers 
using an RNase protection assay (Travers et aI., 1997). 
5.3.2.9 Development of lipogenesis after serum removal 
Further investigation into the acetate incorporation into 3T3-F442A adipocytes 
showed that the lipogenic system in these cells was already well switched on. After 
the overnight period following serum and insulin removal, the rate of lipogenesis did 
not fall, indicating that the system is very robust (see Figure 5.13). Indeed, the rate of 
basal lipogenesis did not change significantly over a further 48 hour period of culture 
in the absence of insulin. 
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A comparison between rates of lipogenesis from glucose and 
acetate in 3T3-F442A adipocytes : the differences in the rate of 
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Figure 5.10. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5~g/l1'll}, ' after which time the serum and insulin were 
removed from the medium. After the cells were serum-starved overnight, the 
hormones Insulin (ins; 100ng.ml) and 1 or Growth Hormone (gh : 100ng/ml) were 
added to the medium for 24 hours prior to, and the 4 hours during the 
measurement of the rate of lipogenesis (con = control). This was determined by 
measuring the amount of either14C-labelled sodium acetate (O.5~Ci/ml) or U_(1 '14C) 
-labelled D-glucose (0.1 ~Cilml) that was incorporated into the cell lipid over a 
4 hour period. Results are the means of 4 observations, +1- S.E.M. 
Figure 5.11. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin, after which time the serum and insulin were removed 
from the medium. After the cells had been serum-staJVed overnight, Insulin On,s; 
1 OOng/ml) an~ I or Growth Hormone (gh ; 1 OOng/ml) were added to the medium for 24 
hours pri·or to the ACC assay .. The ACC activity was determined as outlined in 
section 2.2.5.5. Tbtal ACC activity was the activity found after preincubation with 
citrate for 30 minutes (section 2.2.5.5). Initial activity, a measure of the activity of the 
enzyme in the active state, was measured as described in section 2.2.5.5. Results 
are means of 5 observations, + S.E.M. 
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Figure 5.12. 3T3-F442A pre-adipocyles were differentiated for 8 days in medium 
containing serum and insulin, after which time the serum and insulin were removed 
from the medium. After the cells had been serum-starved overnight, Insulin (ins ; 
100ng/mQ and / or Growth Hormone (gh ; 100ng/ml) were added to the medium for either 
24 or 48 hours prior to the samples being prepared as for the DNA assay (section 2.2.6.2) 
The upper aqueous layer used for determination of DNA content was also used for the 
RNase protection assay (not described) to determine the amount of ACC mRNA 
present. Results were obtained from 4 observations, +/- S.E.M. 
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Figure 5.13. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5~g/ml), after whJch time the serum and insulin were 
removed from the medium (-19 hours). After the cells were serum-starved ovemlght, 
insulin (ins; 1 OOng/ml) was added to the medium for either 24 hours or 48 hours prior 
to, and during, the measurement of the rate of lipogenesis (con = control) . This was 
determined by measuring the amount of 14C-labelled sodium acetate incorporated into 
the cell lipid over a 4 hour period. Results are the means of 3 observations, +1- S.E.M. 
5.4 Discussion 
Lipolysis is under complex acute control, with catecholamines and glucagon having a 
stirnulatoryeffect, and 0 insulin and adenosine resulting in inhibition. GH, 
glucocorticoids, sex steroids and thyroid honnones chronically control the ability of 
these acute factors to influence the rate of lipolysis. 3T3-F442A adipocytes appeared 
to be a good
O 
representative in vitro model to investigate honnonal effects on adipocyte 
metabolism" ItO had been shown that chronic incubation of these cells with GH 
inhibited various indicators of glucose metabolism, including glucose uptake and 
conversion to lipid or carbon dioxide (Schwarz, 1984; Schwarz & Foster, 1986; 
Schwarz & Carter-Su, 1988). GR was also observed to increase lipolysis and 
stimulate the activity of honnone-sensitive lipase in 3T3-F442A adipocytes (Dietz & 
Schwarz, 1991). 
Adenosine is a paracrine / autocrine antilipolytic agent that binds to AI receptors of 
adipocyte membranes. It activates the inhibitory GTP-binding protein, Gj, which 
inhibits adenylate cyclase activity and hence lipolysis. Adenosine is released by 
adipocytes in amounts which inhibit cyclic AMP accumulation and lipolysis (Schwabe 
& Ebert, 1974; Schwabe et al., 1973; Schwabe et al., 1975). The external receptors 
that mediate inhibition (AI) and stimulation (A2) of adenylate cyclase possess 
different specificities towards adenosine analogues. For example, AI receptors show a 
greater affinity for the adenosine analogue PIA than the A2 receptors (Londos & 
Wolff, 1977; Londos et alo, 1978; Londos et alo, 1980). It has been shown that GH 
can enhance lipolysis by decreasing the effects of agents acting via the Gj-based 
antilipolytic system, involving protein serine phosphorylation (Doris et al., 1998). 
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The lipolytic system in 3T3-F442A adipocytes appeared to develop further after the 
removal of senim and insulin from the differentiation medium. This could possibly be 
due to the presence of a bfgh ~oncentration of insulin in the medium. Insulin elicits 
. . 
the phosphorylation of the 132-adrenoceptor which could contribute to a decreased 
catecholamine responsiveness of adenylate cyclase (Hadcock et aI.. 1992). Engfeldt et 
al. (1988) have shown that exposure of human adipocytes to insulin leads to a 
translocation of 13-adrenoceptors from the cell surface to an internal compartment. 
Chronic exposure to insulin also induces a decrease in 133-adrenergic sensitivity due to 
133-adrenoceptor down-regulation (Fe,:e et al., 1994). There may also be other factors 
present in the serum which are responsible for a delay in lipolytic development. 
The maximum response to isoproterenol was achieved with 10-6M agonist (lJ,lM), and 
the EDso (concentration giving a half-maximal effect) was 2xl0·8M (20nM). This is 
the same as the concentrations of isoproterenol required to achieve the half-maximal 
response in ovine adipose tissue explants (Vernon et a1., 1995) and similar to that 
measured in differentiated ovine adipocytes (to·7M) (refer to chapter 4). However, 
although a response to 13-adrenoceptor agonist was observed in the 3T3-F442A 
adipocytes, no response to PIA (an adenosine analogue) was observed. No increase in 
the rate of lipolysis was observed after the addition of adenosine deaminase, which 
hydrolyses any exogenous adenosine present. These observations suggest that the 
inhibitory adenosine Al receptor was not present (or not functional) in these cells, 
although it has been shown previously that the cell lines 3T3-Ll and 3T3-F442A are 
responsive to adenosine after differentiation (Elks et al., 1987; Ravid & Lowenstein, 
1988) after approximately the. same time period. Ravid & Lowenstein (1988) also 
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observed that, during the early phase of 3T3-F442A differentiation, the cells still 
retained their adenosine A2 receptors, while new Al receptors were expressed. Two 
weeks after the induction of differentiation, the A2 receptors had decreased 
substantially, but the AI' receptors remained high (Ravid & Lowenstein, 1988). It 
remains to be investigated if the inhibitory adenosine Al receptor was present in the 
cells being utilised, or whether it appears later in the differentiation process (refer to 
chapter 4). . 
There was a small increase in both the basal and stimulated lipolytic rate in the 
presence of GH after 24 hours incubation. However, after 48 hours, GH failed to have 
a stimulatory effect, although it did reduce inhibition of lipolysis by insulin. This was 
also found by Glenn and colleagues (1992), who showed that GH did not affect 
glycerol release from 3T3-Ll adipoc)1:es when exogenous insulin was absent from the 
cultures for over 48 hours, but that it did reverse insulin inhibition of lipolysis in 3T3-
Ll adipocytes (Glenn et al., 1992). Procedural differences (e.g. cell plating density 
for lipolysis assays, incubation times, medium supplements use of bGH rather than 
hGH) have been suggested for the discrepancy between present findings and the 
demonstration of GH-stimulated lipolysis' in the absence of insulin with the 3T3-
F442A adipocytes (Dietz & Schwarz, 1991). 
The original aim of this study was to determine the mechanism of the effects of GH 
on the inhibition of lipolysis by adenosine. However, in view of the failure of the 
adenosine system to develop in either ovine adipocytes or 3T3-F442A adipocytes, this 
objective was abandoned. Concurrent studies in the laboratory concerned the 
mechanism of the effects of insulin and GH on the rate of lipogenesis in differentiated 
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3T3-F442A adipocytes, with particular emphasis on the involvement of different PKC 
isofonns in the signalling pathways (Millar, 1998). A new objective then was to 
, , 
detennine the roles of PKC isozymes in the regulation of ACC expression and activity 
, ' 
by insulin and GH. 
Initial studies on the chronic effects of insulin and GH on the rate of lipogenesis in 
3T3-F442A 'resulted in stimulation by insulin and a decrease in lipogenesis in the 
presence of GH when the hormones were present for 24 hours. GH also had an 
insulin-antagonistic effect on lipogenesis. However, these effects were small, and too 
small to investigate the role of specific PKC isoforms on lipogenesis. Insulin was 
found to have acute and chronic effects in the adipocytes, both resulting in stimulation 
of lipogenesis. There was an additive effect when insulin was present throughout 
chronic and acute incubation but the increase was still small. When the hormones , , 
were present for a further 24 hours, the overall rate of lipogenesis increased. 
However, the percentage increase or decrease by insulin and GH, respectively, 
remained unaltered. Incubation with the known PI-3Kinase inhibitor, L Y29004, 
confirmed that insulin was indeed having an effect on the lipogenic system via the PI-
3Kinase signal cascade, and not by another pathway. Various different conditions for 
inducing differentiation in 3T3-F442A have been described (for example, Ravid & 
Lowenstein, 1988; Schwarz & Dietz, 1991; PIee-Gautier et al., 1996; Raclot et al., 
1998), so different components in the' medium were altered to try an enhance the 
insulin-stimulation of lipogenesis. However, there was no significant improvement. 
Insulin stimulation of lipogenesis from glucose incorporation was greater than that 
observed when measuring the amount of acetate incorporated into the adipocytes, but 
the effect was still small. This probably reflects the fact that the cells are from a 
lIS 
murine cell line, and' there are certain basic differences between ruminants and non-
ruminants with regard to fatty acid synthesis. It has been reported that the precursor 
for lipogenesis in adipose, tissue is glucose in non-ruminants (Ballard et 01., 1969), 
whereas acetate rather than glucose has been s~own to be the principle precursor in 
adipose tissue from ruminants such as sheep, cattle and goats (Ingle ,et 01., 1972; 
Whitehurst et 01., 1978; Liepa et 01., 1978). 
The rate of lipogenesis is regUIated by a numb~r of enzymes, the most important of 
which is acetyl CoA carboxylase (ACC), and is subject to both chronic and acute 
control. ACC exists in both active and inactive states, with insulin and 
catecholamines causing an increase and decrease to the activation status of the 
enzyme, respectively, while insulin also acts chronically to increase gene transcription 
and therefore the amount of ACC <yernon, 1992). GH decreases the amount of 
adipose tissue ACC and its mRNA (Vernon et 01., 1991 ; Liu et 01., 1994). However, 
when the amount of total and initial ACC activity was measured after chronic 
incubation with GH and insulin (and acute incubation), GH caused a slight reduction 
in both, but the percentage of ACC in the active state remained unaltered. No 
significant effect was detected in the presence of insulin. Insulin did tend to increase 
the amount of ACC mRNA per cell, but again the increase was not large enough to be 
confident in detecting any differences when looking at the effect of different PKC 
isoforms. 
To ensure that the lack of an effect of insulin on the proportion of ACe in the active 
state was not an artefact due to a problem with the assay system, ovine subcutaneous 
adipose tissue was maintained in culture with and without lOOnglml insulin for 24 
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hours, and the proportion of ACC in the active state detennined. As found previously 
in ovine subcutaneous adipose tissue (Vernon et al., 1996), insulin increased the 
proportion of the enzyme in the active state from 26.4% to 96.7%. Thus, the failure of 
insulin to activate ACC would not appear to be an artefact of the assay. 
The reason for the very poor response to insulin is unclear. Curiously, maintaining the 
differentiated 3T3-F442A cells in culture in the absence of insulin (for up to at least 48 
hours after the overnight serum deprival) did not result in any fall in the rate of 
lipogenesis. This suggests that the lack of response to insulin may in part be due to 
lipogenesis being almost fully switched on during differentiation, and perhaps because 
of the absence of any agents to "switch" the process off in the system, there is little 
further scope for an effect of insulin. 
To conclude, the 3T3-F442A fibroblasts developed many of the characteristics of 
adipocytes from primary culture with respect to the lipolytic and lipogenic systems. 
However, they did not appear to develop as well as had previously been reported. 
This could be due to the method of differentiation or some other undetected factor. As 
a result, the aims originally undertaken could not be investigated as there were not 
sufficient differences between basal and hormone-stimulated lipogenesis to confidently 
detect any reduction in hormone effect by further treatments. 
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CHAPTER SIX 
STUDIES ON THE EFFECTS OF 
PHOSPHODIESTERASE (PDE) INHIBITORS ON 
LIPOGENESIS IN 3T3-F442A ADIPOCYTE CELLS 
6.1 Introduction 
The fmdings that the. tate of lipogenesis did not change over at least 66 hours 
(overnight serum I insulin deprivation plus 48 hours) in the absence of insulin 
(Chapter 5) suggest that mechanisms which would normally operate to switch 
lipogenesis off in the absence of insulin were not functioning. For example, when 
~ 
sheep adipose tissue explants are incubated in the absence of insulin for several days, 
. . 
there isa progressive fall in the rate of lipogenesis which is prevented by insulin 
(Vernon & Sasaki, 1989). It thus seemed possible that reducing lipogenesis by the 
addition of isoproterenol might lead to a subsequent enhanced response to insulin. 
Lipolysis is stimulated acutely by catecholamines acting via the p-adrenergic receptor. 
This leads to activation of AC which catalyses the synthesis of cyclic AMP from ATP, 
thereby activating PKA and hormone-sensitive lipase (HSL) and enhancing the rate of 
lipolysis. Stimulation of lipolysis results in a concomitant reduction in lipogenesis. 
As shown in the present chapter, the addition of isoproterenol did indeed decrease the 
rate of lipogenesis in differentiated 3T3-F442A cells, with a concomitant enhanced 
response to insulin, but the effect of insulin was still small. 
Insulin plays a key role in the regulation of lipid carbohydrate metabolism in many 
mammalian cells, principally liver, muscle and adipocytes. Despite recent substantial 
advances in the understanding of intracellular signalling, the detailed mechanisms by 
which insulin regulates these metabolic processes is still unclear. One important 
metabolic action of insulin is to block hydrolysis of stored triglycerides in adipocytes. 
The antilipolytic action of insulin can to a large extent be explained by the ability of 
this hormone to lower intracellular cyclic AMP levels, resulting in the reduction in the 
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activity of PKA, net dephosphorylation, and deactivation of HSL, and thereby 
inhibition of lipolysis. and increased lipogenesis (Nilsson et al., 1980; Beebe et al., 
1985; Londos et al., 1985; Eriksson et al., 1995). This effect of insulin is mainly 
mediated through phosphorylation and activation of phosphodiesterase (PDE) 
isoforms (see chapter 1.6). As the effect of insulin on lipogenesis was too small to 
warrant :further investigation, the modulation of the effect on lipogenesis of 
isoproterenol by' phosphodiesterases was explored. 
6.2 Experimental Procedure 
6.2.1 Culture of 3T3-F442A pre-adipocytes 
3T3-F442A pre-adipocytes were cultured, as described in section 2.2.2.4. Two-day 
confluent pre-adipocytes were induced to differentiate, as described in section 2.2.2.5. 
8 days after the onset of differentiation, the insulin and FCS were removed and the 
. medium was replaced with low glucose medium (l.0 gil). 
6.2.2 Lipogenesis assay 
Isoproterenol and / or PDE inhibitors were added to the medium for a 24 hour period 
after overnight serum and insulin starvation, unless stated otherwise. The 
concentrations of PDE inhibitors used were as follows; rolipram (1 O~M), cilostamide 
(l0J,lM), 8-methoxymethyl-IBfvfX (10~) and IBfvfX (lmM), unless stated otherwise. 
Subsequently, the rate of lipogenesis was determined, as described in section 2.2.6.2. 
119 
6.2.3 Statistical analysis 
Results are presented as means +1- S.E.M, and statistical analysis was by analysis of 
. . 
variance (ANOV A), unless stated otherwise. 
6.3 Results 
6.3.1 Incubation of isoproterenol with 3T3-F442A adipocytes - effect on lipogenesis 
6.3.1.1 The effect of chronic and acute incubation with isoproterenol 
concentrations 
Figure 6.1 shows the chronic effect on the rate of lipogenesis in 3T3-F442A 
adipocytes of increasing concentrations of isoproterenol. Concentrations of 
isoproterenol below 10-6M had no effect on lipogenesis, but concentrations greater 
than 10-6M resulted in the rate of lipogenesis decreasing as isoproterenol 
concentration increased. 
Isoproterenol was included m the medium for different periods pnor to the 
measurement of lipogenesis to determine if it had acute or chronic effects on 
lipogenesis in the 3T3-F442A ad~pocytes. The results shown in Figure 6.2 suggest 
that the effects of isoproterenol were both chronic and acute, as isoproterenol for a 24 
hour period caused a greater reduction in the rate of lipogenesis than over 2 hours. The 
inclusion of isoproterenol during the 4 hour assay as well as during the 24 hour 
incubation period resulted in no greater maximum effect of isoproterenol on the rate 
of lipogenesis, but did move the dose response curve to the left such that inhibition 
was apparent with as little as 10-8M isoproterenol. The rate of lipogenesis only 
partially recovered during the 4 hours of the assay after the isoproterenol had been 
removed. However, it is possible that trace amounts of isoproterenol could still have 
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The effect of different concentrations of isoproterenol 
. on the basal rate of lipogenesis 
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Figure 6.1. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (51J.g/ml) , after which time the serum and insulin were 
removed from the medium and various concentrations of isoproterenol were added for 24 
hours prior to, but not during, the measurement of the rate of lipogenesis. This was 
determined by measuring the amount of 14C-labelled sodium acetate incorporated into 
.ceillipid over a 4 hour period. Results are the means of 8 observations +1- S.E.M. 
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Figure 6.2. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5!lg/ml), after which time the serum and insulin were 
removed from the medium. Various concentrations of isoproterenol were added to the 
medium for either 24 hours or 2 hours prior to the measurement of the rate of 
lipogenesis. Isoproterenol concentrations were also either present or absent during the 
4 hour period the 14C-labelled sodium acetate was incorporated into adipocyte lipid . 
. Results are the means of 2 observations. 
been present in the medium after the medium had been changed, despite the cells 
being washed between. medium changes. This could account for the lack of recovery 
. . 
of the rate of lipogenesis after isoproterenol removal. 
6.3.1.2 Exposure of 3T3-F442A adipocytes to isoproterenol and insulin 
Insulin was added to the cells 24 hours prior to, and for 4 hours during, the lipogenesis 
assay. Different' concentrations of isoproterenol were present throughout the 24 hour 
period to determine if it resulted in an increased response of the cells insulin-
stimulation of lipogenesis. ANOV A showed a significant effect of isoproterenol 
(P<O.002) and also of insulin (P<O.OI5), as shown in Figure 6.3. However, the 
increase in lipogenesis in response to insulin was neither quantitatively (Figure 6.3a) 
nor proportionally (Figure 6.3b) different in cells exposed or not to isoproterenol. 
6.3.2 Effects of various PDE inhibitors on lipogenesis in 3T3-F442A adipocytes 
The 3T3-F442A adipocytes were incubated with various specific and non-specific 
POE inhibitors. These were rolipram (Shakur et ai., 1995), a specific inhibitor of the 
POE4 family; cilostamide (Tang et al., 1994; Verghese et al., 1995), a specific 
inhibitor of the PDE3 family; 8-methoxymethyl-IBMX (nun-IBMX) (Ahn et al., 
1989), a specific inhibitor of the Ca2+ / calmodulin-sensitive POEI family and also 
ruMX, which is a non-specific PDE inhibitor. 
6.3.2.1 Different rates of lipogenesis in the presence or absence of isoproterenol 
The differentiated 3T3-F442A adipocytes were incubated with the indicated POE 
inhibitors in the presence or absence of isoproterenol for the 24 hour period prior to 
the lipogenesis assay. This was done in order to observe the effects of inhibiting 
121 
Figure 6.3; 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5J.LQ1ml), after which time the serum and insulin were 
removed form the medium. Different concentrations of isoproterenol were add~d to the 
medium 24 hours prior to, but not during, the lipogenesis assay. Insulin (INS; 
100ng/ml) was added 24 hours prior to, and during, the measurement of the rate of 
lipogenesis (CON == control), which was determined by measuring the amount of 
14C-labelled sodium acetate incorporated into cell lipid over a 4 hour period. (a) shows 
the absolute values for the rate of lipogenesis, and (b) shows the relative rate of 
insulin-stimulated lipogenesis. Results are for 4, 1, 2, 3 obselVations for isop 
. . 
concentrations 0, 10·7M, 10-6M, 10-4M, respectively, values for 0 and 10-4M isop are 
given + S.E.M. 
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specific PDE family ~n lipogenesis. As shown in Table 6.1, the addition of IBMX 
resulted in the rate of lipogenesis being reduced by over 75% in either the presence or 
absence of isoproterenol. "This shows "that inhibiting cAMP breakdown through the 
action of PDEs in these cells results in a functional effect under unstimulated and p_ 
agonist-stimulated conditions. The selective PDE inhibitors rolipram and cilostamide, 
but not inrn-IBMX, effected a small reduction in the rate of lipogenesis when added 
on their· own. However, their effects were more marked when isoproterenol was 
present (Table 6.1). Indeed, in the presence of isoproterenol, rom-IBMX was also 
effective (Table 6.1). However, it was .noted that none of the selective PDE inhibitors 
could reduce lipogenesis by as much as IBMX. This suggests that more than one PDE 
family may be involved in eliciting maximal effect on this signalling pathway. To 
investigate this,. mixtures of rolipram plus cilostamide and rolipram plus cilostamide 
plus mm-IBMX were added to the cell culture medium together for 24 hours. 
Although the rate of lipogenesis was reduced further, it still did not reach the low 
levels observed after culture with mMX in the absence of isoproterenol (Table 6.1). 
However, the rate of lipogenesis found with rolipram + cilostamide and rolipram + 
cilostamide + mm-IBMX did not differ significantly from that achieved with IBMX 
when isoproterenol was also included in the medium prior to the assay (see Table 6.1). 
This suggests additive effects were elicited on lipogenesis through the action of 
inhibiting specific PDE enzyme families. 
The adipocytes were incubated with the specific and non-specific PDE inhibitors in 
the presence of different concentrations of isoproterenol (see Figure 6.4), and the rate 
of lipogenesis was measured. ANDV A showed that rolipram had a significant effect 
on lipogenesis in both the presence and absence of isoproterenol, as shown in figure 
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The effect of different poe inhibitors·on the rate of lipogenesis 
when isoproterenol was absent or present 
POE inhibitor 
mm+rol+ 
control ibmx rol cil mm rol+cil cil 
no isop 3.688 . 0.81b 2.78c 2.9c 3.248C 2.03d 1.68d 
isop10""'M 1.828 OAb 0.88ed 1.19c 1.16c 0.7200 O.59bd 
rate of lipogenesis (IJ.mol,aCl4hrs/mgDNA) 
Table 6.1. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5JJ.g/ml), after which time the serum and insulin were 
removed from the medium. Different selective and non-selective PDE inhibitors 
(control = no PDE inhibitor, rol = rolipram (10IJ.M) (Shakur et a/., 1995), 
cil = cilostamide (10IJ.M) (Verghese et al., 1995; Tang et al., 1994), mm = 
methoxymethyl-IBMX (10JJ.M) (Ahn et al., 1989) and IBMX (1 mM» were added to 
the medium, with or without isoproterenol (isop ; 10-4M), for 24 hours prior to, but 
not during, the measurement of the rate of lipogenesis. This was determined by . 
measuring the amount of 14C-labelled sodium acetate incorporated into cell lipid 
over a 4 hour period. Results are the means of 6 observations, S.E.M.= 0.2604 for 
no isop' and S.E.M. = 0.1566 for '+ isop'. Values in a row without the same suffix, 
a,b,c,d, differ significantly, P<0.05. 
The effect of different selective POE inhibitors on the rate of 
lipogenesis when various concentrations of isoproterenol are 
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Figure 6.4. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5~ml), after which time the serum and insulin were 
removed from the medium. Various concentrations of isoproterenol were added to 
the medium for 24 hours prior to, but not during, the measurement of the rate of 
lipogenesis, together with different selective POE inhibitors (con = no POE inhibitor, 
rol = rolipram (10~), cil = cilostamide (10~M). mm = 8-methoxy-IBMX (10~» and 
the non-selective POE inhibitor IBMX (1mM). The rate of lipogenesis was 
determined by measuring the amount of 1"'C-labelled sodium acetate incorporated 
. into cell lipid over a 4 hour period. Results are the means of 4 observations, and 
are standardised as a percentage of the dmso control value. (b)-(g) are +/- S.E.M. 
derived from ANOVA. 
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6.4(b) and increased the sensitivity to isoproterenol moving the isoproterenol dose 
response curve to the left. However, ANOV A showed that neither cilostamide nor 
. . 
mm-ffiMX had a significant effect on lipogenesis in this study (Figures 6.4(c)(d». 
The two different combinations of selective PDE inhibitors did not differ significantly 
from each other, although they did increase sensitivity to isoproterenol and reduce the 
rate of lipogenesis significantly (Figure 6.4(f)(g)). However, llMX alone resulted in 
the greatestinciease in sensitivity to isoproterenol (Figure 6.4(e)). The pattern of 
reduction in lipogenesis in the presence of isoproterenol shows that there appear to be 
2 phases involved. When either rolipram or IBMX alone, or the selective PDE 
inhibitors together, are incubated with the adipocytes in the absence of isoproterenol, 
the inhibitors cause a reduction in the rate of lipogenesis. This level of lipogenesis 
stays relatively constant as isoproterenol concentrations increase, until 1 a-8M. There 
is then a further drop in lipogenic rate as isoproterenol concentration increases. This 
is consistent with the isoproterenol dose response curve in Figure 6.1, which shows 
that isoproterenol dose not have an effect on the rate of lipogenesis until 
concentrations exceed 1 a-8M. 
As ffiMX was clearly more effective than 'the combination of all three PDE inhibitors 
on reducing the rate of lipogenesis, it is possible it may be having effects on 
lipogenesis by another mechanism in addition to inhibition of PDEs. mMX can 
inhibit certain effects of adenosine and thus, under certain conditions, could alter AC 
activity and influence cAMP content and lipolysis I lipogenesis (Londos et al., 1978). 
However, this is unlikely here, as no response to adenosine has been observed in 
earlier studies in 3T3-F442A adipocytes (Chapter 5). 
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6.3.3 Different concentrations of selective and non-selective PDE inhibitors 
6.3.3.1 IBMX dose re~ponse data 
. . 
The effect of different concentrations 'of IBMX on lipogenesis was observed in the 
absence of isoproterenol. Figure 6.5 shows that the concentration routinely used in 
other experiments (1mM) resulted in the greatest reduction in lipogenesis, with the 
rate decreasing as IBMX concentration increased. 
6.3.3.2 Selective.PDE inhibitor dose response data 
The 3T3-F442A adipocytes were chronically incubated with a range of concentrations 
of selective PDE inhibitors, as shown in Figure 6.6, to investigate the effect on 
lipogenesis. Earlier literature had suggested that 10J.lM was the optimum 
concentration of each of the PDE inhibitors. Higher concentrations of both rolipram 
and mm-IBMX had no further effect on the rate of lipogenesis. However, it appeared 
that higher concentrations than those routinely used of cilostamide reduced the rate of 
lipogenesis further in the presence of isoproterenol. This suggests that higher 
concentrations of cilostamide were required to be present to fully inhibit the PDE3 
enzyme. However, higher con~entrations of cilostamide may be toxic to the cell or 
affect other components within the cells. 
6.3.4 Chronic and acute incubation of PDE inhibitors with 3T3-F442A 
adipocytes 
IBMX, rolipram, cilostamide and mm-IBMX were added to the medium, either in a 
mixture or separately, for either 24 hours or 2 hours prior to the measurement of the 
rate of lipogenesis. Isoproterenol (10-4M) was present for 24 hours prior to the assay. 
The PDE inhibitors were also either present or absent during the assay, as shown in 
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Figure 6.7. ANOV A shows a significant effect of time (P<O.023) and also of PDE 
inhibitor (P<O.OOOI) ~n the rate of lipogenesis. For the untransfonned data shown in 
. . 
Figure 6.7a, .the lowest overall rate of lipogenesis was found after exposure to the 
inhibitors for 24+4 hours, and the greatest rate. of lipogenesis was found after 2 hours 
or 2+4 hours, with 24 hours culture being intermediate. IDMX had the most effect on 
the rate of lipogenesis, with the selective PDE inhibitors alone having a small effect 
and theconibinations being intermediate. Significant effects of time (p<O.OOOl) and 
PDE inhibitor (p<O.OOOl) were also found when the relative rates of lipogenesis were 
compared, as shown in Figure 6.7b. The PDE inhibitors were required to be present 
. . 
for over 2 hours, and the lowest rate of lipogenesis was observed after either 24+4 
hours or 2+4 hours. 
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Figure 6.S. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5llg/ml), after which time the serum and insulin were 
removed from the medium. Various concentrations of the non-selective PDE inhibitor 
IBMX were added to the medium for 24 hours prior to, but not during, the measurement 
of the rate of lipogenesis. This was determined by measuring the amount of 14C-labelled 
.sodium acetate incorporated into cell lipid over a 4 hour period. Results are the means 
of 2 observations. 
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Figure 6.6. 3T3-F442A pre~adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5 J.1g/m I) , after which time the serum and insulin were 
removed from the medium. Various concentrations of selective PDE inhibitor (with 
. isoproterenol at a concentration of 10-4M) were added to the medium 24 hours prior to, 
but not during, the measurement of the rate of lipogenesis (isop = isoproterenol , 
rol = rOlipram, cil = cilostamide, mm = methoxymethyl-IBMX). This was determined by 
measuring the amount of 14C-labelled sodium acetate incorporated into cell lipid over a 
4 hour period. Results are the means of 2 observations. 
Figure 6.7. 3T3-F442A pre-adipocytes were differentiated for 8 days in medium 
containing serum and insulin (5~mO, after which time the serum and Insulin were 
removed from the medium,' Selective poe inhibitors (con = control, rol = rolipram 
. (1 O~), cil = cilostamide (1 O~), mm = methoxymethyl-IBMX (1 O~» and the non-
. . 
selective POE inhibitor IBMX (1 mM) were added to the medium for either 24 hours or 2 
hours p~or to the measurement of the rate of lipogenesis (isoproterenol (10-4M) was 
present for 24 hours prior to the assay). The POE inhibitors were also either present or 
absent during lipogenesis, the rate of which was determined by measuring the amount 
of 14C-labelled sodium acetate incorporated into cell lipid over a 4 hour period, 
(a) shows the absolute values for the rate of lipogenesis, + S.E.M., while (b) shows 
the relative rate of lipogenesis, + S.E.M. Results are the means of 3 observations. 
The effect of different POE inhibitors when they are present for 
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6.4 Discussion 
Insulin-stimulation of lipogenesis in 3T3-F442A adipocytes observed previously 
(Chapter 5) was notas larg~ as expected, so it was decided to subject the adipocytes to 
exposure to isoproterenol prior to measuring the insulin stimulation· of lipogenesis. 
Agents which increase cyclic AMP inhibit lipogenesis and this effect is usually 
reversed by insulin (Correze et a/. J 1982). The addition of isoproterenol to the culture 
was expected to improve the effective response to insulin. However, although the rate 
of lipogenesis was decreased by isoproterenol and the size of the increase in 
lipogenesis induced by insulin acc~ntuated slightly (but not significantly), the 
response to insulin was still considered to be too small to explore further. One curious 
observation was that the inhibition of lipogenesis by isoproterenol appears to involve 
both an acute and a chronic component as exposure to isoproterenol for 24 hours had a 
greater inhibitory effect than exposure. for 2 hours. 
The inhibitory effects of isoproterenol on lipogenesis are thought to be mediated by 
cyclic AMP, and so should be modulated by inhibitors of POEs, especially at sub-
optimal concentrations of isoprQte~enol. While the classes of POEs involved in the 
regulation of lipolysis and adipogenesis have been identified, namely PDE3 and 
PDE4, respectively, it is still not clear which POE enzymes have a role in modulating 
the rate of lipogenesis. Thus, cells were cultured in the presence of various selective 
and non-selective POE inhibitors in the presence or absence of isoproterenol to 
establish which isoforms modulated the inhibition of lipogenesis by cyclic AMP. In 
the absence of isoproterenol, the three specific inhibitors of POE1, POE3 and POE4, 
either alone or together, did not have the same effect on the rate of lipogenesis as the 
non-selective POE inhibitor, ffiMX. However, in the presence of isoproterenol, the 
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three specific PDE irihibitors all had some effect on inhibition of lipogenesis, and the 
combination of either PDE3 and PDE 4 enzymes inhibitors, or PDEl, 3 and 4 enzyme 
. . 
inhibitors, reduced the rate· of lipogenesis to levels which did not differ significantly 
. . 
from that achieved with IBMX, as shown in Table 6.1 and Figure 6.4 .. 
The pattern ·of reduction in lipogenesis in the presence of isoproterenol shows that 
there appear to be 2 phases involved. The incubation of the PDE inhibitors with 
adipocytes in the presence of different concentrations of isoproterenol appeared to 
involve a biphasic reduction in lipogenesis. When either rolipram or IBMX alone, or 
the selective PDE inhibitors together, are incubated with the adipocytes in the absence 
of isoproterenol, the inhibitors cause a reduction in the rate of lipogenesis. This level 
of lipogenesis stays relatively constant as isoproterenol concentrations increase, until 
1 a-8M. There is then a further droP. in lipogenic rate as isoproterenol concentration 
increases. This is consistent with the isoproterenol dose response curve in Figure 6.1, 
which shows that isoproterenol dose not have an effect on the rate of lipogenesis until 
concentrations exceed 1 a-8M. 
Both PDE3B and PDE4 enzymes are found in adipocytes, and have been implicated in 
signalling pathways in adipocytes, with PDE4 being considered important in 
adipocyte differentiation, and PDE3 being an important factor for lipolysis (Elks & 
Manganiello, 1985; MacKenzie et al.,· 1998). It has been suggested that there is 
compartmentalisation of cAMP signalling between a pool controlled by PDE3 activity 
and another pool controlled by PDE4 activity, as it has been observed that there were 
differences in response to selective PDE inhibitors for these isoforms in adipocytes 
(Elks & Manganiello, 1985; MacKenzie et al., 1998) and other cell types (Faux & 
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Scott, 1996; Erdogan & Houslay, 1997; Houslay & Milligan, 1997). However, while 
PDE3 appears to be the most important isoform of PDE involved in the regulation of 
, 
lipolysis, it does not 'appear to be the only isoform involved. Arner and colleagues 
(1993) showed that inhibition ofPDE3 stimulated lipolysis, but not to the same extent 
as a non-selective PDE inhibitor, suggesting that other PDE isoforms w~re involved in 
lipolysis regulation. In contrast to lipolysis, inhibition of PDE1, PDE3 and PDE4 
isoforms appears to be equally effective in accentuating the inhibition of lipogenesis 
by isoproterenol, and the combination of all fuee inhibitors achieved a similar effect 
on lipogenesis as the non-specific PDE inhibitor, mMX, in the presence of 
isoproterenol. In the absence of isoproterenol, mMX was clearly much more 
effective than the combination of all three inhibitors, so may be having effects on 
lipogenesis by another mechanism in addition to inhibition of PDEs. mMX can 
inhibit certain effects of adenosine and thus, under certain conditions, could alter AC 
activity and influence cAMP content and lipolysis I lipogenesis (Londos et al., 1978). 
However, this is unlikely here, as no response to adenosine has been observed in 
earlier studies in 3T3-F442A adipocytes (Chapter 5). 
Thus the pool of cyclic AMP involved in the inhibition of lipogenesis may not be the 
same as that involved in the stimulation of lipolysis by catecholamine. Lipolysis is 
under acute control by catecholamines, whereas the effects on lipogenesis appear to 
involve both acute and chronic corn:ponents, which is consistent with the two 
metabolic processes being modulated by different pools of cyclic AMP. The basis of 
the apparent chronic effect of isoproterenol on lipogenesis in the 3T3-F442A 
adipocytes was not determined, but could be due to a change in the amount of one or 
more lipogenesis enzymes. Agents which increase cyclic AMP levels decreased the 
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expression of lipogenic enzyme genes in rat adipose tissue in vitro (Foufelle et al., 
1994) and also In differentiating 3T3-F442A (Spiegleman & Green, 1981)and 3T3-Ll 
adipocytes (Weiss et ~/., 1.980;' PauIauskis & SuI, 1988 ; Moustaid & SuI, 1991). The 
studies by Spiegelman md Green (1981) also ,showed that cyclic AMP could inhibit 
lipogenic enzyme gene expression by a mechanism which did not involve lipolysis. 
This observation is consistent with different pools of cyclic AMP modulating 
lipolysis and lipogenesis. 
The identity of the PDE isoforms involved in mediating aspects of insulin stimulation 
of lipogenesis in the 3T3-F442A adipocytes remains to be investigated. It has already 
been shown that PDE3B activation / phosphorylation is inhibited by the PI-3K 
inhibitor wortmannin, thus blocking the antilipolytic action of insulin (Okada et al., 
1994). Wijkander and colleagues (1~98) have shown that PKB is responsible for the 
phosphorylation of PDE3B in vitro, but insulin-induced activation of p70 S6 kinase 
and MAP kinases are not involved in its activation (Wijkander et al., 1998). Further 
investigation is required into the involvement of specific PDE isoforms in insulin 
signalling to help elucidate this complex pathway in adipocytes. 
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CHAPTER SEVEN 
GENERAL DISCUSSION 
General Discussion 
It has become increasingly clear that technological developments in a variety of 
scientific and engineering "fields will be required to support the ever increasing world 
population, which is estimated to double over the next four decades (Bauman, 1992). 
The need for technological innovations in agriculture production systems is clear. 
Because the GH-mediated changes in adipose tissue metabolism playa pivotal role in 
accounting for "the effects of GH on animal growth and carcass composition, 
considerable effort has been made to increase our understanding of how GH alters 
nutrient utilisation in adipose tissue. " The expansion of our knowledge of GH has 
enabled scientists to conceptualise and develop strategies to modify carcass 
composition, improve feed efficiency, enhance growth rate and milk yield, while 
concurrently decreasing adipose tissue accretion (for review, see Etherton & Bauman, 
1998). 
Food energy in animals is stored primarily as triacylglycerols in lipid storage droplets 
of adipocytes. The important features of adipocyte metabolism are the synthesis, 
storage and subsequent hydrolysis of these triacylglycerols, and the relative rates of 
their synthesis and breakdown determine the amount of lipid within the adipocyte. 
The release of fatty acids (lipolysis) to fulfil metabolic needs during periods of 
negative energy balance" is under complex acute and chronic endocrine control 
01 emon, 1992). The crucial step in triacylglyceride breakdown is activation of the 
HSL, which is mediated by the cyclic AMP and the AC system, and the subsequent 
cascade of protein phosphorylation (Figure 7.1). Lipolysis is stimulated acutely by 
catecholamines acting via p-:-adrenergic receptors and glucagon acting via the 
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Figure 7.1 . Endocrine control of lipolysis 
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glucagon receptor. It is inhibited by adenosine acting via the adenosine Al receptor 
and also catecholamines acting via the a2-adrenergic receptor. 
Acute, insulin-like effects of GH have been observed in some species (not sheep), but 
these effects have been controversial and their physiological significance uncertain. 
Chronia treatment with GH seems to increase the rate of lipolysis by affecting both the 
inhibitory arid stimulatory systems. Initial studies showed that chronic treatment with 
GH in sheep adipose tissue explants in vitro increased the response to catecholamine, 
thereby increasing the rate of isoproterenol-stimulated lipolysis, which is consistent 
with the findings of Watt et aZ. (1991). A decrease in response to PIA was also 
observed in sheep adipose tissue explants after chronic culture with GH, which had 
previously been found (Vernon et al., 1991b; Doris et al., 1996, 1998). 
GH also chronically decreases adiposity in animals by having insulin-antagonistic 
effects resulting in a decrease in lipogenesis, both in vivo and in vitro (Nyberg & 
Smith, 1977; Vernon, 1982; Walton & Etherton, 1986; Etherton et al., 1987) (Chapter 
1, section 1.3.3). However, ili:e signalling system involved in the chronic, insulin-
antagonistic effect of GH on lipogenesis is' not known. 
Inhibitors of different proteins involved in various signalling pathways have been used 
to try and determine the mode of action of the chronic effects of GH (Table 7.1). 
Studies with sheep adipocytes using inhibitors such as rapamycin and PD 98059 
suggest that neither p70S6K nor MAP kinase are involved with chronic related effects 
ofGH (see section 1.3.3). However, anti-lipogenic, insulin-antagonistic effects ofGH 
appear to involve both protein serine kinases and phosphatases (Vernon, 1996) by use 
131 
• 
Effects of ~ome inhibitors on attenuation of lipogenesis and the antilipolytic effects of PIA by growth ho~one 
Inhibitor 
Actinomycin 0 
H7 
Okadaic acid 
Wortmannin 
PO 98059 
PMA (chronic) 
in sheep adipose tissue 
Target 
gene transcription 
serine kinases 
serine phosphatases 
Pl3-kinase 
MAP kinase 
PKC isoforms 
GH inhibition 
of lipogenesis 
prevented 
prev~nted 
prevented 
mimicked 
no effect 
partially prevented 
GH inhibition of antilipolytic 
effect of PIA 
prevented 
prevented 
mimicked 
mimicked 
no effect 
mimicked 
Table 7.1. Explants of adipose tissue from 6 month old, castrated, male sheep were maintained in culture for 22 hours in the absence of 
exogenous hormones and inhibitors, and then for a further 24 hours in the presence and absence of 4.SnM growth hormone plus or minus an 
inhibitor. Subsequently, the rate of lipogenesis or response to PIA were assessed (Chapter 2, section 2.2.3). 
From Vernon (1996), Doris et al. (1998) and unpublished observations. 
of the inhibitors H7, staurosporine and okadaic acid. It has been shown that the loss 
of the acute, insulin-like effects of GH and the development of enhanced lipolysis in 
rat adipocytes are both prevented by the addition of the transcription inhibitor, 
Actinomycin D (Goodman et al., 1987; Goodman, 1993). Borland et ai. (1994) found 
that the inhibition of lipogenesis in sheep adipose tissue by GH was prevented by 
Actinomycin D and required polyamines, effects of which include a role in gene 
transcription' (Sc'alabrino et al., 1991; Sjoholm, 1993), activation of a number of 
protein kinases and phosphatases (Morgan, 1990) and enhancing hormone binding to 
plasma membrane receptors (Pedersen et al., 1989). At least one isoform of PKC has 
, , 
also been shown to be involved in GH inhibition of lipogenesis as pretreatment with 
phorbol ester (PMA), which down-regulates PKC, partially prevented the GH effect. 
PKC has also been suggested as being involved in GH inhibition of the anti-lipolytic 
effect of adenosine (Doris et al., 1998). 
The studies by Borland et al. (1994) which found that the inhibition of lipogenesis in 
sheep adipose tissue by GH required polyamines, and that the product(s) of gene 
transcription must have a very short half-life (less than 3 hours) prompted the 
investigation into whether the cytokine OOa. could be this putative protein. TNFa. 
had been shown to chronically increase the rate of basal lipolysis in rat epididymal 
adipocytes (Green et al., 1994; Gasic et al., 1999), an effect similar to that of GH, and 
therefore was a possible candidate to mediate the action of GH. TNFa. also has insulin 
antagonistic effects. The mitogenic effects of GH are mediated by IGF-l, and there 
was the possibility that chronic metabolic effects of GH could be by an analogous 
mechanism. However, although TNFa. did result in a small increase in basal lipolysis 
in sheep and rat adipose tissue explants, it had no effect on the rate of isoproterenol-
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stimulated lipolysis, 'unlike GH. lNFa. did show a tendency to decrease the response 
to adenosine in sheep, and rat explants (consistent with Gasic et al., 1999), but the 
effect was very small. 
Increasing the proximity to the lymph nodes embedded in guinea pig popliteal adipose 
tissue had previously been shown to result in an increase in lipolysis when cultured 
with lymph 'node lymphoid cells (pond & Mattacks, 1995; Mattacks & Pond, 1997), 
so it was decided to investigate if the effects of lNFa. on lipolytic rate in sheep 
popliteal tissue could be enhanced by using tissue from near to the lymph node. 
However, although adipose tissue from near to the lymph node showed a smaller 
increase in response to isoproterenol and diminished response to adenosine, there 
were no differences in the ability of lNFa. to stimulate basal or catecholamine-
stimulated lipolysis. 
However, lNFa. did cause a reduction in insulin stimulation of lipogenesis in ovine 
subcutaneous tissue explants, although it did not have any effects by itself. This is 
consistent with previous findings which suggest that the cytokine has a role in the 
induction of a generalised state of insulin resistance. In 3T3-F442A adipocytes, 
TNFa inhibits enzymes involved in fat synthesis (Pekala et al., 1983; Torti et al., 
1985; Semb et al., 1987; Pape & Kim, 1988), and results in peripheral insulin 
resistance in rats (Lang et al., 1992) and humans (Van der Poll et al., 1991). 
However, the role of lNFa. in regulating adipocyte lipolysis and promoting insulin 
resistance in vivo is still controversial, and some of the findings published have been 
contradictory (refer to ChapterJ). Although I found that the effects oflNFa on basal 
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lipolysis in rats and 'sheep were similar to those found by Green et al. (1994), and 
TNFa had similar effects to GH on inhibition of insulin-stimulated lipogenesis, TNFa 
, . 
did not mimic all the effects of GH on adipose tissue metabolism, and its effects were 
smaller than those of GH. I therefore concluded that TNFa was not the putative 
secreted protein involved in GH regulation of lipolysis and lipogenesis in adipose 
tissue. 
It has been found that chronic exposure to phorbol ester (PMA) partly attenuated the 
antilipogenic effect of GH in sheep adipocytes, suggesting the involvement of one or 
, , 
more isoforms of PKC 01 emon, 1996). PKC is a family of phospholipid-dependent 
kinasesinvolved in basic cellular functions, including regulation of growth, 
differentiation and gene expression (pears et al., 1992; Nishizuka, 1995). The role of 
individual PKC's in these processes in not yet known, although it seems likely that 
individual PKC's have unique rather than overlapping functions as most cells express 
more than one type ofPKC. 
All of the PKC's require phosphatidylserine for maximal activity. However, PKC's 
can be grouped according to differences i~their dependence on other activators. In 
addition to phosphatidylserine, conventional PKC's require calcium and 
diacylglycerol (DAG) and consist of PKC a, ~I, ~II and y (Coussens et al., 1986; 
Knopf et al., 1986; Parker et al., 1986), novel PKC's require only DAG and are 
insensitive to calcium (pKC 0, E, ll, 8) (Ono & Nishizuka, 1987; Ohno et al., 1988~ 
Bacher et al., 1991; Osada et al., 1992), and atypical PKC's (s, t/')..) are thought to 
require nothing more but phospholipid (Ono et al., 1989; Selbie et al., 1993; Akimoto 
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et al., 1994). There ruso exists PKC J.I. (Johannes et ai" 1994) and PKD (Valverde et 
al., 1994), which are ~ought to be human/murine homologues, and are structurally 
. . 
quite different from the other isofonns; ·therefore, they may represent a new PKC sub-
family. PKC isofonns display distinct regulatory properties and tissue distributions 
(Bomer et al., 1992; Hata et al., 1993; Hug & 8arre, 1993; 8elbie et al., .1993; 8tabel 
& Parker, 1993; Akimoto et. ai" 1994; Hirai et al., 1994; Dieterich et ai" 1996), which 
is consistent With individual isofonns probably serving diverse functional roles. 
PKC has been implicated in having a role in some of the signalling events mediated 
. . 
by GH (see Figure 7.2). GH increases cellular levels ofDAG in various cells (Doglio 
et al., 1989; Catalioto et al., 1992). Inhibition/down-regulation ofPKC by prolonged 
exposure of cells to PMA resulted in attenuation of the activation of MAP kinases and 
two 86 kinases by GH in 3T3-F442A pre-adipocytes (Anderson, 1992, 1993). GH 
requires specific PKC isofonns to activate MAP kinases in 3T3-F442A pre-adipocytes 
(MacKenzie et al., 1997) arid evidence suggests that PKC lies downstream of PI-
3kinase and upstream of MAP kinases (Kilgour et al., 1996; MacKenzie et al., 1997) 
and p70S6 kinase (Anderson et a!., 1992, 1993) in the signalling pathways utilised by 
GH in 3T3-F442A pre-adipocytes. PKC is~fonns have also been implicated in being 
involved in the cell differentiating effects of GH (Gurland et al., 1990; Campbell et 
ai" 1992; Ailhaud et ai" 1992; Catalioto et al., 1992). PKC also mediates the GH 
signal transduction pathways resulting in inhibition and stimulation of lipogenesis and 
lipolysis in adipocyte metabolism (Smal & De Meyrs, 1987; Gorin et al., 1990;' 
Vernon, 1996), and appears to be involved in mediating GH reduction in sensitivity to 
adenosine of sheep adipose tissue (Vernon, 1996; Doris et ai" 1998). However, the 
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effects are different.· In lipogenesis, PMA partly prevents the effects of GH, whereas 
PMA mimics the effect of GH on the antiipolytic effect of PIA. 
While inhibitor studies implicate isofonns of PKC, they cannot distinguish which 
ones are involved. Other studies in the laboratory were using an antisen~e approach to 
eliminate specific isofonns of PKC to determine their role in the differentiation of 
3T3-F442A ·pre.:.adipocytes (Fleming et al., 1998). This approach was subsequently 
used to show that PKC 'Y and PKC Il were involved in the chronic effect of GH on 
lipogenesis in differentiated 3T3-F442A adipocytes (Millar, 1998). Hence, I decided 
to try an use that approach to determine the isoforms involved in the GH effects on the 
antilipolytic effect of PIA. To investigate the involvement of specific PKC isofonns 
in the reduction of sensitivity of sheep adipocytes to adenosine in isoproterenol-
stimulated lipolysis, an ovine primary adipocyte cell culture was required, as tissue 
explants are not a suitable system for· antisense manipulation. However, upon 
investigation it was apparent that the ovine primary adipocytes developed some, but 
not all, of the features of the lipolytic system after the induction of differentiation. 
Unstimulated and isoproterenol-stimulated lipolysis developed with time after 
differentiation, reaching a maximum after' 10 days, consistent with previous findings 
for GPDH activity and lipogenesis in these cells (Soret et al., 1998, 1999). However, 
response to adenosine did not develop in this time period. 
Initial studies had utilised adipocytes that were differentiated in the presence of 
insulin, T 3 and lipid. More recent studies have shown that the inclusion of 
rosiglitazone and dexamethasone, along with ex-cyte, T3 and dexamethasone enhance 
differentiation of ovine pre-adipocytes (Soret et al., 1999). The effect on lipolysis of 
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different combinations of these additions. to the differentiation medium were 
investigated. It was immediately apparent that the cells showed little differentiation in 
the absence of insulin, as obserVed previously (Aso et al., 1995; Adams et al., 1996; 
. . 
Soret et al., 1999). It waS found that the maximum rate of stimulated lipolysis was 
observed in the presence of insulin, ex-cyte, dexamethasone and rosiglitazone, but that 
the addition of T3 to this combination caused a reduction in lipolysis. This effect of 
T 3 was unexpected, as hyperthyroidism increases, whereas hypothyroidism decreases, 
response to isoproterenol in rat adipose tissue, and hypothyroidism decreased the 
lipolytic response to catecholamines in neonatal lambs. T3 also causes over a 2-fold 
increase in ~3-adrenoceptor concentration in differentiating 3T3-F442A adipocytes 
due to an increase in the half-life of ~3-adrenoceptor mRNA (El Hadri et al., 1996). 
However, although manipulation of the differentiation medium showed an increase in 
isoproterenol-stimulated lipolysis and sensitivity to isoproterenol under most 
conditions tested, no response to adenosine was observed. 
As no effect of adenosine was observed in the ovine primary adipocytes, the lipolytic 
system in the murine pre-adipocyte cell line, 3T3-F442A, was determined with a view 
to using this system instead to investigate the molecular mechanisms involved in GH 
action. In accordance with previous findings (Dietz & Schwarz, 1991), the basal and 
isoproterenol-stimulated lipolytic system developed with time, reaching a maximum 
after 10 days of differentiation. However, as with the ovine primary adipocytes, no 
significant response to adenosine was observed. 
No increase in the rate of lipolysis was observed after the addition of adenosine 
deaminase (which hydrolyses any exogenous adenosine present) in either the ovine 
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primary adipocytes or the 3T3-F442A adipocytes and no decrease was found on the 
addition of PIA, suggesting that the inhibitory adenosine Al receptor was either not 
present or not functional iIi these cells. It has been shown previously that, although 
, , 
different cell types showed a response to adenosine after differentiation, the effect was 
not apparent until later stages of differentiation (a minimum of 8 days) (Elks et al., 
1987; Ravid'& Lowenstein, 1988; Saulnier-Blache et al., 1991; B0rglum et al., 1996). 
Mersmann et al: (1997) have also found that no inhibitory adenosine receptors are 
present in suckling pigs at early stages of development. It therefore seems that the 
inhibitory adenosine Al receptors are not present at early stages of adipocyte 
differentiation, and that their expression in the differentiating adipocytes depends on 
species. ' It would be interesting to determine the expression of the adenosine 
receptors at various stages of differentiation in the ovine primary adipocytes and the 
3T3-F442A adipocytes. In view of the failure of the adenosine system to develop in 
either cell system, the investigation into the mechanism of the effects of GH on the 
inhibition of lipolysis by adenosine was abandoned. 
Concurrent studies in the laboratory concerned the mechanism of the effects of insulin 
and GH on the rate of lipogenesis in differentiated 3T3-F442A adipocytes, with 
particular emphasis on the involvement of different PKC isoforms in the signalling 
pathways (Millar, 1998). The role of PKC in mediating the effects of insulin is 
undetermined. PKC has been associated with attenuation of the insulin response and 
the induction of insulin resistance (Houslay, 1991; Chin et al., 1993). PKC appears to 
counter-regulate insulin action via induction of serine / threonine phosphorylation of 
the insulin receptor, which has been associated with decreased insulin receptor 
tyrosine kinase activity (see Houslay, 1991, 1994) and with decreased ability of the 
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insulin receptor to promote activation of the PI-3Kinase complex (Chin et al., 1993). 
PKC activation also results in serine phosphorylation of IRS-I, which contributes to 
inhibition of insulin signalling (De Fea & Roth, 1997). These effects are mainly due 
to activation of the PKCa. isoform (Chin et al., 1994; Danielson et al., 1995). PKC 
also suppresses the insulin-mediated increase in PKB activity in 3T3-Ll adipocytes 
(Barthel et al., 1998). 
However, it has been observed that insulin activates a number of PKC isoforms in 
adipocytes (Farese et al., 1992; Bandyopadhyay et al., 1997). PKC also appears to be 
required to mediate insulin-stimulated lipogenesis (Smal & De Meyrs, 1987) and 
glucose transport (Standaert et al., 1990; Grunberger, 1991; Yano et al., 1993; 
Chalfant et al., 1995) in the adipocyte. Therefore, mediation of the metabolic effects 
of insulin by PKC isoforms appears, to be complex. Using antisense technology to 
deplete specific PKC isoforms, Millar (1998) found that in 3T3-F442A adipocytes, 
PKC J.l is essential, and that PKC e is at least partly required, for insulin-stimulation of 
lipogenesis. PKC f..I. is partly required for GH reduction of basal lipogenesis, but other 
PKC-independent pathways al~o appear to be involved. PKC 'Y was found to be 
. 
essential for the GH antagonism of insulin stimulation of lipogenesis in 3T3-F442A 
adipocytes (Millar, 1998). 
GH and insulin effects on the rate of lipogenesis involve alteration in the expression 
and activation status of key lipogenic enzymes such as ACC and PDH (Dietz & 
Schwarz, 1991; Bauman & Vernon, 1993; Harris et al., 1993; Vernon et al., 1993; 
Denton & Tavare, 1995; Moule et al., 1995). GH has been shown to suppress both 
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the activation status' and expression of ACC and FAS (Dietz & Schwarz, 1991; 
Bauman & Vernon, 1993; Harris et al., 1993; Vernon et al., 1993) and prevent the 
activation of ACC by tnsulin (Vernon et al., 1991). I therefore decided to attempt to 
determine if specific PKC isoforms were invol~ed in the mediation of ~ese effects on 
expression and activation status of ACC in 3T3-F442A adipocytes. HO'Yever, despite 
observiI).g an increase and decrease in the presence of insulin and GH, respectively, in 
the rate of lipogenesis in the 3T3-F442A adipocytes, the effects were small. There 
was no significant effect on either total ACC or ACC in the active state by insulin and 
GH, although insulin did have a slight effect on increasing the levels of ACC mRNA. 
A number of modifications to the original system did result in some improvement, but 
the size of response to either hormone was still not large enough to confidently detect 
any differences When looking at the different PKC isoforms. 
The reason for the poor response to insulin is unclear. It was found that maintaining 
the differentiated 3T3-F442A cells in culture in the absence of insulin for up to 48 
hours did not result in any fall in the rate of lipogenesis. This suggests that the 
lipogenic system is fully switched on during differentiation, and possibly is not 
switched off after the removal of insulin, thus leaving little scope for a further increase 
by insulin. 
Isoproterenol was included in the studies to reduce the rate of lipogenesis, and 
hopefully result in a larger increase in lipogenesis in the presence of insulin., 
Isoproterenol did reduce the rate of basal lipogenesis in 3T3-F442A adipocytes. 
However, although I observed a slight increase in lipogenic rate in the presence of 
140 
insulin and isoproterenol, the effect was still small. Hence, as an alternative, the 
modulation of the effect on lipogenesis of isoproterenol by PDEs was explored. 
ln adipocytes, the intracel1ular concentrations. of cyclic AMP are control1ed by the 
complex coordinate regulation of both AC and cyclic AMP PDE activi~ies. Changes 
in intr3:cellular cyclic AMP greatly affect the metabolic status of the cell, with 
catecholamines -increasing the levels of cyclic AMP, and ultimately the rate of 
lipolysis, while .PDE's reduce the levels of· cyclic AMP by hydrolysis, thereby 
decreasing lipolysis and increasing lipogenesis. Different PDE isoforms have been 
found to have different roles in cel1 metabolism. For example, the PDE isoform, 
PDE4 has been implicated in playing an important part in adipocyte differentiation 
(Elks & Manganiello, 1985; MacKenzie et aI., .1998), whereas PDE3 has been found 
to play an important role in regulating lipolysis in mature adipocytes (Elks & 
Manganiello, 1985). This suggests that the differences in response to selective 
inhibitors for these PDE enzymes reflects compartmentalisation of cAMP signalling 
(Erdogan & Houslay, 1997; Faux & Scott, 1996; Houslay & Milligan, 1997). 
However, while the classes of PDE involved in the regulation of lipolysis and 
adipogenesis have been identified, namelyPDE3 and PDE4 respectively, it is still not 
clear which PDE enzymes have a role in modulating the rate of lipogenesis. 
Using selective and non-selective inhibitors m the presence and absence of 
isoproterenol, I found that both PDE3 and PDE4 appeared to be involved in 
modulating lipogenesis. Other fIndings have indicated that more than one POE 
enzyme is involved in the regulation of lipolysis, although PDE3 has the most effect 
(Arner et al., 1993). I found that none of the selective PDE enzyme inhibitors used, 
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either together or individually, had as much of an effect on lipogenesis as IDMX (a 
non-selective POE inhibitor) had. However, in. the presence of isoproterenol, the 
combination of POE3 and.POE4 inhibitors achieved a similar effect on lipogenesis as 
the non-specific inhibitor, IDMX. Thus, the .pool of cyclic AMP involved in the 
inhibition of lipogenesis may be different to the one involved in the stimulation of 
lipolysi~ by catecholamines .. 
The failure of the antilipolytic system of adipocytes to develop during adipogenesis 
and the poor response of the differentiated 3T3-F442A adipocytes to insulin and also 
GH truncated my ambitions to investigate the intracellular signalling system, in 
particular the role for specific isoforms of PKC, in the chronic metabolic effects of 
GH and also insulin. The study has, however, shown that effects of GH on adipocytes 
are not mediated by TNF a. Furthe~ore, effects of a number of factors on the 
development of the lipolytic system of ovine adipocytes have been identified, and a 
role for both PDE3 and PDE4 enzymes in the modulation of lipogenesis has been 
demonstrated. For the future, it may be possible to use differentiated ovine pre-
adipocytes to further explore the roles of PKC isoforms in the control of lipogenesis 
by GH and insulin, as these cells have a much greater response (IO-foid in the case of 
insulin) to the honnones than 3T3-F442A adipocytes. However, whether the ovine 
cells are susceptible to antisense manipulation is not known, and the appropriate 
oligonucleotide sequences for such studies would need to be defmed. Whether a 
suitable cell culture system for investigating the effects of GH in the response to· 
adenosine can be established remains uncertain as the reason for the lack of response 
to adenosine requires to be determined first. 
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